data_1nku_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nku _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.433 ' NH2' ' CD1' ' A' ' 14' ' ' ILE . 13.3 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.367 0.604 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.433 ' CD1' ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 69' ' ' ALA . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 68' ' ' VAL . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.639 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' C ' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' ALA . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 95' ' ' ILE . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.427 ' H ' ' HG ' ' A' ' 142' ' ' SER . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.427 ' HG ' ' H ' ' A' ' 139' ' ' THR . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 175' ' ' HIS . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG22 HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.409 HD21 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.631 ' C ' ' H ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG11 HE21 ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.702 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.405 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.403 HE21 HG11 ' A' ' 76' ' ' VAL . 92.0 mm-40 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.504 ' O ' ' OG ' ' A' ' 118' ' ' SER . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 9.8 m170 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 142' ' ' SER . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.545 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.646 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.545 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HZ1' ' A' ' 91' ' ' LYS . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 48' ' ' THR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.72 ' HZ1' ' NE2' ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 92' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.447 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 130' ' ' THR . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.495 ' H ' ' HG ' ' A' ' 142' ' ' SER . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 5' ' ' GLY . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 52' ' ' LYS . 26.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 40' ' ' GLN . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 82' ' ' ASP . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 86' ' ' ILE . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.444 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.549 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 176' ' ' VAL . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.668 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.482 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 36' ' ' CYS . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' N ' HG22 ' A' ' 35' ' ' ILE . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.6 pp0? -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.47 ' CD2' ' NH2' ' A' ' 53' ' ' ARG . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.711 HH12 ' CD2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.711 ' CD2' HH12 ' A' ' 57' ' ' ARG . 56.1 t60 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' ILE . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 86' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 92' ' ' ILE . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.694 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 20.5 m120 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 61.4 tp60 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.532 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.602 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.557 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.694 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.557 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.676 ' CG2' ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.676 ' H ' ' CG2' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.574 ' CG1' ' H ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.574 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 48.0 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' VAL . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.452 HG21 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.452 ' H ' HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 142' ' ' SER . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.511 ' H ' ' HG1' ' A' ' 139' ' ' THR . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 98' ' ' ASN . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.479 ' O ' ' OG ' ' A' ' 146' ' ' SER . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.594 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.594 ' N ' ' HG1' ' A' ' 160' ' ' THR . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.492 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.622 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.472 HH21 ' CD1' ' A' ' 14' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' SER . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.475 ' OH ' ' CZ2' ' A' ' 21' ' ' TRP . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 ' CD1' HH21 ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.475 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.551 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.428 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HZ1' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 83' ' ' ALA . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.598 ' H ' ' C ' ' A' ' 84' ' ' GLY . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 92' ' ' ILE . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 95' ' ' ILE . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.563 ' C ' ' CD1' ' A' ' 156' ' ' PHE . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.261 0.553 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' ALA . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.442 ' CH2' ' OG ' ' A' ' 164' ' ' SER . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.713 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.461 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 96' ' ' ILE . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 108' ' ' ASN . 3.0 m120 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.435 HE21 ' HB ' ' A' ' 177' ' ' VAL . 20.0 tp60 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.454 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.531 ' N ' ' HG ' ' A' ' 146' ' ' SER . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.442 ' OG ' ' CH2' ' A' ' 46' ' ' TRP . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.44 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 176' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.608 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.44 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 3' ' ' ARG . 3.5 ttt-85 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.502 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.418 HG23 HD13 ' A' ' 14' ' ' ILE . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.612 HE21 ' NZ ' ' A' ' 91' ' ' LYS . 40.4 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 53' ' ' ARG . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG1' ' A' ' 68' ' ' VAL . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.441 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.569 ' H ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.709 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.709 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.45 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.612 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 96' ' ' ILE . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.484 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.484 ' N ' ' HG ' ' A' ' 133' ' ' SER . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.49 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.735 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' OE2' ' CD ' ' A' ' 30' ' ' LYS . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.498 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.435 ' OH ' ' OE1' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.584 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 86' ' ' ILE . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.6 HD21 ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.401 HE21 ' CA ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' H ' HG23 ' A' ' 160' ' ' THR . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.735 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 31.3 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 171' ' ' LEU . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.6 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 178' ' ' GLY . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.6 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' SER . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' LEU . 32.0 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.446 ' HA ' HE21 ' A' ' 41' ' ' GLN . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HZ1' HG12 ' A' ' 86' ' ' ILE . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.599 HH11 ' CD2' ' A' ' 61' ' ' HIS . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' HH11 ' A' ' 57' ' ' ARG . 5.7 t-80 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 86' ' ' ILE . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 118' ' ' SER . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.524 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 4.5 t-20 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 121' ' ' ASN . 1.4 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.587 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' A' ' 5' ' ' GLY . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.734 ' HE1' HE21 ' A' ' 167' ' ' GLN . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.457 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 84' ' ' GLY . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.55 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.413 ' HA ' HD21 ' A' ' 98' ' ' ASN . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.439 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' O ' ' OG ' ' A' ' 118' ' ' SER . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.49 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' GLY . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.734 HE21 ' HE1' ' A' ' 21' ' ' TRP . 33.8 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.42 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.427 ' CD2' ' CZ2' ' A' ' 117' ' ' TRP . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.686 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 14' ' ' ILE . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.695 ' HG ' ' HH ' ' A' ' 102' ' ' TYR . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HZ1' HG13 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.731 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.731 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.642 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.496 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.566 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 HG13 ' HZ1' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 96' ' ' ILE . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.695 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 118' ' ' SER . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.1 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.587 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HZ1' ' A' ' 91' ' ' LYS . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 48' ' ' THR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.72 ' HZ1' ' NE2' ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 92' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.447 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 130' ' ' THR . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.495 ' H ' ' HG ' ' A' ' 142' ' ' SER . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.563 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 53' ' ' ARG . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.719 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.719 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 43.5 t60 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.663 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HZ2' ' CB ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 95' ' ' ILE . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 158' ' ' GLY . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.564 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.419 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.463 ' CG1' ' H ' ' A' ' 179' ' ' CYS . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.623 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 169' ' ' CYS . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.477 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' ALA . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.489 ' N ' ' HG ' ' A' ' 118' ' ' SER . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.546 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 158' ' ' GLY . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.546 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.511 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.54 ' CE2' ' SD ' ' A' ' 166' ' ' MET . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.513 ' N ' ' SD ' ' A' ' 34' ' ' MET . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.459 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.572 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.562 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 14' ' ' ILE . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' CYS . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.614 ' CG ' ' HE2' ' A' ' 88' ' ' HIS . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 44' ' ' LEU . 47.2 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.406 ' N ' HE21 ' A' ' 41' ' ' GLN . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.408 ' HG2' ' H ' ' A' ' 72' ' ' GLN . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 71' ' ' MET . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.649 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.614 ' HE2' ' CG ' ' A' ' 40' ' ' GLN . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 122' ' ' HIS . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CD1' ' OD1' ' A' ' 98' ' ' ASN . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' GLY . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.488 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.61 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.583 ' O ' ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 4' ' ' CYS . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.569 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.433 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.459 HE21 ' CB ' ' A' ' 74' ' ' GLU . 21.4 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' CB ' HE21 ' A' ' 72' ' ' GLN . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' ASP . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' LEU . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.569 ' OD1' ' SG ' ' A' ' 59' ' ' CYS . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.531 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.2 m-70 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 92' ' ' ILE . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' O ' ' OG ' ' A' ' 118' ' ' SER . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.474 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.565 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.565 ' N ' ' HG1' ' A' ' 160' ' ' THR . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.508 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.508 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' CYS . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' VAL . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.494 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' ' CE3' ' A' ' 46' ' ' TRP . 25.4 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.619 HH21 ' CD2' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CD2' HH21 ' A' ' 57' ' ' ARG . 52.0 t-80 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.606 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.408 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 132' ' ' LEU . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.403 ' H ' HG23 ' A' ' 131' ' ' THR . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.496 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.407 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.496 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.471 ' OD1' ' CD2' ' A' ' 182' ' ' TYR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.7 t80 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.633 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 8' ' ' SER . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.442 ' CD1' ' NE2' ' A' ' 9' ' ' GLN . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.685 ' NZ ' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.464 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.685 ' NH1' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' CD1' ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 18.4 m120 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CZ2' ' CD2' ' A' ' 171' ' ' LEU . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.411 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 37.2 mm-40 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 132' ' ' LEU . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.677 ' H ' ' HG1' ' A' ' 131' ' ' THR . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.446 ' N ' ' HG ' ' A' ' 133' ' ' SER . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.425 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.425 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.607 ' O ' ' N ' ' A' ' 169' ' ' CYS . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 165' ' ' PHE . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' CD2' ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.414 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.411 ' OH ' ' NE2' ' A' ' 128' ' ' GLN . 10.8 t80 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CG ' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' A' ' 8' ' ' SER . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 20' ' ' GLU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 41' ' ' GLN . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' HZ1' ' CD1' ' A' ' 86' ' ' ILE . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.678 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.74 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 82.5 t60 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.513 ' C ' ' NH1' ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.513 ' NH1' ' C ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.685 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 10.4 m-70 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.621 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.3 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.477 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HG ' HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 26.7 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' NZ ' ' NE2' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 49' ' ' VAL . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.417 ' CG2' ' HH ' ' A' ' 163' ' ' TYR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.674 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.442 ' CG2' ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.674 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.505 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 139' ' ' THR . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.519 ' CD1' ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 158' ' ' GLY . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HH ' ' CG2' ' A' ' 135' ' ' ILE . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.401 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.633 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' OH ' ' CZ2' ' A' ' 21' ' ' TRP . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.758 ' HE1' HE21 ' A' ' 167' ' ' GLN . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 41' ' ' GLN . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' CZ2' ' NE2' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.531 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.578 HH11 ' CD2' ' A' ' 61' ' ' HIS . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.578 ' CD2' HH11 ' A' ' 57' ' ' ARG . 2.1 t60 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HZ2' ' A' ' 91' ' ' LYS . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HZ2' HG22 ' A' ' 86' ' ' ILE . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 117' ' ' TRP . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 122' ' ' HIS . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.469 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.569 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.48 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.758 HE21 ' HE1' ' A' ' 21' ' ' TRP . 40.9 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 182' ' ' TYR . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.319 0.58 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.414 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' OE1' ' CE3' ' A' ' 46' ' ' TRP . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.579 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 86' ' ' ILE . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 1.7 t60 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.414 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 4' ' ' CYS . 43.3 ttm180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.328 0.585 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 HH11 ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.555 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE1' ' OE1' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.575 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' CD2' HH21 ' A' ' 57' ' ' ARG . 65.4 t-80 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.663 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' OD1' ' OE1' ' A' ' 110' ' ' GLU . 22.5 t-20 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' OE1' ' OD1' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.492 ' O ' ' OG ' ' A' ' 118' ' ' SER . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.539 ' N ' ' HG ' ' A' ' 118' ' ' SER . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.555 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.91 151.45 33.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.069 -1.019 . . . . 0.0 109.338 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' NH2' ' CD1' ' A' ' 14' ' ' ILE . 13.3 ptm180 -141.88 164.7 29.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' CD1' ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 69' ' ' ALA . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 68' ' ' VAL . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.639 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' C ' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' ALA . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 95' ' ' ILE . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.427 ' H ' ' HG ' ' A' ' 142' ' ' SER . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.427 ' HG ' ' H ' ' A' ' 139' ' ' THR . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 175' ' ' HIS . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 -106.87 102.22 41.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.09 -63.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.314 2.01 . . . . 0.0 112.115 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.06 -2.62 66.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -173.35 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -1.183 . . . . 0.0 109.607 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -138.25 83.5 21.77 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.738 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.507 2.138 . . . . 0.0 112.35 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.673 ' H2 ' HH12 ' A' ' 3' ' ' ARG . 13.4 ptp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -88.19 148.83 24.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.673 HH12 ' H2 ' ' A' ' 1' ' ' MET . 10.2 mpt_? -108.84 172.04 7.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -0.799 . . . . 0.0 109.81 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG22 HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.409 HD21 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.631 ' C ' ' H ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG11 HE21 ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.702 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.405 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.403 HE21 HG11 ' A' ' 76' ' ' VAL . 92.0 mm-40 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.504 ' O ' ' OG ' ' A' ' 118' ' ' SER . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 9.8 m170 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 142' ' ' SER . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.545 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.646 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.545 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 -123.8 83.68 54.39 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.6 Cg_endo -80.58 -63.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.739 2.293 . . . . 0.0 112.132 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.28 -14.59 2.27 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 183' ' ' PRO . 16.7 m120 -91.5 1.25 57.26 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.439 -1.036 . . . . 0.0 108.602 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -141.39 158.41 63.77 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.597 2.198 . . . . 0.0 112.224 179.901 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HZ1' ' A' ' 91' ' ' LYS . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 48' ' ' THR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.72 ' HZ1' ' NE2' ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 92' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.447 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 130' ' ' THR . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.495 ' H ' ' HG ' ' A' ' 142' ' ' SER . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.506 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.435 0.636 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.9 152.41 45.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.923 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -123.17 152.08 41.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.559 -0.713 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 5' ' ' GLY . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 52' ' ' LYS . 26.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 40' ' ' GLN . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 82' ' ' ASP . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 86' ' ' ILE . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.444 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.549 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 176' ' ' VAL . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.668 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.482 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 -118.92 80.05 17.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.78 -20.48 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.662 2.241 . . . . 0.0 111.932 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.27 71.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.33 42.65 24.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 0.0 109.439 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -128.74 80.72 72.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.515 -0.741 . . . . 0.0 109.217 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.794 2.329 . . . . 0.0 111.997 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 24.4 pt-20 -104.62 162.42 13.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.691 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 -140.36 179.0 6.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 109.639 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 36' ' ' CYS . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' N ' HG22 ' A' ' 35' ' ' ILE . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.6 pp0? -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.47 ' CD2' ' NH2' ' A' ' 53' ' ' ARG . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.711 HH12 ' CD2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.711 ' CD2' HH12 ' A' ' 57' ' ' ARG . 56.1 t60 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' ILE . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 86' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 92' ' ' ILE . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.694 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 20.5 m120 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 61.4 tp60 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.532 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.602 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.557 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.694 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.557 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.676 ' CG2' ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.676 ' H ' ' CG2' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 -123.37 82.23 52.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.64 -69.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.64 65.29 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -135.31 19.27 3.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -1.084 . . . . 0.0 109.393 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -132.38 151.12 77.7 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.651 -0.656 . . . . 0.0 109.297 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.561 2.174 . . . . 0.0 112.282 179.736 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 178' ' ' GLY . 1.1 pt-20 -103.8 154.5 19.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.9 163.51 12.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.096 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' CG1' ' H ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.574 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 48.0 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' VAL . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.452 HG21 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.452 ' H ' HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 142' ' ' SER . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.511 ' H ' ' HG1' ' A' ' 139' ' ' THR . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 98' ' ' ASN . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.479 ' O ' ' OG ' ' A' ' 146' ' ' SER . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.594 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.594 ' N ' ' HG1' ' A' ' 160' ' ' THR . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.492 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.622 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -122.25 83.79 46.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.3 -9.69 26.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.182 1.921 . . . . 0.0 112.18 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.54 24.12 37.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 57.14 44.7 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.491 -1.005 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -128.06 151.57 76.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.534 -0.729 . . . . 0.0 109.041 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 C-N-CA 122.37 2.047 . . . . 0.0 112.249 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.223 0.535 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -104.75 154.41 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 109.059 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.472 HH21 ' CD1' ' A' ' 14' ' ' ILE . 0.7 OUTLIER -148.66 166.68 27.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' SER . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.475 ' OH ' ' CZ2' ' A' ' 21' ' ' TRP . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 ' CD1' HH21 ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.475 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.551 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.428 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HZ1' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 83' ' ' ALA . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.598 ' H ' ' C ' ' A' ' 84' ' ' GLY . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 92' ' ' ILE . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 95' ' ' ILE . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.563 ' C ' ' CD1' ' A' ' 156' ' ' PHE . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 -91.98 115.72 65.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.46 -63.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.18 1.92 . . . . 0.0 112.564 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.37 25.54 56.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.0 t30 59.36 44.82 14.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.115 . . . . 0.0 109.385 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -105.43 151.61 39.75 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.585 2.19 . . . . 0.0 112.208 179.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -102.49 150.37 23.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.913 . . . . 0.0 109.517 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -143.48 168.92 18.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.587 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' ALA . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.442 ' CH2' ' OG ' ' A' ' 164' ' ' SER . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.713 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.461 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 96' ' ' ILE . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 108' ' ' ASN . 3.0 m120 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.435 HE21 ' HB ' ' A' ' 177' ' ' VAL . 20.0 tp60 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.454 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.531 ' N ' ' HG ' ' A' ' 146' ' ' SER . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.442 ' OG ' ' CH2' ' A' ' 46' ' ' TRP . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.44 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 176' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.608 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.44 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 -122.59 78.64 47.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.98 -13.29 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.889 2.392 . . . . 0.0 112.712 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 84.11 23.28 52.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 58.97 43.73 17.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -1.051 . . . . 0.0 109.617 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -131.03 79.79 70.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.346 -0.846 . . . . 0.0 109.367 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.929 2.42 . . . . 0.0 112.249 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.764 0.792 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 178' ' ' GLY . 39.7 mm-40 -142.0 162.22 36.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 3' ' ' ARG . 3.5 ttt-85 -123.95 153.25 41.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.502 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.418 HG23 HD13 ' A' ' 14' ' ' ILE . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.612 HE21 ' NZ ' ' A' ' 91' ' ' LYS . 40.4 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 53' ' ' ARG . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG1' ' A' ' 68' ' ' VAL . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.441 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.569 ' H ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.709 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.709 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.45 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.612 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 96' ' ' ILE . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.484 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.484 ' N ' ' HG ' ' A' ' 133' ' ' SER . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.49 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -119.8 84.93 32.69 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.85 -138.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.32 -7.07 59.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -135.69 26.75 3.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -1.082 . . . . 0.0 109.564 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 155.53 37.04 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 109.284 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.188 0.518 . . . . 0.0 109.64 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 78.9 mm-40 -130.63 155.09 47.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -127.27 150.78 49.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.735 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' OE2' ' CD ' ' A' ' 30' ' ' LYS . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.498 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.435 ' OH ' ' OE1' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.584 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 86' ' ' ILE . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.6 HD21 ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.401 HE21 ' CA ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' H ' HG23 ' A' ' 160' ' ' THR . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.735 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 31.3 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 171' ' ' LEU . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.6 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 2' ' ' GLU . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.6 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 -124.32 82.57 57.71 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.12 -69.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.63 2.22 . . . . 0.0 111.762 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.56 -11.62 71.69 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -143.71 20.83 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -1.202 . . . . 0.0 110.079 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -136.18 154.49 77.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.522 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 122.594 2.196 . . . . 0.0 112.187 179.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.04 141.76 43.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -144.27 155.8 44.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.05 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' SER . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' LEU . 32.0 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.446 ' HA ' HE21 ' A' ' 41' ' ' GLN . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HZ1' HG12 ' A' ' 86' ' ' ILE . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.599 HH11 ' CD2' ' A' ' 61' ' ' HIS . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' HH11 ' A' ' 57' ' ' ARG . 5.7 t-80 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 86' ' ' ILE . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 118' ' ' SER . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.524 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 4.5 t-20 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 121' ' ' ASN . 1.4 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.587 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -123.67 81.03 54.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -69.68 -23.04 31.58 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.79 2.326 . . . . 0.0 111.93 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 93.2 8.64 61.28 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 0.2 OUTLIER 69.44 19.07 7.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -1.011 . . . . 0.0 109.459 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -130.04 80.49 70.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.713 0 C-N-CA 122.851 2.368 . . . . 0.0 112.22 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.417 0.627 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -105.19 149.79 25.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.517 -0.739 . . . . 0.0 109.135 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -131.26 155.25 47.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 0.0 109.213 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' A' ' 5' ' ' GLY . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.734 ' HE1' HE21 ' A' ' 167' ' ' GLN . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.457 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 84' ' ' GLY . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.55 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.413 ' HA ' HD21 ' A' ' 98' ' ' ASN . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.439 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' O ' ' OG ' ' A' ' 118' ' ' SER . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.49 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' GLY . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.734 HE21 ' HE1' ' A' ' 21' ' ' TRP . 33.8 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.42 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.427 ' CD2' ' CZ2' ' A' ' 117' ' ' TRP . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.686 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 -124.04 81.82 56.69 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -69.9 -58.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.618 2.212 . . . . 0.0 112.034 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.4 -9.07 67.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -171.98 16.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -147.28 80.02 9.48 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.236 179.905 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.623 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.41 158.83 16.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.741 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 -113.49 160.05 18.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.128 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 14' ' ' ILE . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.695 ' HG ' ' HH ' ' A' ' 102' ' ' TYR . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HZ1' HG13 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.731 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.731 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.642 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.496 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.566 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 HG13 ' HZ1' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 96' ' ' ILE . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.695 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 118' ' ' SER . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.1 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.623 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.83 80.67 56.17 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.67 -25.09 24.77 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.751 2.301 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.32 65.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 58.9 42.06 20.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.44 -1.035 . . . . 0.0 109.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -87.86 150.02 47.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.209 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 C-N-CA 122.337 2.025 . . . . 0.0 112.163 179.908 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HZ1' ' A' ' 91' ' ' LYS . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 48' ' ' THR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.72 ' HZ1' ' NE2' ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 92' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.447 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 130' ' ' THR . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.495 ' H ' ' HG ' ' A' ' 142' ' ' SER . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.506 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.612 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 62.7 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.372 0.606 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -110.49 149.84 29.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.531 -0.731 . . . . 0.0 109.614 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.96 151.92 44.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.187 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.563 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 53' ' ' ARG . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.719 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.719 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 43.5 t60 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.663 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HZ2' ' CB ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 95' ' ' ILE . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 158' ' ' GLY . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.564 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.419 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.463 ' CG1' ' H ' ' A' ' 179' ' ' CYS . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.623 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.612 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -103.06 113.47 65.85 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.05 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.051 1.834 . . . . 0.0 112.187 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . 94.66 -1.24 65.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 11.7 m-20 -177.77 28.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.292 . . . . 0.0 110.037 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.34 80.4 58.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.296 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.821 2.347 . . . . 0.0 112.325 -179.955 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 6.4 tpp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.294 0.569 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' H ' ' CG ' ' A' ' 1' ' ' MET . 83.2 tt0 -96.44 147.51 23.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.235 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 -100.53 156.86 17.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 169' ' ' CYS . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.477 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' ALA . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.489 ' N ' ' HG ' ' A' ' 118' ' ' SER . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.546 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 158' ' ' GLY . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.546 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.511 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.54 ' CE2' ' SD ' ' A' ' 166' ' ' MET . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.513 ' N ' ' SD ' ' A' ' 34' ' ' MET . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.459 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.572 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.562 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 -121.52 80.25 38.54 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -83.14 -51.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.036 2.49 . . . . 0.0 112.15 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.29 65.73 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.8 36.88 28.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.424 -1.045 . . . . 0.0 109.212 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -147.66 80.4 9.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.295 . . . . 0.0 112.283 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' OE1' ' O ' ' A' ' 178' ' ' GLY . 94.7 mt-10 -104.54 155.47 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.563 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -119.92 155.65 32.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 14' ' ' ILE . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' CYS . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.614 ' CG ' ' HE2' ' A' ' 88' ' ' HIS . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 44' ' ' LEU . 47.2 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.406 ' N ' HE21 ' A' ' 41' ' ' GLN . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HG2' ' H ' ' A' ' 72' ' ' GLN . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 71' ' ' MET . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.649 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.614 ' HE2' ' CG ' ' A' ' 40' ' ' GLN . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 122' ' ' HIS . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CD1' ' OD1' ' A' ' 98' ' ' ASN . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 158' ' ' GLY . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.488 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.61 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.583 ' O ' ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.481 ' O ' ' OE1' ' A' ' 2' ' ' GLU . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 -119.77 80.72 24.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.698 2.265 . . . . 0.0 112.556 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.63 25.78 37.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 m120 60.34 46.58 9.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.497 -1.002 . . . . 0.0 109.709 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -123.72 80.59 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.501 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.835 2.357 . . . . 0.0 112.315 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.704 0.764 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 50.4 tp10 -143.7 148.02 35.12 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.625 -0.672 . . . . 0.0 109.386 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 -117.75 158.13 25.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 0.0 109.269 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 4' ' ' CYS . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.569 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.433 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.459 HE21 ' CB ' ' A' ' 74' ' ' GLU . 21.4 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' CB ' HE21 ' A' ' 72' ' ' GLN . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' ASP . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' LEU . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.569 ' OD1' ' SG ' ' A' ' 59' ' ' CYS . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.531 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.2 m-70 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 92' ' ' ILE . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' O ' ' OG ' ' A' ' 118' ' ' SER . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.474 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.565 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.565 ' N ' ' HG1' ' A' ' 160' ' ' THR . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.508 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.508 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' CYS . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' VAL . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 -120.01 83.23 30.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.57 31.72 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.907 2.405 . . . . 0.0 112.329 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.48 26.04 48.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.0 t30 61.79 42.98 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.387 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.87 80.25 73.07 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.234 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.306 -1.66 0 C-N-CA 122.757 2.305 . . . . 0.0 112.128 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.542 0.687 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -119.95 160.6 22.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.767 -0.583 . . . . 0.0 109.766 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 -118.96 149.26 41.91 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.494 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' ' CE3' ' A' ' 46' ' ' TRP . 25.4 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.619 HH21 ' CD2' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CD2' HH21 ' A' ' 57' ' ' ARG . 52.0 t-80 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.606 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.408 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 132' ' ' LEU . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.403 ' H ' HG23 ' A' ' 131' ' ' THR . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.496 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.407 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.496 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.471 ' OD1' ' CD2' ' A' ' 182' ' ' TYR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 42.7 t80 -72.21 123.33 89.34 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.606 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 73.4 Cg_endo -78.28 -172.7 1.57 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.377 2.051 . . . . 0.0 112.902 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.08 -3.53 60.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' OD1' ' A' ' 185' ' ' ASN . 24.7 p30 -94.2 13.01 24.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -1.058 . . . . 0.0 109.43 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -109.24 151.62 42.14 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.312 -1.344 0 C-N-CA 122.43 2.087 . . . . 0.0 112.161 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.641 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.6 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' H ' ' CG ' ' A' ' 1' ' ' MET . 81.1 mt-10 -91.82 147.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.02 . . . . 0.0 109.719 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.633 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -134.93 151.56 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 109.005 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 8' ' ' SER . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.442 ' CD1' ' NE2' ' A' ' 9' ' ' GLN . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.685 ' NZ ' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.464 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.685 ' NH1' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' CD1' ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 18.4 m120 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CZ2' ' CD2' ' A' ' 171' ' ' LEU . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.411 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 37.2 mm-40 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 132' ' ' LEU . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.677 ' H ' ' HG1' ' A' ' 131' ' ' THR . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.446 ' N ' ' HG ' ' A' ' 133' ' ' SER . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.425 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.425 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.607 ' O ' ' N ' ' A' ' 169' ' ' CYS . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 165' ' ' PHE . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 ' CD2' ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.414 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.423 ' O ' ' OE1' ' A' ' 2' ' ' GLU . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.641 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.411 ' OH ' ' NE2' ' A' ' 128' ' ' GLN . 10.8 t80 -119.71 90.61 43.62 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.29 -64.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.268 1.979 . . . . 0.0 111.52 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.15 -13.38 15.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -118.45 10.91 12.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -1.017 . . . . 0.0 109.606 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -148.38 155.95 42.58 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.479 -0.763 . . . . 0.0 109.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.609 2.206 . . . . 0.0 112.176 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 tpp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.57 153.8 22.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CG ' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 -118.04 164.86 14.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.487 -0.758 . . . . 0.0 109.468 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' A' ' 8' ' ' SER . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 20' ' ' GLU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 41' ' ' GLN . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' HZ1' ' CD1' ' A' ' 86' ' ' ILE . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.678 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.74 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 82.5 t60 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.513 ' C ' ' NH1' ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.513 ' NH1' ' C ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.685 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 10.4 m-70 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 183' ' ' PRO . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.621 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -122.2 83.96 45.86 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 3.0 Cg_exo -72.36 -74.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.762 2.308 . . . . 0.0 111.672 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.492 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 89.67 -13.93 62.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 83.4 m-20 -149.33 30.25 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -1.224 . . . . 0.0 109.85 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -123.66 80.82 55.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 C-N-CA 122.878 2.385 . . . . 0.0 112.277 -179.779 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -109.14 161.59 15.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 108.951 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -122.69 153.83 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 109.618 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.3 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.443 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.477 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HG ' HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 26.7 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' NZ ' ' NE2' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 49' ' ' VAL . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.417 ' CG2' ' HH ' ' A' ' 163' ' ' TYR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.674 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.442 ' CG2' ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.674 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.505 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 139' ' ' THR . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.519 ' CD1' ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 158' ' ' GLY . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HH ' ' CG2' ' A' ' 135' ' ' ILE . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.401 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.633 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 -122.81 82.75 49.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.5 Cg_endo -80.81 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.634 2.223 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.57 -14.72 1.8 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 183' ' ' PRO . 37.6 t-20 -90.22 1.95 55.91 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.376 -1.073 . . . . 0.0 108.759 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -108.82 156.87 38.2 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 122.813 2.342 . . . . 0.0 112.315 179.875 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 178' ' ' GLY . 20.5 pt-20 -117.42 148.45 41.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.78 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 -125.64 159.89 31.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' OH ' ' CZ2' ' A' ' 21' ' ' TRP . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.758 ' HE1' HE21 ' A' ' 167' ' ' GLN . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 41' ' ' GLN . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' CZ2' ' NE2' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.531 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.578 HH11 ' CD2' ' A' ' 61' ' ' HIS . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.578 ' CD2' HH11 ' A' ' 57' ' ' ARG . 2.1 t60 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HZ2' ' A' ' 91' ' ' LYS . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HZ2' HG22 ' A' ' 86' ' ' ILE . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 117' ' ' TRP . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 122' ' ' HIS . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.469 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.569 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.48 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.758 HE21 ' HE1' ' A' ' 21' ' ' TRP . 40.9 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 182' ' ' TYR . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' O ' ' OE2' ' A' ' 2' ' ' GLU . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 -123.88 86.65 53.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.17 -82.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.266 1.977 . . . . 0.0 111.976 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 83.61 3.24 89.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.01 24.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -1.207 . . . . 0.0 109.783 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -133.63 80.29 56.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 0.0 109.428 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.306 -1.663 0 C-N-CA 122.876 2.384 . . . . 0.0 112.362 -179.994 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 177' ' ' VAL . 19.8 pt-20 -76.29 150.83 36.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 -148.11 173.13 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.562 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.414 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' OE1' ' CE3' ' A' ' 46' ' ' TRP . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.579 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 86' ' ' ILE . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 1.7 t60 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.49 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 -123.72 79.46 56.09 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.2 -8.17 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.884 2.389 . . . . 0.0 112.174 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.496 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 82.09 24.77 54.15 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.5 OUTLIER 44.2 40.85 3.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.62 -0.929 . . . . 0.0 109.516 -179.707 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -125.99 80.44 67.68 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--N 1.306 -1.708 0 C-N-CA 122.937 2.425 . . . . 0.0 112.319 -179.975 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -76.43 143.69 40.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 4' ' ' CYS . 43.3 ttm180 -132.88 157.0 46.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.421 -0.8 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 HH11 ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.555 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE1' ' OE1' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.575 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' CD2' HH21 ' A' ' 57' ' ' ARG . 65.4 t-80 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.663 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' OD1' ' OE1' ' A' ' 110' ' ' GLU . 22.5 t-20 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' OE1' ' OD1' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.492 ' O ' ' OG ' ' A' ' 118' ' ' SER . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.539 ' N ' ' HG ' ' A' ' 118' ' ' SER . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.555 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 -124.22 81.51 57.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 185' ' ' ASN . 32.5 Cg_exo -53.78 -40.7 79.08 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.536 2.158 . . . . 0.0 112.007 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.49 -14.18 2.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 183' ' ' PRO . 11.4 p30 -159.54 21.56 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.974 -1.31 . . . . 0.0 109.893 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.09 83.82 9.96 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.567 2.178 . . . . 0.0 112.249 -179.83 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.849 ' NH2' HD13 ' A' ' 14' ' ' ILE . 13.3 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.367 0.604 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.71 HG11 ' CG1' ' A' ' 14' ' ' ILE . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 56' ' ' TYR . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 44' ' ' LEU . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 40' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' THR . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.498 HG21 HD22 ' A' ' 44' ' ' LEU . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 41' ' ' GLN . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.502 ' OD1' HG23 ' A' ' 85' ' ' ILE . 18.4 t-20 -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 68' ' ' VAL . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 65' ' ' PRO . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 68' ' ' VAL . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG12 HG22 ' A' ' 92' ' ' ILE . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 76' ' ' VAL . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG23 ' OD1' ' A' ' 55' ' ' ASN . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 76' ' ' VAL . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 68' ' ' VAL . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 171' ' ' LEU . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 37.4 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.617 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 149' ' ' LEU . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 120' ' ' VAL . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 125' ' ' GLN . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 178' ' ' GLY . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CE2' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 14' ' ' ILE . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 7' ' ' VAL . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 165' ' ' PHE . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 47' ' ' ILE . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.473 HD22 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' A' ' 85' ' ' ILE . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.598 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 76' ' ' VAL . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 56' ' ' TYR . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.725 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.435 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.598 ' OE1' HG21 ' A' ' 76' ' ' VAL . 19.6 mm100 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 103' ' ' LEU . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 112' ' ' PHE . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.498 ' N ' HG23 ' A' ' 116' ' ' VAL . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 123' ' ' GLN . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.521 ' H ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' A' ' 177' ' ' VAL . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 133' ' ' SER . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 6' ' ' TRP . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.431 ' H ' HG23 ' A' ' 131' ' ' THR . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.716 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB1' ' NH2' ' A' ' 152' ' ' ARG . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 149' ' ' LEU . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.531 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 127' ' ' THR . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 128' ' ' GLN . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.742 HE22 ' HB3' ' A' ' 91' ' ' LYS . 6.7 tp-100 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.742 ' HB3' HE22 ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 81.7 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 7' ' ' VAL . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 7' ' ' VAL . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.626 HD12 ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 156' ' ' PHE . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HE3' HD22 ' A' ' 12' ' ' LEU . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.583 ' CG ' HG22 ' A' ' 85' ' ' ILE . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.583 HG22 ' CG ' ' A' ' 55' ' ' ASN . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.45 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 149' ' ' LEU . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 145' ' ' LEU . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 160' ' ' THR . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.594 HE22 ' HH2' ' A' ' 6' ' ' TRP . 43.2 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 31' ' ' LEU . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 127' ' ' THR . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE2' HD22 ' A' ' 132' ' ' LEU . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.762 HG11 ' CD1' ' A' ' 13' ' ' TYR . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 12' ' ' LEU . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CD1' HG11 ' A' ' 7' ' ' VAL . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.438 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.782 ' NE1' HD21 ' A' ' 50' ' ' LEU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.782 HD21 ' NE1' ' A' ' 46' ' ' TRP . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.56 HH22 ' CE1' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.56 ' CE1' HH22 ' A' ' 57' ' ' ARG . 13.0 t-80 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' PHE . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 83' ' ' ALA . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' HG21 ' A' ' 80' ' ' VAL . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 88' ' ' HIS . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 76' ' ' VAL . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.542 ' OD1' ' CD2' ' A' ' 154' ' ' PHE . 80.9 m-20 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 172' ' ' VAL . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 6' ' ' TRP . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 159' ' ' THR . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.553 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.474 HD21 HD11 ' A' ' 149' ' ' LEU . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 145' ' ' LEU . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.542 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 161' ' ' ILE . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.515 HG21 ' OG ' ' A' ' 138' ' ' SER . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 156' ' ' PHE . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.553 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 125' ' ' GLN . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.84 HG22 ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.84 ' H ' HG22 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.557 ' HG3' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' HG12 ' A' ' 7' ' ' VAL . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.595 ' CE2' HD22 ' A' ' 132' ' ' LEU . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG13 ' N ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.801 ' N ' HG13 ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' HE1' ' A' ' 117' ' ' TRP . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD13 ' HG3' ' A' ' 53' ' ' ARG . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.7 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 37' ' ' LEU . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.896 ' OH ' HG21 ' A' ' 95' ' ' ILE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.486 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 96' ' ' ILE . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.732 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.896 HG21 ' OH ' ' A' ' 56' ' ' TYR . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' VAL . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.626 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 103' ' ' LEU . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 26' ' ' THR . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 6' ' ' TRP . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 149' ' ' LEU . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 157' ' ' VAL . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 157' ' ' VAL . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.705 ' SD ' HD12 ' A' ' 171' ' ' LEU . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.705 HD12 ' SD ' ' A' ' 166' ' ' MET . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 177' ' ' VAL . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.898 ' NH2' HD13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CE2' HD22 ' A' ' 132' ' ' LEU . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 9' ' ' GLN . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.876 ' H ' HG12 ' A' ' 7' ' ' VAL . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.898 HD13 ' NH2' ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.462 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 31' ' ' LEU . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 161' ' ' ILE . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.655 ' CE2' HD21 ' A' ' 50' ' ' LEU . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 13' ' ' TYR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.655 HD21 ' CE2' ' A' ' 46' ' ' TRP . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 64' ' ' ASP . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 80' ' ' VAL . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' VAL . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.714 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 85' ' ' ILE . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 86' ' ' ILE . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 116' ' ' VAL . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 6' ' ' TRP . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 145' ' ' LEU . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 145' ' ' LEU . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' HG13 ' A' ' 157' ' ' VAL . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 155' ' ' LYS . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 38' ' ' GLU . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 179' ' ' CYS . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.424 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.47 ' H ' HG23 ' A' ' 176' ' ' VAL . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.261 0.553 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.579 ' CE2' HD22 ' A' ' 132' ' ' LEU . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG11 ' CG1' ' A' ' 14' ' ' ILE . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 47' ' ' ILE . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG11 ' A' ' 7' ' ' VAL . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 25' ' ' GLU . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' OE1' ' A' ' 33' ' ' GLU . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 48' ' ' THR . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 12' ' ' LEU . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 44' ' ' LEU . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 41' ' ' GLN . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 47' ' ' ILE . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 86' ' ' ILE . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.752 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.752 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.415 ' O ' HG22 ' A' ' 68' ' ' VAL . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.557 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.653 ' OE1' HG21 ' A' ' 76' ' ' VAL . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 68' ' ' VAL . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 103' ' ' LEU . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CH2' HD23 ' A' ' 171' ' ' LEU . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.579 HD22 ' CE2' ' A' ' 6' ' ' TRP . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.517 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 149' ' ' LEU . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.445 ' SD ' HG11 ' A' ' 172' ' ' VAL . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD23 ' CH2' ' A' ' 117' ' ' TRP . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.445 HG11 ' SD ' ' A' ' 166' ' ' MET . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.422 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.723 ' NH2' HG23 ' A' ' 14' ' ' ILE . 3.5 ttt-85 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 4' ' ' CYS . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.723 HG23 ' NH2' ' A' ' 3' ' ' ARG . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 23' ' ' VAL . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.497 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 41' ' ' GLN . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.586 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 80' ' ' VAL . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.525 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.68 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.658 HG22 HG22 ' A' ' 76' ' ' VAL . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 116' ' ' VAL . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' PHE . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' CH2' HD23 ' A' ' 171' ' ' LEU . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 132' ' ' LEU . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.466 ' N ' HG22 ' A' ' 131' ' ' THR . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.737 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.765 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' CH2' ' A' ' 117' ' ' TRP . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 129' ' ' ALA . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.579 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HZ2' ' HG3' ' A' ' 30' ' ' LYS . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 113' ' ' ALA . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 53' ' ' ARG . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.478 ' NE1' HD21 ' A' ' 50' ' ' LEU . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 41' ' ' GLN . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.478 HD21 ' NE1' ' A' ' 46' ' ' TRP . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG3' HD13 ' A' ' 37' ' ' LEU . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HH ' ' CD ' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' HZ2' ' A' ' 52' ' ' LYS . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.659 HD21 ' HE2' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 145' ' ' LEU . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 132' ' ' LEU . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 116' ' ' VAL . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.659 ' HE2' HD21 ' A' ' 98' ' ' ASN . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 160' ' ' THR . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.57 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 178' ' ' GLY . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.57 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.724 HG13 ' CG1' ' A' ' 14' ' ' ILE . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.724 ' CG1' HG13 ' A' ' 7' ' ' VAL . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 169' ' ' CYS . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 168' ' ' ALA . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 42' ' ' ALA . 21.2 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.411 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.64 HG12 ' HB1' ' A' ' 83' ' ' ALA . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 95' ' ' ILE . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.673 HD21 ' HE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.503 ' CH2' HD23 ' A' ' 171' ' ' LEU . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 122' ' ' HIS . 2.5 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.455 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 149' ' ' LEU . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 145' ' ' LEU . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.673 ' HE2' HD21 ' A' ' 98' ' ' ASN . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.404 ' CD1' HG12 ' A' ' 35' ' ' ILE . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 34' ' ' MET . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.503 HD23 ' CH2' ' A' ' 117' ' ' TRP . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.812 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 14' ' ' ILE . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.691 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 102' ' ' TYR . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 161' ' ' ILE . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.692 HG21 HD12 ' A' ' 44' ' ' LEU . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' ILE . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.511 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 96' ' ' ILE . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 76' ' ' VAL . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 85' ' ' ILE . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 55' ' ' ASN . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HG2' HH11 ' A' ' 87' ' ' ARG . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB2' HG22 ' A' ' 80' ' ' VAL . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 95' ' ' ILE . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 92' ' ' ILE . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 68' ' ' VAL . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.563 ' CH2' HD23 ' A' ' 171' ' ' LEU . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.526 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 155' ' ' LYS . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 38' ' ' GLU . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.816 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.583 HE22 ' HH2' ' A' ' 6' ' ' TRP . 25.5 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.816 HD12 ' SD ' ' A' ' 166' ' ' MET . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.66 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 127' ' ' THR . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 129' ' ' ALA . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 4' ' ' CYS . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 12' ' ' LEU . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.587 HD23 HG21 ' A' ' 48' ' ' THR . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.587 HG21 HD23 ' A' ' 44' ' ' LEU . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.561 ' HZ3' HD12 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.745 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.745 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 64' ' ' ASP . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.531 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 80' ' ' VAL . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 76' ' ' VAL . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.733 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 80' ' ' VAL . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 76' ' ' VAL . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 171' ' ' LEU . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 37.9 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 38' ' ' GLU . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.504 HD23 ' CH2' ' A' ' 117' ' ' TRP . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 127' ' ' THR . 50.5 t-20 -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.742 HE22 ' HB3' ' A' ' 91' ' ' LYS . 6.7 tp-100 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.742 ' HB3' HE22 ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 81.7 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.807 ' C ' HD11 ' A' ' 132' ' ' LEU . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.611 ' CE2' HD22 ' A' ' 132' ' ' LEU . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HB3' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OD2' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' OD2' HG22 ' A' ' 14' ' ' ILE . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.889 ' CE3' ' HB2' ' A' ' 168' ' ' ALA . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' A' ' 161' ' ' ILE . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 86' ' ' ILE . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH1' ' ND1' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.518 ' ND1' ' NH1' ' A' ' 57' ' ' ARG . 8.0 t-80 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 64' ' ' ASP . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.407 ' CG2' HD11 ' A' ' 96' ' ' ILE . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.629 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.629 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.639 ' H ' HD12 ' A' ' 92' ' ' ILE . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.639 HD12 ' H ' ' A' ' 89' ' ' ARG . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 76' ' ' VAL . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 103' ' ' LEU . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.421 ' CH2' HD23 ' A' ' 171' ' ' LEU . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.807 HD11 ' C ' ' A' ' 5' ' ' GLY . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 145' ' ' LEU . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 161' ' ' ILE . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.552 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 158' ' ' GLY . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.889 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD23 ' CH2' ' A' ' 117' ' ' TRP . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.612 ' N ' HG13 ' A' ' 176' ' ' VAL . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.592 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 12' ' ' LEU . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.755 ' NE1' HD21 ' A' ' 50' ' ' LEU . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.526 HD12 HD12 ' A' ' 50' ' ' LEU . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.755 HD21 ' NE1' ' A' ' 46' ' ' TRP . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 85' ' ' ILE . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG13 ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 64' ' ' ASP . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 96' ' ' ILE . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 55' ' ' ASN . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 76' ' ' VAL . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' VAL . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.6 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.544 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 149' ' ' LEU . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.544 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.607 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD13 ' A' ' 171' ' ' LEU . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.852 HD13 ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 125' ' ' GLN . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.72 ' O ' HG12 ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.699 ' NH1' HD13 ' A' ' 14' ' ' ILE . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.71 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 4' ' ' CYS . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' NH1' ' A' ' 3' ' ' ARG . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 113' ' ' ALA . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 22.7 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HE1' HD21 ' A' ' 50' ' ' LEU . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 48' ' ' THR . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 47' ' ' ILE . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' GLN . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.586 HD21 ' HE1' ' A' ' 46' ' ' TRP . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.765 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 92' ' ' ILE . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.729 ' HD1' HG13 ' A' ' 92' ' ' ILE . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.729 HG13 ' HD1' ' A' ' 88' ' ' HIS . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 103' ' ' LEU . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 116' ' ' VAL . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 112' ' ' PHE . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.719 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 149' ' ' LEU . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 145' ' ' LEU . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.649 ' O ' HG13 ' A' ' 157' ' ' VAL . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 155' ' ' LYS . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 159' ' ' THR . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB2' ' HH2' ' A' ' 46' ' ' TRP . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 171' ' ' LEU . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 125' ' ' GLN . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 127' ' ' THR . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 176' ' ' VAL . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 177' ' ' VAL . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' HG12 ' A' ' 7' ' ' VAL . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 31' ' ' LEU . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 25' ' ' GLU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 55' ' ' ASN . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.536 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 71' ' ' MET . 9.2 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 80' ' ' VAL . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 83' ' ' ALA . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.2 m80 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.491 ' CG2' HG22 ' A' ' 76' ' ' VAL . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.618 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' H ' ' A' ' 123' ' ' GLN . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.536 ' H ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.548 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.586 ' CE2' HD22 ' A' ' 132' ' ' LEU . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 47' ' ' ILE . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' CB ' ' A' ' 113' ' ' ALA . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.704 HD13 ' HG3' ' A' ' 53' ' ' ARG . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.647 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.688 ' NE2' ' CE3' ' A' ' 46' ' ' TRP . 81.8 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.688 ' CE3' ' NE2' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 12' ' ' LEU . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 47' ' ' ILE . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 41' ' ' GLN . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' HD13 ' A' ' 37' ' ' LEU . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB3' HG22 ' A' ' 85' ' ' ILE . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 85' ' ' ILE . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 6.7 t60 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' N ' HG13 ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 76' ' ' VAL . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 71' ' ' MET . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 31' ' ' LEU . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.45 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.586 HD22 ' CE2' ' A' ' 6' ' ' TRP . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.721 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HB2' HG21 ' A' ' 157' ' ' VAL . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' A' ' 125' ' ' GLN . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 127' ' ' THR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.7 t80 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.836 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.672 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 4' ' ' CYS . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' ILE . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.504 ' HB2' HD13 ' A' ' 47' ' ' ILE . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.773 HD21 ' SG ' ' A' ' 169' ' ' CYS . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.711 HD13 ' CE2' ' A' ' 165' ' ' PHE . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.558 HD13 HD13 ' A' ' 86' ' ' ILE . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 12' ' ' LEU . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.49 ' N ' HG23 ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 46' ' ' TRP . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.715 ' HZ1' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.483 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 64' ' ' ASP . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.67 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.67 HG12 ' HB1' ' A' ' 83' ' ' ALA . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 44' ' ' LEU . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.869 ' HE ' HD11 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.869 HD11 ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.53 HD21 ' HA ' ' A' ' 95' ' ' ILE . 90.2 m-20 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 117' ' ' TRP . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.465 ' N ' HG23 ' A' ' 116' ' ' VAL . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG12 ' A' ' 172' ' ' VAL . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.672 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.619 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.456 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 35' ' ' ILE . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.45 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.773 ' SG ' HD21 ' A' ' 31' ' ' LEU . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD23 ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.45 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 177' ' ' VAL . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HG2' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CE2' HD22 ' A' ' 132' ' ' LEU . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 4' ' ' CYS . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 8' ' ' SER . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 12' ' ' LEU . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CG ' HD13 ' A' ' 50' ' ' LEU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 23' ' ' VAL . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 113' ' ' ALA . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 56' ' ' TYR . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 41' ' ' GLN . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 16' ' ' TYR . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 51' ' ' LYS . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.683 HG13 HG21 ' A' ' 92' ' ' ILE . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 80' ' ' VAL . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.594 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.698 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.754 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.754 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 35.2 t-80 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.683 HG21 HG13 ' A' ' 76' ' ' VAL . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 117' ' ' TRP . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' VAL . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 21.2 t-20 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.599 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 6' ' ' TRP . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.764 ' HB1' HH12 ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.764 HH12 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.68 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.68 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 125' ' ' GLN . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.432 ' O ' HG22 ' A' ' 127' ' ' THR . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 176' ' ' VAL . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.625 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.6 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' HD13 ' A' ' 47' ' ' ILE . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.429 ' N ' HG23 ' A' ' 47' ' ' ILE . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 41' ' ' GLN . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' LEU . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 53' ' ' ARG . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 92' ' ' ILE . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HA ' HD12 ' A' ' 92' ' ' ILE . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 76' ' ' VAL . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.525 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 132' ' ' LEU . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 137' ' ' THR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.644 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.576 HG23 ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 155' ' ' LYS . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 125' ' ' GLN . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 127' ' ' THR . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.617 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.589 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.694 ' CE2' HD22 ' A' ' 132' ' ' LEU . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.548 ' CD1' HG22 ' A' ' 7' ' ' VAL . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.579 ' CG1' HG11 ' A' ' 7' ' ' VAL . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 165' ' ' PHE . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 37' ' ' LEU . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.47 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 95' ' ' ILE . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' OE1' ' OE1' ' A' ' 38' ' ' GLU . 7.3 pt20 -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 HG21 ' A' ' 48' ' ' THR . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.472 ' CZ2' ' OE1' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.621 HG21 HD23 ' A' ' 44' ' ' LEU . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.551 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 85' ' ' ILE . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 57' ' ' ARG . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 2.0 t-160 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 79' ' ' LEU . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' VAL . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.694 HG22 ' CG ' ' A' ' 55' ' ' ASN . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG21 HG13 ' A' ' 76' ' ' VAL . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.832 HD11 ' NE2' ' A' ' 40' ' ' GLN . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.56 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 116' ' ' VAL . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' PHE . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' N ' HG23 ' A' ' 116' ' ' VAL . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.684 ' HB2' HG12 ' A' ' 172' ' ' VAL . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.443 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 6' ' ' TRP . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.605 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' A' ' 157' ' ' VAL . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.47 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.516 ' SD ' HD22 ' A' ' 171' ' ' LEU . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.472 ' OE1' ' CZ2' ' A' ' 46' ' ' TRP . 17.6 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' A' ' 166' ' ' MET . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.943 ' O ' HG13 ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.477 ' H ' HG23 ' A' ' 176' ' ' VAL . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.319 0.58 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CE3' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.535 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HB3' HG22 ' A' ' 49' ' ' VAL . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB2' HG21 ' A' ' 49' ' ' VAL . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 48' ' ' THR . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 48' ' ' THR . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 41' ' ' GLN . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.783 ' CG ' HG22 ' A' ' 85' ' ' ILE . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.586 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.586 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.675 ' O ' HG23 ' A' ' 68' ' ' VAL . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' PHE . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG22 ' CG2' ' A' ' 92' ' ' ILE . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.783 HG22 ' CG ' ' A' ' 55' ' ' ASN . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 87' ' ' ARG . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 86' ' ' ILE . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.412 ' CD2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.671 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 76' ' ' VAL . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' OE1' HG21 ' A' ' 76' ' ' VAL . 23.5 mm100 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.9 OUTLIER 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.635 HD13 ' CE3' ' A' ' 6' ' ' TRP . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.617 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' HG13 ' A' ' 157' ' ' VAL . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 155' ' ' LYS . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.535 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 177' ' ' VAL . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.721 ' NH1' HD13 ' A' ' 14' ' ' ILE . 43.3 ttm180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.328 0.585 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' NH1' ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.852 HD21 ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 87' ' ' ARG . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 3.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 9.6 t60 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.684 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 80' ' ' VAL . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' VAL . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.763 HG23 ' N ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.763 ' N ' HG23 ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.422 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.578 HG21 ' CE1' ' A' ' 60' ' ' PHE . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.684 HD11 ' SD ' ' A' ' 71' ' ' MET . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 21.8 t30 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.564 ' CH2' HD23 ' A' ' 171' ' ' LEU . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.609 ' HB2' HG12 ' A' ' 172' ' ' VAL . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 135' ' ' ILE . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.695 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 132' ' ' LEU . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 149' ' ' LEU . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.474 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.564 HD23 ' CH2' ' A' ' 117' ' ' TRP . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.609 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 127' ' ' THR . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.884 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.884 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' A' ' 2' ' ' GLU . 1.1 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 1' ' ' MET . 7.9 mm-40 -77.91 151.45 33.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.069 -1.019 . . . . 0.0 109.338 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.849 ' NH2' HD13 ' A' ' 14' ' ' ILE . 13.3 ptm180 -141.88 164.7 29.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.71 HG11 ' CG1' ' A' ' 14' ' ' ILE . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 56' ' ' TYR . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 44' ' ' LEU . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 40' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' THR . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.498 HG21 HD22 ' A' ' 44' ' ' LEU . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 41' ' ' GLN . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.502 ' OD1' HG23 ' A' ' 85' ' ' ILE . 18.4 t-20 -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 68' ' ' VAL . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 65' ' ' PRO . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 68' ' ' VAL . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG12 HG22 ' A' ' 92' ' ' ILE . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 76' ' ' VAL . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG23 ' OD1' ' A' ' 55' ' ' ASN . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 76' ' ' VAL . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 68' ' ' VAL . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 171' ' ' LEU . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 37.4 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.617 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 149' ' ' LEU . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 120' ' ' VAL . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 125' ' ' GLN . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 178' ' ' GLY . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 -106.87 102.22 41.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.09 -63.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.314 2.01 . . . . 0.0 112.115 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.06 -2.62 66.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -173.35 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -1.183 . . . . 0.0 109.607 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -138.25 83.5 21.77 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.738 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.507 2.138 . . . . 0.0 112.35 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' NH1' ' A' ' 3' ' ' ARG . 13.4 ptp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -88.19 148.83 24.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.582 ' NH1' ' O ' ' A' ' 1' ' ' MET . 10.2 mpt_? -108.84 172.04 7.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -0.799 . . . . 0.0 109.81 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CE2' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 14' ' ' ILE . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 7' ' ' VAL . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 165' ' ' PHE . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 47' ' ' ILE . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.473 HD22 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' A' ' 85' ' ' ILE . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.598 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 76' ' ' VAL . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 56' ' ' TYR . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.725 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.435 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.598 ' OE1' HG21 ' A' ' 76' ' ' VAL . 19.6 mm100 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 103' ' ' LEU . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 112' ' ' PHE . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.498 ' N ' HG23 ' A' ' 116' ' ' VAL . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 123' ' ' GLN . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.521 ' H ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' A' ' 177' ' ' VAL . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 133' ' ' SER . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 6' ' ' TRP . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.431 ' H ' HG23 ' A' ' 131' ' ' THR . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.716 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB1' ' NH2' ' A' ' 152' ' ' ARG . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 149' ' ' LEU . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.531 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 127' ' ' THR . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 128' ' ' GLN . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 -123.8 83.68 54.39 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.6 Cg_endo -80.58 -63.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.739 2.293 . . . . 0.0 112.132 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.28 -14.59 2.27 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 183' ' ' PRO . 75.9 m-20 -91.5 1.25 57.26 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.439 -1.036 . . . . 0.0 108.602 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -141.39 158.41 63.77 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.597 2.198 . . . . 0.0 112.224 179.901 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.742 HE22 ' HB3' ' A' ' 91' ' ' LYS . 6.7 tp-100 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.742 ' HB3' HE22 ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 81.7 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.435 0.636 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.9 152.41 45.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.923 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -123.17 152.08 41.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.559 -0.713 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 7' ' ' VAL . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 7' ' ' VAL . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.626 HD12 ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 156' ' ' PHE . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HE3' HD22 ' A' ' 12' ' ' LEU . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.583 ' CG ' HG22 ' A' ' 85' ' ' ILE . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.583 HG22 ' CG ' ' A' ' 55' ' ' ASN . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.45 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 149' ' ' LEU . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 145' ' ' LEU . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 160' ' ' THR . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.594 HE22 ' HH2' ' A' ' 6' ' ' TRP . 43.2 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 31' ' ' LEU . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 127' ' ' THR . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 -118.92 80.05 17.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.78 -20.48 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.662 2.241 . . . . 0.0 111.932 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.27 71.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.33 42.65 24.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 0.0 109.439 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -128.74 80.72 72.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.515 -0.741 . . . . 0.0 109.217 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.794 2.329 . . . . 0.0 111.997 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 24.4 pt-20 -104.62 162.42 13.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.691 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 -140.36 179.0 6.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 109.639 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE2' HD22 ' A' ' 132' ' ' LEU . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.762 HG11 ' CD1' ' A' ' 13' ' ' TYR . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 12' ' ' LEU . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CD1' HG11 ' A' ' 7' ' ' VAL . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.438 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.782 ' NE1' HD21 ' A' ' 50' ' ' LEU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.782 HD21 ' NE1' ' A' ' 46' ' ' TRP . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.56 HH22 ' CE1' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.56 ' CE1' HH22 ' A' ' 57' ' ' ARG . 13.0 t-80 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' PHE . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 83' ' ' ALA . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' HG21 ' A' ' 80' ' ' VAL . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 88' ' ' HIS . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 76' ' ' VAL . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.542 ' OD1' ' CD2' ' A' ' 154' ' ' PHE . 80.9 m-20 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 172' ' ' VAL . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 6' ' ' TRP . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 159' ' ' THR . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.474 HD21 HD11 ' A' ' 149' ' ' LEU . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 145' ' ' LEU . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.542 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 161' ' ' ILE . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.515 HG21 ' OG ' ' A' ' 138' ' ' SER . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 156' ' ' PHE . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 125' ' ' GLN . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.84 HG22 ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.84 ' H ' HG22 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 -123.37 82.23 52.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.64 -69.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.64 65.29 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -135.31 19.27 3.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -1.084 . . . . 0.0 109.393 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -132.38 151.12 77.7 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.651 -0.656 . . . . 0.0 109.297 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.561 2.174 . . . . 0.0 112.282 179.736 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 178' ' ' GLY . 1.1 pt-20 -103.8 154.5 19.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.557 ' HG3' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -103.9 163.51 12.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.096 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' HG12 ' A' ' 7' ' ' VAL . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.595 ' CE2' HD22 ' A' ' 132' ' ' LEU . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG13 ' N ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.801 ' N ' HG13 ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' HE1' ' A' ' 117' ' ' TRP . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD13 ' HG3' ' A' ' 53' ' ' ARG . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.7 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 37' ' ' LEU . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.896 ' OH ' HG21 ' A' ' 95' ' ' ILE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.486 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 96' ' ' ILE . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.732 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.896 HG21 ' OH ' ' A' ' 56' ' ' TYR . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' VAL . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.626 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 103' ' ' LEU . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 26' ' ' THR . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 6' ' ' TRP . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 149' ' ' LEU . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 157' ' ' VAL . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 157' ' ' VAL . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.705 ' SD ' HD12 ' A' ' 171' ' ' LEU . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.705 HD12 ' SD ' ' A' ' 166' ' ' MET . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 177' ' ' VAL . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -122.25 83.79 46.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.3 -9.69 26.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.182 1.921 . . . . 0.0 112.18 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.54 24.12 37.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 57.14 44.7 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.491 -1.005 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -128.06 151.57 76.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.534 -0.729 . . . . 0.0 109.041 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 C-N-CA 122.37 2.047 . . . . 0.0 112.249 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.223 0.535 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -104.75 154.41 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 109.059 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.898 ' NH2' HD13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -148.66 166.68 27.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CE2' HD22 ' A' ' 132' ' ' LEU . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 9' ' ' GLN . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.876 ' H ' HG12 ' A' ' 7' ' ' VAL . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.898 HD13 ' NH2' ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.462 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 31' ' ' LEU . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 161' ' ' ILE . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.655 ' CE2' HD21 ' A' ' 50' ' ' LEU . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 13' ' ' TYR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.655 HD21 ' CE2' ' A' ' 46' ' ' TRP . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 64' ' ' ASP . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 80' ' ' VAL . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' VAL . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 85' ' ' ILE . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 86' ' ' ILE . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 116' ' ' VAL . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 6' ' ' TRP . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 145' ' ' LEU . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 145' ' ' LEU . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' HG13 ' A' ' 157' ' ' VAL . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 155' ' ' LYS . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 38' ' ' GLU . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 179' ' ' CYS . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.424 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.47 ' H ' HG23 ' A' ' 176' ' ' VAL . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 -91.98 115.72 65.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.46 -63.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.18 1.92 . . . . 0.0 112.564 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.37 25.54 56.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.0 t30 59.36 44.82 14.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.115 . . . . 0.0 109.385 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -105.43 151.61 39.75 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.585 2.19 . . . . 0.0 112.208 179.675 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -102.49 150.37 23.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.913 . . . . 0.0 109.517 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -143.48 168.92 18.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.587 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.579 ' CE2' HD22 ' A' ' 132' ' ' LEU . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG11 ' CG1' ' A' ' 14' ' ' ILE . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 47' ' ' ILE . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG11 ' A' ' 7' ' ' VAL . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 25' ' ' GLU . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' OE1' ' A' ' 33' ' ' GLU . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.585 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 48' ' ' THR . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 12' ' ' LEU . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 44' ' ' LEU . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 41' ' ' GLN . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 47' ' ' ILE . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 86' ' ' ILE . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.752 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.752 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.415 ' O ' HG22 ' A' ' 68' ' ' VAL . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.557 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.653 ' OE1' HG21 ' A' ' 76' ' ' VAL . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 68' ' ' VAL . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 103' ' ' LEU . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CH2' HD23 ' A' ' 171' ' ' LEU . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.579 HD22 ' CE2' ' A' ' 6' ' ' TRP . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.517 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 149' ' ' LEU . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.445 ' SD ' HG11 ' A' ' 172' ' ' VAL . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD23 ' CH2' ' A' ' 117' ' ' TRP . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.445 HG11 ' SD ' ' A' ' 166' ' ' MET . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.422 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 -122.59 78.64 47.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.98 -13.29 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.889 2.392 . . . . 0.0 112.712 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 84.11 23.28 52.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 58.97 43.73 17.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -1.051 . . . . 0.0 109.617 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -131.03 79.79 70.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.346 -0.846 . . . . 0.0 109.367 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.929 2.42 . . . . 0.0 112.249 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.764 0.792 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 178' ' ' GLY . 39.7 mm-40 -142.0 162.22 36.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.723 ' NH2' HG23 ' A' ' 14' ' ' ILE . 3.5 ttt-85 -123.95 153.25 41.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 4' ' ' CYS . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.723 HG23 ' NH2' ' A' ' 3' ' ' ARG . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 23' ' ' VAL . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.497 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 41' ' ' GLN . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.586 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 80' ' ' VAL . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.525 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.68 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.658 HG22 HG22 ' A' ' 76' ' ' VAL . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 116' ' ' VAL . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' PHE . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' CH2' HD23 ' A' ' 171' ' ' LEU . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 132' ' ' LEU . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.466 ' N ' HG22 ' A' ' 131' ' ' THR . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.737 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.765 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' CH2' ' A' ' 117' ' ' TRP . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 129' ' ' ALA . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.579 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -119.8 84.93 32.69 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.85 -138.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.32 -7.07 59.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -135.69 26.75 3.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -1.082 . . . . 0.0 109.564 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -97.79 155.53 37.04 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 109.284 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.188 0.518 . . . . 0.0 109.64 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 78.9 mm-40 -130.63 155.09 47.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -127.27 150.78 49.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HZ2' ' HG3' ' A' ' 30' ' ' LYS . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 113' ' ' ALA . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 53' ' ' ARG . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.478 ' NE1' HD21 ' A' ' 50' ' ' LEU . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 41' ' ' GLN . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.478 HD21 ' NE1' ' A' ' 46' ' ' TRP . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG3' HD13 ' A' ' 37' ' ' LEU . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HH ' ' CD ' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' HZ2' ' A' ' 52' ' ' LYS . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.659 HD21 ' HE2' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 145' ' ' LEU . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 132' ' ' LEU . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 116' ' ' VAL . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.659 ' HE2' HD21 ' A' ' 98' ' ' ASN . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 160' ' ' THR . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.57 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 2' ' ' GLU . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.57 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 -124.32 82.57 57.71 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.12 -69.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.63 2.22 . . . . 0.0 111.762 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.56 -11.62 71.69 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -143.71 20.83 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -1.202 . . . . 0.0 110.079 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -136.18 154.49 77.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.522 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 122.594 2.196 . . . . 0.0 112.187 179.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.04 141.76 43.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -144.27 155.8 44.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.05 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.724 HG13 ' CG1' ' A' ' 14' ' ' ILE . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.724 ' CG1' HG13 ' A' ' 7' ' ' VAL . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 169' ' ' CYS . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 168' ' ' ALA . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 42' ' ' ALA . 21.2 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.411 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.64 HG12 ' HB1' ' A' ' 83' ' ' ALA . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 95' ' ' ILE . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.673 HD21 ' HE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.503 ' CH2' HD23 ' A' ' 171' ' ' LEU . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.538 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 122' ' ' HIS . 2.5 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.455 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 149' ' ' LEU . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 145' ' ' LEU . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.673 ' HE2' HD21 ' A' ' 98' ' ' ASN . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.404 ' CD1' HG12 ' A' ' 35' ' ' ILE . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 34' ' ' MET . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.503 HD23 ' CH2' ' A' ' 117' ' ' TRP . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.812 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -123.67 81.03 54.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -69.68 -23.04 31.58 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.79 2.326 . . . . 0.0 111.93 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 93.2 8.64 61.28 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 0.2 OUTLIER 69.44 19.07 7.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -1.011 . . . . 0.0 109.459 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -130.04 80.49 70.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.713 0 C-N-CA 122.851 2.368 . . . . 0.0 112.22 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.417 0.627 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -105.19 149.79 25.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.517 -0.739 . . . . 0.0 109.135 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -131.26 155.25 47.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 0.0 109.213 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 14' ' ' ILE . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.549 ' C ' ' HD1' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.691 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 102' ' ' TYR . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 161' ' ' ILE . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.692 HG21 HD12 ' A' ' 44' ' ' LEU . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' ILE . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.511 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 96' ' ' ILE . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 76' ' ' VAL . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 85' ' ' ILE . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 55' ' ' ASN . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HG2' HH11 ' A' ' 87' ' ' ARG . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB2' HG22 ' A' ' 80' ' ' VAL . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 95' ' ' ILE . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 92' ' ' ILE . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 68' ' ' VAL . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.563 ' CH2' HD23 ' A' ' 171' ' ' LEU . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.526 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 155' ' ' LYS . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 38' ' ' GLU . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.816 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.583 HE22 ' HH2' ' A' ' 6' ' ' TRP . 25.5 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.816 HD12 ' SD ' ' A' ' 166' ' ' MET . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.66 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 127' ' ' THR . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 129' ' ' ALA . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 -124.04 81.82 56.69 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -69.9 -58.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.618 2.212 . . . . 0.0 112.034 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.4 -9.07 67.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -171.98 16.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -147.28 80.02 9.48 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.236 179.905 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.622 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.41 158.83 16.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.741 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 -113.49 160.05 18.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.128 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 4' ' ' CYS . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 12' ' ' LEU . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.587 HD23 HG21 ' A' ' 48' ' ' THR . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.587 HG21 HD23 ' A' ' 44' ' ' LEU . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.561 ' HZ3' HD12 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.745 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.745 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 64' ' ' ASP . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.531 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 80' ' ' VAL . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 76' ' ' VAL . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.733 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 80' ' ' VAL . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 76' ' ' VAL . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 171' ' ' LEU . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 37.9 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 38' ' ' GLU . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.504 HD23 ' CH2' ' A' ' 117' ' ' TRP . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 127' ' ' THR . 50.5 t-20 -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.83 80.67 56.17 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.67 -25.09 24.77 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.751 2.301 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.32 65.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 58.9 42.06 20.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.44 -1.035 . . . . 0.0 109.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -87.86 150.02 47.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.209 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 C-N-CA 122.337 2.025 . . . . 0.0 112.163 179.908 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.742 HE22 ' HB3' ' A' ' 91' ' ' LYS . 6.7 tp-100 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.742 ' HB3' HE22 ' A' ' 40' ' ' GLN . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' HD21 ' A' ' 98' ' ' ASN . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 81.7 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 62.7 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.372 0.606 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -110.49 149.84 29.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.531 -0.731 . . . . 0.0 109.614 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.96 151.92 44.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.187 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.807 ' C ' HD11 ' A' ' 132' ' ' LEU . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.611 ' CE2' HD22 ' A' ' 132' ' ' LEU . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HB3' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OD2' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.596 ' HD1' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.596 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.889 ' CE3' ' HB2' ' A' ' 168' ' ' ALA . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' A' ' 161' ' ' ILE . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 86' ' ' ILE . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH1' ' ND1' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.518 ' ND1' ' NH1' ' A' ' 57' ' ' ARG . 8.0 t-80 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 64' ' ' ASP . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.407 ' CG2' HD11 ' A' ' 96' ' ' ILE . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.629 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.629 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.639 ' H ' HD12 ' A' ' 92' ' ' ILE . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.639 HD12 ' H ' ' A' ' 89' ' ' ARG . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 76' ' ' VAL . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 103' ' ' LEU . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.421 ' CH2' HD23 ' A' ' 171' ' ' LEU . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.807 HD11 ' C ' ' A' ' 5' ' ' GLY . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 145' ' ' LEU . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 161' ' ' ILE . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.552 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 158' ' ' GLY . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.889 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD23 ' CH2' ' A' ' 117' ' ' TRP . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.612 ' N ' HG13 ' A' ' 176' ' ' VAL . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.592 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -103.06 113.47 65.85 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.05 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.051 1.834 . . . . 0.0 112.187 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . 94.66 -1.24 65.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 11.7 m-20 -177.77 28.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.292 . . . . 0.0 110.037 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.34 80.4 58.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.296 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.821 2.347 . . . . 0.0 112.325 -179.955 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 6.4 tpp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.294 0.569 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.408 ' H ' ' CG ' ' A' ' 1' ' ' MET . 83.2 tt0 -96.44 147.51 23.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.235 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 -100.53 156.86 17.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 12' ' ' LEU . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.489 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.755 ' NE1' HD21 ' A' ' 50' ' ' LEU . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.526 HD12 HD12 ' A' ' 50' ' ' LEU . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.755 HD21 ' NE1' ' A' ' 46' ' ' TRP . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 85' ' ' ILE . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG13 ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 64' ' ' ASP . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 96' ' ' ILE . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 55' ' ' ASN . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 76' ' ' VAL . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.489 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' VAL . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.6 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.544 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 149' ' ' LEU . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.544 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.607 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD13 ' A' ' 171' ' ' LEU . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.852 HD13 ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 125' ' ' GLN . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.72 ' O ' HG12 ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 -121.52 80.25 38.54 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -83.14 -51.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.036 2.49 . . . . 0.0 112.15 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.29 65.73 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.8 36.88 28.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.424 -1.045 . . . . 0.0 109.212 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -147.66 80.4 9.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.295 . . . . 0.0 112.283 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' OE1' ' O ' ' A' ' 178' ' ' GLY . 94.7 mt-10 -104.54 155.47 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.563 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.699 ' NH1' HD13 ' A' ' 14' ' ' ILE . 95.6 mtt180 -119.92 155.65 32.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.71 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 4' ' ' CYS . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' NH1' ' A' ' 3' ' ' ARG . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 113' ' ' ALA . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 22.7 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HE1' HD21 ' A' ' 50' ' ' LEU . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 48' ' ' THR . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 47' ' ' ILE . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' GLN . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.586 HD21 ' HE1' ' A' ' 46' ' ' TRP . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.765 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 92' ' ' ILE . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.729 ' HD1' HG13 ' A' ' 92' ' ' ILE . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.729 HG13 ' HD1' ' A' ' 88' ' ' HIS . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 103' ' ' LEU . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 116' ' ' VAL . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 112' ' ' PHE . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.719 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 149' ' ' LEU . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 145' ' ' LEU . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.649 ' O ' HG13 ' A' ' 157' ' ' VAL . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 155' ' ' LYS . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 159' ' ' THR . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB2' ' HH2' ' A' ' 46' ' ' TRP . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 171' ' ' LEU . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 125' ' ' GLN . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 127' ' ' THR . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 176' ' ' VAL . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 177' ' ' VAL . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.481 ' O ' ' OE1' ' A' ' 2' ' ' GLU . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 -119.77 80.72 24.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.698 2.265 . . . . 0.0 112.556 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.63 25.78 37.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 m120 60.34 46.58 9.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.497 -1.002 . . . . 0.0 109.709 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -123.72 80.59 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.501 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.835 2.357 . . . . 0.0 112.315 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.704 0.764 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -143.7 148.02 35.12 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.625 -0.672 . . . . 0.0 109.386 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 -117.75 158.13 25.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 0.0 109.269 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' HG12 ' A' ' 7' ' ' VAL . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 31' ' ' LEU . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 25' ' ' GLU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 55' ' ' ASN . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.536 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 71' ' ' MET . 9.2 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 80' ' ' VAL . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 83' ' ' ALA . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.2 m80 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.491 ' CG2' HG22 ' A' ' 76' ' ' VAL . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.618 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' H ' ' A' ' 123' ' ' GLN . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.536 ' H ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.548 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 -120.01 83.23 30.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.57 31.72 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.907 2.405 . . . . 0.0 112.329 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.48 26.04 48.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.0 t30 61.79 42.98 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.387 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.87 80.25 73.07 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.234 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.306 -1.66 0 C-N-CA 122.757 2.305 . . . . 0.0 112.128 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.542 0.687 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -119.95 160.6 22.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.767 -0.583 . . . . 0.0 109.766 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 -118.96 149.26 41.91 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.586 ' CE2' HD22 ' A' ' 132' ' ' LEU . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 47' ' ' ILE . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' CB ' ' A' ' 113' ' ' ALA . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.704 HD13 ' HG3' ' A' ' 53' ' ' ARG . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.647 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.688 ' NE2' ' CE3' ' A' ' 46' ' ' TRP . 81.8 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.688 ' CE3' ' NE2' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 12' ' ' LEU . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 47' ' ' ILE . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 41' ' ' GLN . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' HD13 ' A' ' 37' ' ' LEU . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB3' HG22 ' A' ' 85' ' ' ILE . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 85' ' ' ILE . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 6.7 t60 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' N ' HG13 ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 76' ' ' VAL . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 71' ' ' MET . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 31' ' ' LEU . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.45 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.586 HD22 ' CE2' ' A' ' 6' ' ' TRP . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.721 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HB2' HG21 ' A' ' 157' ' ' VAL . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' A' ' 125' ' ' GLN . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 127' ' ' THR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 42.7 t80 -72.21 123.33 89.34 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.606 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 73.4 Cg_endo -78.28 -172.7 1.57 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.377 2.051 . . . . 0.0 112.902 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.08 -3.53 60.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' OD1' ' A' ' 185' ' ' ASN . 24.7 p30 -94.2 13.01 24.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -1.058 . . . . 0.0 109.43 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -109.24 151.62 42.14 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.312 -1.344 0 C-N-CA 122.43 2.087 . . . . 0.0 112.161 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.641 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.6 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 177' ' ' VAL . 81.1 mt-10 -91.82 147.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.02 . . . . 0.0 109.719 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -134.93 151.56 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 109.005 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.836 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.672 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 4' ' ' CYS . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' ILE . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.504 ' HB2' HD13 ' A' ' 47' ' ' ILE . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.773 HD21 ' SG ' ' A' ' 169' ' ' CYS . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.711 HD13 ' CE2' ' A' ' 165' ' ' PHE . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.558 HD13 HD13 ' A' ' 86' ' ' ILE . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 12' ' ' LEU . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.49 ' N ' HG23 ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 46' ' ' TRP . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.715 ' HZ1' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.483 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 64' ' ' ASP . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.67 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.67 HG12 ' HB1' ' A' ' 83' ' ' ALA . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 44' ' ' LEU . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.869 ' HE ' HD11 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.869 HD11 ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.53 HD21 ' HA ' ' A' ' 95' ' ' ILE . 90.2 m-20 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 117' ' ' TRP . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.465 ' N ' HG23 ' A' ' 116' ' ' VAL . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG12 ' A' ' 172' ' ' VAL . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.672 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.619 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.456 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 35' ' ' ILE . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.45 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.773 ' SG ' HD21 ' A' ' 31' ' ' LEU . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD23 ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.45 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.423 ' O ' ' OE1' ' A' ' 2' ' ' GLU . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.641 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -119.71 90.61 43.62 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.29 -64.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.268 1.979 . . . . 0.0 111.52 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.15 -13.38 15.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -118.45 10.91 12.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -1.017 . . . . 0.0 109.606 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -148.38 155.95 42.58 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.479 -0.763 . . . . 0.0 109.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.609 2.206 . . . . 0.0 112.176 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 tpp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.57 153.8 22.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HG2' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 -118.04 164.86 14.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.487 -0.758 . . . . 0.0 109.468 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CE2' HD22 ' A' ' 132' ' ' LEU . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 4' ' ' CYS . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 8' ' ' SER . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 12' ' ' LEU . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CG ' HD13 ' A' ' 50' ' ' LEU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 23' ' ' VAL . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 113' ' ' ALA . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 56' ' ' TYR . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 41' ' ' GLN . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 16' ' ' TYR . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 51' ' ' LYS . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.683 HG13 HG21 ' A' ' 92' ' ' ILE . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 80' ' ' VAL . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.594 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.698 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.754 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.754 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 35.2 t-80 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.683 HG21 HG13 ' A' ' 76' ' ' VAL . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 117' ' ' TRP . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' VAL . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 21.2 t-20 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.599 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 6' ' ' TRP . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.764 ' HB1' HH12 ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.764 HH12 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.68 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.68 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 125' ' ' GLN . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.432 ' O ' HG22 ' A' ' 127' ' ' THR . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 10.4 m-70 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 176' ' ' VAL . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.625 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -122.2 83.96 45.86 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 3.0 Cg_exo -72.36 -74.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.762 2.308 . . . . 0.0 111.672 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.492 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 89.67 -13.93 62.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 83.4 m-20 -149.33 30.25 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -1.224 . . . . 0.0 109.85 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -123.66 80.82 55.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 C-N-CA 122.878 2.385 . . . . 0.0 112.277 -179.779 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -109.14 161.59 15.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 108.951 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -122.69 153.83 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 109.618 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.6 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' HD13 ' A' ' 47' ' ' ILE . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 ' N ' HG23 ' A' ' 47' ' ' ILE . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 41' ' ' GLN . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' LEU . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 53' ' ' ARG . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 92' ' ' ILE . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HA ' HD12 ' A' ' 92' ' ' ILE . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 76' ' ' VAL . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.525 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 132' ' ' LEU . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 137' ' ' THR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.644 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.576 HG23 ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 155' ' ' LYS . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 125' ' ' GLN . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 127' ' ' THR . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.589 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 -122.81 82.75 49.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.5 Cg_endo -80.81 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.634 2.223 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.57 -14.72 1.8 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 183' ' ' PRO . 37.6 t-20 -90.22 1.95 55.91 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.376 -1.073 . . . . 0.0 108.759 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -108.82 156.87 38.2 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 122.813 2.342 . . . . 0.0 112.315 179.875 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 178' ' ' GLY . 20.5 pt-20 -117.42 148.45 41.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.78 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 -125.64 159.89 31.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.694 ' CE2' HD22 ' A' ' 132' ' ' LEU . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.548 ' CD1' HG22 ' A' ' 7' ' ' VAL . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.579 ' CG1' HG11 ' A' ' 7' ' ' VAL . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 165' ' ' PHE . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 37' ' ' LEU . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 95' ' ' ILE . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' OE1' ' OE1' ' A' ' 38' ' ' GLU . 7.3 pt20 -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 HG21 ' A' ' 48' ' ' THR . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.472 ' CZ2' ' OE1' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.621 HG21 HD23 ' A' ' 44' ' ' LEU . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.551 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 85' ' ' ILE . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 57' ' ' ARG . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 2.0 t-160 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 79' ' ' LEU . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' VAL . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.694 HG22 ' CG ' ' A' ' 55' ' ' ASN . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG21 HG13 ' A' ' 76' ' ' VAL . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.832 HD11 ' NE2' ' A' ' 40' ' ' GLN . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.56 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 116' ' ' VAL . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' PHE . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' N ' HG23 ' A' ' 116' ' ' VAL . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.684 ' HB2' HG12 ' A' ' 172' ' ' VAL . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.443 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 6' ' ' TRP . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.605 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.432 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' A' ' 157' ' ' VAL . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.432 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.47 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.516 ' SD ' HD22 ' A' ' 171' ' ' LEU . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.472 ' OE1' ' CZ2' ' A' ' 46' ' ' TRP . 17.6 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' A' ' 166' ' ' MET . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.943 ' O ' HG13 ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.477 ' H ' HG23 ' A' ' 176' ' ' VAL . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' O ' ' OE2' ' A' ' 2' ' ' GLU . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 -123.88 86.65 53.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.17 -82.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.266 1.977 . . . . 0.0 111.976 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 83.61 3.24 89.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.01 24.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -1.207 . . . . 0.0 109.783 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -133.63 80.29 56.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 0.0 109.428 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.306 -1.663 0 C-N-CA 122.876 2.384 . . . . 0.0 112.362 -179.994 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 177' ' ' VAL . 19.8 pt-20 -76.29 150.83 36.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 -148.11 173.13 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.562 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CE3' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.535 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HB3' HG22 ' A' ' 49' ' ' VAL . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB2' HG21 ' A' ' 49' ' ' VAL . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 48' ' ' THR . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 48' ' ' THR . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 41' ' ' GLN . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.783 ' CG ' HG22 ' A' ' 85' ' ' ILE . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.586 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.586 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.675 ' O ' HG23 ' A' ' 68' ' ' VAL . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' PHE . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG22 ' CG2' ' A' ' 92' ' ' ILE . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.783 HG22 ' CG ' ' A' ' 55' ' ' ASN . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 87' ' ' ARG . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 86' ' ' ILE . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.412 ' CD2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.671 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 76' ' ' VAL . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' OE1' HG21 ' A' ' 76' ' ' VAL . 23.5 mm100 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.9 OUTLIER 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.635 HD13 ' CE3' ' A' ' 6' ' ' TRP . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.617 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' HG13 ' A' ' 157' ' ' VAL . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 155' ' ' LYS . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.535 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.49 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 -123.72 79.46 56.09 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.2 -8.17 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.884 2.389 . . . . 0.0 112.174 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.496 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 82.09 24.77 54.15 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.5 OUTLIER 44.2 40.85 3.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.62 -0.929 . . . . 0.0 109.516 -179.707 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -125.99 80.44 67.68 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--N 1.306 -1.708 0 C-N-CA 122.937 2.425 . . . . 0.0 112.319 -179.975 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -76.43 143.69 40.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.721 ' NH1' HD13 ' A' ' 14' ' ' ILE . 43.3 ttm180 -132.88 157.0 46.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.421 -0.8 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' NH1' ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.852 HD21 ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 87' ' ' ARG . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 3.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 9.6 t60 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.684 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 80' ' ' VAL . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' VAL . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.763 HG23 ' N ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.763 ' N ' HG23 ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.422 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.578 HG21 ' CE1' ' A' ' 60' ' ' PHE . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.684 HD11 ' SD ' ' A' ' 71' ' ' MET . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 21.8 t30 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.564 ' CH2' HD23 ' A' ' 171' ' ' LEU . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.609 ' HB2' HG12 ' A' ' 172' ' ' VAL . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 135' ' ' ILE . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.695 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 132' ' ' LEU . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 149' ' ' LEU . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.474 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD23 ' CH2' ' A' ' 117' ' ' TRP . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.609 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 127' ' ' THR . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.884 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.884 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 -124.22 81.51 57.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 185' ' ' ASN . 32.5 Cg_exo -53.78 -40.7 79.08 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.536 2.158 . . . . 0.0 112.007 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.49 -14.18 2.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 183' ' ' PRO . 11.4 p30 -159.54 21.56 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.974 -1.31 . . . . 0.0 109.893 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.09 83.82 9.96 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.567 2.178 . . . . 0.0 112.249 -179.83 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.849 ' NH2' HD13 ' A' ' 14' ' ' ILE . 13.3 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.367 0.604 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.71 HG11 ' CG1' ' A' ' 14' ' ' ILE . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 56' ' ' TYR . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 44' ' ' LEU . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 40' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' THR . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.498 HG21 HD22 ' A' ' 44' ' ' LEU . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 41' ' ' GLN . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.652 ' ND2' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 68' ' ' VAL . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 65' ' ' PRO . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 68' ' ' VAL . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG12 HG22 ' A' ' 92' ' ' ILE . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 76' ' ' VAL . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.652 HG23 ' ND2' ' A' ' 55' ' ' ASN . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 76' ' ' VAL . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 68' ' ' VAL . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 171' ' ' LEU . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.617 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 149' ' ' LEU . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 120' ' ' VAL . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 125' ' ' GLN . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 178' ' ' GLY . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CE2' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 14' ' ' ILE . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 7' ' ' VAL . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 165' ' ' PHE . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 47' ' ' ILE . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.473 HD22 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' A' ' 85' ' ' ILE . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.748 HG21 ' NE2' ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 76' ' ' VAL . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 56' ' ' TYR . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.725 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.435 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.748 ' NE2' HG21 ' A' ' 76' ' ' VAL . 92.0 mm-40 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 103' ' ' LEU . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 112' ' ' PHE . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.498 ' N ' HG23 ' A' ' 116' ' ' VAL . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 123' ' ' GLN . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 9.8 m170 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.521 ' H ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' A' ' 177' ' ' VAL . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 133' ' ' SER . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 6' ' ' TRP . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.431 ' H ' HG23 ' A' ' 131' ' ' THR . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.716 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB1' ' NH2' ' A' ' 152' ' ' ARG . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 149' ' ' LEU . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.531 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 127' ' ' THR . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 128' ' ' GLN . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 7' ' ' VAL . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 7' ' ' VAL . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.626 HD12 ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 156' ' ' PHE . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 52' ' ' LYS . 26.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HE3' HD22 ' A' ' 12' ' ' LEU . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' HE22 ' A' ' 40' ' ' GLN . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.583 ' CG ' HG22 ' A' ' 85' ' ' ILE . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.583 HG22 ' CG ' ' A' ' 55' ' ' ASN . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.45 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 149' ' ' LEU . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 145' ' ' LEU . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 160' ' ' THR . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 31' ' ' LEU . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 127' ' ' THR . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE2' HD22 ' A' ' 132' ' ' LEU . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.762 HG11 ' CD1' ' A' ' 13' ' ' TYR . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 12' ' ' LEU . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CD1' HG11 ' A' ' 7' ' ' VAL . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.438 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.6 pp0? -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.782 ' NE1' HD21 ' A' ' 50' ' ' LEU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.782 HD21 ' NE1' ' A' ' 46' ' ' TRP . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.728 HH12 ' CD2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.728 ' CD2' HH12 ' A' ' 57' ' ' ARG . 56.1 t60 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' PHE . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 83' ' ' ALA . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' HG21 ' A' ' 80' ' ' VAL . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 88' ' ' HIS . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 76' ' ' VAL . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.694 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 20.5 m120 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 61.4 tp60 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.532 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 172' ' ' VAL . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 6' ' ' TRP . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 159' ' ' THR . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.553 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.474 HD21 HD11 ' A' ' 149' ' ' LEU . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 145' ' ' LEU . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.694 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 161' ' ' ILE . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.515 HG21 ' OG ' ' A' ' 138' ' ' SER . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 156' ' ' PHE . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.553 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 125' ' ' GLN . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.84 HG22 ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.84 ' H ' HG22 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.557 ' HG3' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' HG12 ' A' ' 7' ' ' VAL . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.595 ' CE2' HD22 ' A' ' 132' ' ' LEU . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG13 ' N ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.801 ' N ' HG13 ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' HE1' ' A' ' 117' ' ' TRP . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD13 ' HG3' ' A' ' 53' ' ' ARG . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 48.0 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 37' ' ' LEU . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.896 ' OH ' HG21 ' A' ' 95' ' ' ILE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.486 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 96' ' ' ILE . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.732 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.896 HG21 ' OH ' ' A' ' 56' ' ' TYR . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' VAL . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.626 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 103' ' ' LEU . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 26' ' ' THR . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 6' ' ' TRP . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 149' ' ' LEU . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 157' ' ' VAL . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 157' ' ' VAL . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.705 ' SD ' HD12 ' A' ' 171' ' ' LEU . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.705 HD12 ' SD ' ' A' ' 166' ' ' MET . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 177' ' ' VAL . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.898 ' NH2' HD13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CE2' HD22 ' A' ' 132' ' ' LEU . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 9' ' ' GLN . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.876 ' H ' HG12 ' A' ' 7' ' ' VAL . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.898 HD13 ' NH2' ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.462 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 31' ' ' LEU . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 161' ' ' ILE . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.655 ' CE2' HD21 ' A' ' 50' ' ' LEU . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 13' ' ' TYR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.655 HD21 ' CE2' ' A' ' 46' ' ' TRP . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 64' ' ' ASP . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 80' ' ' VAL . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' VAL . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.714 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 85' ' ' ILE . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 86' ' ' ILE . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 116' ' ' VAL . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 6' ' ' TRP . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 145' ' ' LEU . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 145' ' ' LEU . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' HG13 ' A' ' 157' ' ' VAL . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 155' ' ' LYS . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 38' ' ' GLU . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 179' ' ' CYS . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.424 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.47 ' H ' HG23 ' A' ' 176' ' ' VAL . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.261 0.553 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.579 ' CE2' HD22 ' A' ' 132' ' ' LEU . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG11 ' CG1' ' A' ' 14' ' ' ILE . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 47' ' ' ILE . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG11 ' A' ' 7' ' ' VAL . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 25' ' ' GLU . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' OE1' ' A' ' 33' ' ' GLU . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 48' ' ' THR . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 12' ' ' LEU . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 44' ' ' LEU . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 41' ' ' GLN . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 47' ' ' ILE . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 86' ' ' ILE . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.752 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.752 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.415 ' O ' HG22 ' A' ' 68' ' ' VAL . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.557 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.653 ' OE1' HG21 ' A' ' 76' ' ' VAL . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 68' ' ' VAL . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 103' ' ' LEU . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 108' ' ' ASN . 3.0 m120 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CH2' HD23 ' A' ' 171' ' ' LEU . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.483 HE21 ' HB ' ' A' ' 177' ' ' VAL . 20.0 tp60 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.579 HD22 ' CE2' ' A' ' 6' ' ' TRP . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.517 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 149' ' ' LEU . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.445 ' SD ' HG11 ' A' ' 172' ' ' VAL . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD23 ' CH2' ' A' ' 117' ' ' TRP . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.445 HG11 ' SD ' ' A' ' 166' ' ' MET . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.422 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.723 ' NH2' HG23 ' A' ' 14' ' ' ILE . 3.5 ttt-85 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 4' ' ' CYS . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.723 HG23 ' NH2' ' A' ' 3' ' ' ARG . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 23' ' ' VAL . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.652 HE21 ' NZ ' ' A' ' 91' ' ' LYS . 40.4 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.497 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 41' ' ' GLN . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.586 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 80' ' ' VAL . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.525 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.68 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.652 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.658 HG22 HG22 ' A' ' 76' ' ' VAL . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 116' ' ' VAL . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' PHE . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' CH2' HD23 ' A' ' 171' ' ' LEU . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 132' ' ' LEU . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.466 ' N ' HG22 ' A' ' 131' ' ' THR . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.737 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.765 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' CH2' ' A' ' 117' ' ' TRP . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 129' ' ' ALA . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.579 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.773 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HZ2' ' HG3' ' A' ' 30' ' ' LYS . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 113' ' ' ALA . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 53' ' ' ARG . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' N ' HE21 ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.478 ' NE1' HD21 ' A' ' 50' ' ' LEU . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 41' ' ' GLN . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.478 HD21 ' NE1' ' A' ' 46' ' ' TRP . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG3' HD13 ' A' ' 37' ' ' LEU . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HH ' ' CD ' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' HZ2' ' A' ' 52' ' ' LYS . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' N ' HD22 ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.427 HE21 ' CA ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 145' ' ' LEU . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 132' ' ' LEU . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 116' ' ' VAL . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 160' ' ' THR . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.773 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 31.3 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.57 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 178' ' ' GLY . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.57 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.724 HG13 ' CG1' ' A' ' 14' ' ' ILE . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.724 ' CG1' HG13 ' A' ' 7' ' ' VAL . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 169' ' ' CYS . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 168' ' ' ALA . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 46' ' ' TRP . 32.0 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.485 ' HA ' HE21 ' A' ' 41' ' ' GLN . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.411 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.617 HH11 ' CD2' ' A' ' 61' ' ' HIS . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.617 ' CD2' HH11 ' A' ' 57' ' ' ARG . 5.7 t-80 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.64 HG12 ' HB1' ' A' ' 83' ' ' ALA . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 95' ' ' ILE . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.503 ' CH2' HD23 ' A' ' 171' ' ' LEU . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.524 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 4.5 t-20 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 121' ' ' ASN . 1.4 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.455 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 149' ' ' LEU . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 145' ' ' LEU . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.404 ' CD1' HG12 ' A' ' 35' ' ' ILE . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 34' ' ' MET . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.503 HD23 ' CH2' ' A' ' 117' ' ' TRP . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.812 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 14' ' ' ILE . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.795 ' HE1' HE21 ' A' ' 167' ' ' GLN . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 102' ' ' TYR . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 161' ' ' ILE . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.692 HG21 HD12 ' A' ' 44' ' ' LEU . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' ILE . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.511 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 96' ' ' ILE . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 76' ' ' VAL . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 85' ' ' ILE . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 55' ' ' ASN . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HG2' HH11 ' A' ' 87' ' ' ARG . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB2' HG22 ' A' ' 80' ' ' VAL . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 95' ' ' ILE . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 92' ' ' ILE . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 68' ' ' VAL . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.563 ' CH2' HD23 ' A' ' 171' ' ' LEU . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.526 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 155' ' ' LYS . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 38' ' ' GLU . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.816 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.795 HE21 ' HE1' ' A' ' 21' ' ' TRP . 33.8 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.816 HD12 ' SD ' ' A' ' 166' ' ' MET . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.66 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 127' ' ' THR . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 129' ' ' ALA . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 4' ' ' CYS . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 12' ' ' LEU . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.587 HD23 HG21 ' A' ' 48' ' ' THR . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.587 HG21 HD23 ' A' ' 44' ' ' LEU . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.561 ' HZ3' HD12 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.745 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.745 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 64' ' ' ASP . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.531 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 80' ' ' VAL . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 76' ' ' VAL . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.733 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 80' ' ' VAL . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 76' ' ' VAL . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 171' ' ' LEU . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.1 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 38' ' ' GLU . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.504 HD23 ' CH2' ' A' ' 117' ' ' TRP . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 127' ' ' THR . 0.7 OUTLIER -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.807 ' C ' HD11 ' A' ' 132' ' ' LEU . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.611 ' CE2' HD22 ' A' ' 132' ' ' LEU . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HB3' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OD2' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' OD2' HG22 ' A' ' 14' ' ' ILE . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.889 ' CE3' ' HB2' ' A' ' 168' ' ' ALA . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' A' ' 161' ' ' ILE . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 86' ' ' ILE . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.719 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.719 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 43.5 t60 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 64' ' ' ASP . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.407 ' CG2' HD11 ' A' ' 96' ' ' ILE . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.629 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.629 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.639 ' H ' HD12 ' A' ' 92' ' ' ILE . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.639 HD12 ' H ' ' A' ' 89' ' ' ARG . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 76' ' ' VAL . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 103' ' ' LEU . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.421 ' CH2' HD23 ' A' ' 171' ' ' LEU . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.807 HD11 ' C ' ' A' ' 5' ' ' GLY . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 145' ' ' LEU . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 161' ' ' ILE . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.552 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 158' ' ' GLY . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.889 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD23 ' CH2' ' A' ' 117' ' ' TRP . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.612 ' N ' HG13 ' A' ' 176' ' ' VAL . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.592 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 12' ' ' LEU . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.755 ' NE1' HD21 ' A' ' 50' ' ' LEU . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.526 HD12 HD12 ' A' ' 50' ' ' LEU . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.755 HD21 ' NE1' ' A' ' 46' ' ' TRP . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 85' ' ' ILE . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG13 ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 64' ' ' ASP . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 96' ' ' ILE . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 55' ' ' ASN . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 76' ' ' VAL . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' VAL . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.6 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.544 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 149' ' ' LEU . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.544 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.607 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD13 ' A' ' 171' ' ' LEU . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.852 HD13 ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 125' ' ' GLN . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.72 ' O ' HG12 ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.699 ' NH1' HD13 ' A' ' 14' ' ' ILE . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.71 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 4' ' ' CYS . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' NH1' ' A' ' 3' ' ' ARG . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 113' ' ' ALA . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.2 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HE1' HD21 ' A' ' 50' ' ' LEU . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 48' ' ' THR . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 47' ' ' ILE . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' GLN . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.586 HD21 ' HE1' ' A' ' 46' ' ' TRP . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.765 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 92' ' ' ILE . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.729 ' HD1' HG13 ' A' ' 92' ' ' ILE . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.729 HG13 ' HD1' ' A' ' 88' ' ' HIS . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 103' ' ' LEU . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 116' ' ' VAL . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 112' ' ' PHE . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.719 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 149' ' ' LEU . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 145' ' ' LEU . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.649 ' O ' HG13 ' A' ' 157' ' ' VAL . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 155' ' ' LYS . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 159' ' ' THR . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB2' ' HH2' ' A' ' 46' ' ' TRP . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 171' ' ' LEU . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 125' ' ' GLN . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 127' ' ' THR . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 176' ' ' VAL . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 177' ' ' VAL . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' HG12 ' A' ' 7' ' ' VAL . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 31' ' ' LEU . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 25' ' ' GLU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 55' ' ' ASN . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.536 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.482 HE21 ' CB ' ' A' ' 74' ' ' GLU . 21.4 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.482 ' CB ' HE21 ' A' ' 72' ' ' GLN . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 80' ' ' VAL . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 83' ' ' ALA . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.2 m-70 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.491 ' CG2' HG22 ' A' ' 76' ' ' VAL . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.618 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' H ' ' A' ' 123' ' ' GLN . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.536 ' H ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.548 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.586 ' CE2' HD22 ' A' ' 132' ' ' LEU . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 47' ' ' ILE . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' CB ' ' A' ' 113' ' ' ALA . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.704 HD13 ' HG3' ' A' ' 53' ' ' ARG . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.494 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' NE2' HD12 ' A' ' 86' ' ' ILE . 8.7 mm100 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HG2' HG21 ' A' ' 49' ' ' VAL . 25.4 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 12' ' ' LEU . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 47' ' ' ILE . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 41' ' ' GLN . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' HD13 ' A' ' 37' ' ' LEU . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB3' HG22 ' A' ' 85' ' ' ILE . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 85' ' ' ILE . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.638 HH21 ' CD2' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CD2' HH21 ' A' ' 57' ' ' ARG . 52.0 t-80 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' N ' HG13 ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 76' ' ' VAL . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 HD12 ' NE2' ' A' ' 40' ' ' GLN . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 71' ' ' MET . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 31' ' ' LEU . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.45 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.586 HD22 ' CE2' ' A' ' 6' ' ' TRP . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.721 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HB2' HG21 ' A' ' 157' ' ' VAL . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' A' ' 125' ' ' GLN . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 127' ' ' THR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.7 t80 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.836 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.672 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 4' ' ' CYS . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' ILE . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.504 ' HB2' HD13 ' A' ' 47' ' ' ILE . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.773 HD21 ' SG ' ' A' ' 169' ' ' CYS . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.711 HD13 ' CE2' ' A' ' 165' ' ' PHE . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.558 HD13 HD13 ' A' ' 86' ' ' ILE . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 12' ' ' LEU . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.49 ' N ' HG23 ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 46' ' ' TRP . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.715 ' HZ1' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.483 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 64' ' ' ASP . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.67 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.67 HG12 ' HB1' ' A' ' 83' ' ' ALA . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 44' ' ' LEU . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.869 ' HE ' HD11 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.869 HD11 ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 18.4 m120 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 117' ' ' TRP . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.465 ' N ' HG23 ' A' ' 116' ' ' VAL . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG12 ' A' ' 172' ' ' VAL . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.411 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 37.2 mm-40 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.672 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.619 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 35' ' ' ILE . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.45 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.773 ' SG ' HD21 ' A' ' 31' ' ' LEU . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD23 ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.45 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 177' ' ' VAL . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.411 ' OH ' ' NE2' ' A' ' 128' ' ' GLN . 10.8 t80 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HG2' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CE2' HD22 ' A' ' 132' ' ' LEU . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 4' ' ' CYS . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 8' ' ' SER . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 12' ' ' LEU . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CG ' HD13 ' A' ' 50' ' ' LEU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 23' ' ' VAL . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 113' ' ' ALA . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 56' ' ' TYR . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 41' ' ' GLN . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 16' ' ' TYR . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 51' ' ' LYS . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.421 HD21 ' HA3' ' A' ' 84' ' ' GLY . 51.5 t-20 -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.683 HG13 HG21 ' A' ' 92' ' ' ILE . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 80' ' ' VAL . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.594 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.698 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.754 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.754 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 82.5 t60 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.683 HG21 HG13 ' A' ' 76' ' ' VAL . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 117' ' ' TRP . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' VAL . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.599 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 6' ' ' TRP . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.764 ' HB1' HH12 ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.764 HH12 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.68 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.68 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 125' ' ' GLN . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.432 ' O ' HG22 ' A' ' 127' ' ' THR . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 10.4 m-70 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 176' ' ' VAL . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.625 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.3 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' HD13 ' A' ' 47' ' ' ILE . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 26.7 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.429 ' N ' HG23 ' A' ' 47' ' ' ILE . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 41' ' ' GLN . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' LEU . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' NZ ' ' NE2' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 53' ' ' ARG . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 92' ' ' ILE . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HA ' HD12 ' A' ' 92' ' ' ILE . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 76' ' ' VAL . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 132' ' ' LEU . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 137' ' ' THR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.644 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.576 HG23 ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 155' ' ' LYS . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 125' ' ' GLN . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 127' ' ' THR . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.617 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.589 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.694 ' CE2' HD22 ' A' ' 132' ' ' LEU . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.548 ' CD1' HG22 ' A' ' 7' ' ' VAL . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.579 ' CG1' HG11 ' A' ' 7' ' ' VAL . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.809 ' HE1' HE21 ' A' ' 167' ' ' GLN . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 165' ' ' PHE . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 37' ' ' LEU . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 95' ' ' ILE . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 HG21 ' A' ' 48' ' ' THR . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' CZ2' ' NE2' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.621 HG21 HD23 ' A' ' 44' ' ' LEU . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.551 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 85' ' ' ILE . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.59 HH11 ' CD2' ' A' ' 61' ' ' HIS . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CD2' HH11 ' A' ' 57' ' ' ARG . 2.1 t60 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 79' ' ' LEU . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' VAL . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.694 HG22 ' CG ' ' A' ' 55' ' ' ASN . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG21 HG13 ' A' ' 76' ' ' VAL . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.832 HD11 ' NE2' ' A' ' 40' ' ' GLN . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.56 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 116' ' ' VAL . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' PHE . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' N ' HG23 ' A' ' 116' ' ' VAL . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.684 ' HB2' HG12 ' A' ' 172' ' ' VAL . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.443 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 6' ' ' TRP . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.605 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' A' ' 157' ' ' VAL . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.48 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.516 ' SD ' HD22 ' A' ' 171' ' ' LEU . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.809 HE21 ' HE1' ' A' ' 21' ' ' TRP . 40.9 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' A' ' 166' ' ' MET . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.943 ' O ' HG13 ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.477 ' H ' HG23 ' A' ' 176' ' ' VAL . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.319 0.58 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CE3' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.535 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HB3' HG22 ' A' ' 49' ' ' VAL . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB2' HG21 ' A' ' 49' ' ' VAL . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 48' ' ' THR . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 48' ' ' THR . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 41' ' ' GLN . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.783 ' CG ' HG22 ' A' ' 85' ' ' ILE . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.586 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.586 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.675 ' O ' HG23 ' A' ' 68' ' ' VAL . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' PHE . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 ' NE2' ' A' ' 93' ' ' GLN . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.783 HG22 ' CG ' ' A' ' 55' ' ' ASN . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 87' ' ' ARG . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 86' ' ' ILE . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.412 ' CD2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.671 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 76' ' ' VAL . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.629 ' NE2' HG21 ' A' ' 76' ' ' VAL . 95.9 mm-40 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 1.7 t60 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.635 HD13 ' CE3' ' A' ' 6' ' ' TRP . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.617 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' HG13 ' A' ' 157' ' ' VAL . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 155' ' ' LYS . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.535 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 177' ' ' VAL . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.721 ' NH1' HD13 ' A' ' 14' ' ' ILE . 43.3 ttm180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.328 0.585 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' NH1' ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.852 HD21 ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE1' ' OE1' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 87' ' ' ARG . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.593 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.593 ' CD2' HH21 ' A' ' 57' ' ' ARG . 65.4 t-80 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.684 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 80' ' ' VAL . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' VAL . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.763 HG23 ' N ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.763 ' N ' HG23 ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.422 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.578 HG21 ' CE1' ' A' ' 60' ' ' PHE . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.684 HD11 ' SD ' ' A' ' 71' ' ' MET . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' OD1' ' OE1' ' A' ' 110' ' ' GLU . 22.5 t-20 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' OE1' ' OD1' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.564 ' CH2' HD23 ' A' ' 171' ' ' LEU . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.609 ' HB2' HG12 ' A' ' 172' ' ' VAL . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 135' ' ' ILE . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.695 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 132' ' ' LEU . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 149' ' ' LEU . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.474 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 HE21 ' A' ' 41' ' ' GLN . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.564 HD23 ' CH2' ' A' ' 117' ' ' TRP . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.609 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 127' ' ' THR . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.884 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.884 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' A' ' 2' ' ' GLU . 1.1 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 1' ' ' MET . 7.9 mm-40 -77.91 151.45 33.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.069 -1.019 . . . . 0.0 109.338 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.849 ' NH2' HD13 ' A' ' 14' ' ' ILE . 13.3 ptm180 -141.88 164.7 29.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.99 135.85 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.822 . . . . 0.0 109.752 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.27 1.39 73.13 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CZ3' ' NE2' ' A' ' 167' ' ' GLN . 57.1 m95 -55.22 -37.05 66.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -1.195 . . . . 0.0 109.35 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.71 HG11 ' CG1' ' A' ' 14' ' ' ILE . 3.4 p -94.59 129.47 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 110.715 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -94.0 -26.11 16.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -168.05 -139.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.985 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.14 89.44 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 109.895 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.56 -24.52 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.404 2.069 . . . . 0.0 112.318 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.41 -40.67 97.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.7 -48.29 79.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.825 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 ' NH2' ' A' ' 3' ' ' ARG . 8.3 mt -57.4 -41.62 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.08 83.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.22 -39.04 89.3 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.553 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.0 t-80 -57.41 -50.5 72.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.349 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.7 m-20 -66.21 -39.48 89.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.812 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -56.23 -46.89 79.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.011 -1.056 . . . . 0.0 110.375 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.0 mt-10 -157.14 -114.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.115 -0.99 . . . . 0.0 108.728 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.494 ' O ' ' O ' ' A' ' 20' ' ' GLU . 57.9 t90 49.62 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.779 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 101.46 -0.5 53.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.57 114.05 64.43 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.375 -1.073 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.44 126.68 12.42 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.903 1.736 . . . . 0.0 112.299 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.13 135.09 54.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.5 p -112.51 2.66 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.783 . . . . 0.0 109.24 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -79.1 127.37 31.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.654 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -38.49 91.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 110.245 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 30' ' ' LYS . 19.1 pttp -64.64 -42.47 95.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 29' ' ' LYS . 94.8 mttt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.87 -43.26 84.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.84 99.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 109.59 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -65.89 -32.2 73.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.019 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.1 tpt -72.18 -51.93 18.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.301 -0.875 . . . . 0.0 111.065 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.0 tp -62.39 -35.14 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.084 -1.01 . . . . 0.0 111.054 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 100.0 m -72.67 -49.26 32.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.936 -1.103 . . . . 0.0 110.484 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 56' ' ' TYR . 3.8 mm? -71.87 -33.9 68.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.51 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -53.89 -34.74 60.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.068 -1.02 . . . . 0.0 109.739 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.28 -30.92 56.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 44' ' ' LEU . 93.6 mt-30 -60.75 -35.56 76.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 110.597 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 2.1 pp0? -57.24 -33.64 67.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.844 -1.16 . . . . 0.0 110.224 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.78 110.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.001 -1.062 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.63 -35.21 3.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 40' ' ' GLN . 11.7 mt -94.02 164.22 13.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.583 -0.951 . . . . 0.0 109.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -87.27 156.67 19.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -55.06 -40.25 70.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' THR . 3.8 tp -61.23 -36.09 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.028 . . . . 0.0 110.259 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.498 HG21 HD22 ' A' ' 44' ' ' LEU . 90.0 m -63.81 -39.46 94.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.074 -1.016 . . . . 0.0 109.706 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 41' ' ' GLN . 74.4 t -66.37 -41.86 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.807 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.69 -45.02 95.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.135 . . . . 0.0 110.442 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -62.29 -51.3 68.22 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.903 -1.123 . . . . 0.0 108.834 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -65.63 -29.84 70.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.222 -0.924 . . . . 0.0 109.168 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -53.48 -42.61 67.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 108.818 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.27 -43.72 81.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.225 -0.922 . . . . 0.0 108.756 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.652 ' ND2' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -64.79 -39.1 93.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 57.6 t80 -56.47 -43.72 79.89 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.25 -36.3 75.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.312 -0.867 . . . . 0.0 109.277 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.41 73.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -31.94 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.926 -1.108 . . . . 0.0 111.802 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.5 m-85 -106.49 -41.06 5.39 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.83 -1.169 . . . . 0.0 112.662 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -55.04 -42.48 72.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.517 -1.365 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.66 -37.75 87.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.34 -16.86 60.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.999 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.85 172.13 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 0.0 108.652 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 68' ' ' VAL . 59.7 Cg_endo -81.83 -53.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.541 2.161 . . . . 0.0 113.701 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 2.3 p -51.35 -37.01 17.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.65 -1.281 . . . . 0.0 110.02 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 50.1 tttp -61.19 -46.4 90.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -0.81 . . . . 0.0 111.528 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 65' ' ' PRO . 21.1 m -59.59 -38.06 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.478 -1.389 . . . . 0.0 109.658 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -64.98 -25.04 67.7 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.05 7.18 44.88 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.66 -0.65 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 68' ' ' VAL . 29.2 mtm -90.41 166.14 13.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 109.885 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -111.42 174.02 6.07 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.482 0.658 . . . . 0.0 109.83 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.5 -26.98 67.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.576 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -67.84 -31.88 72.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.085 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 70.9 m-20 -65.15 -43.52 91.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.086 -1.009 . . . . 0.0 110.774 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG12 HG22 ' A' ' 92' ' ' ILE . 11.6 m -65.6 -39.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.919 -1.113 . . . . 0.0 109.221 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -67.88 -35.83 79.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.855 . . . . 0.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.64 -43.75 79.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 110.893 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -72.44 -25.33 61.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.0 109.867 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 76' ' ' VAL . 24.7 t -51.37 -28.58 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.056 -1.028 . . . . 0.0 108.907 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -48.81 -41.56 33.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 108.547 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -89.62 122.99 33.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -112.45 27.33 9.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.74 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . . . -46.89 -20.38 0.68 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.652 HG23 ' ND2' ' A' ' 55' ' ' ASN . 29.6 pt -121.18 169.39 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.704 -0.88 . . . . 0.0 108.834 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.9 mt -44.04 144.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -98.7 130.95 45.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.768 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -179.92 90.44 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -51.73 -34.56 39.64 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.117 -0.989 . . . . 0.0 108.794 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.62 -46.04 95.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -63.63 -42.8 98.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -1.194 . . . . 0.0 109.469 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 76' ' ' VAL . 65.4 mt -59.06 -41.24 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.222 -0.924 . . . . 0.0 108.511 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.78 -37.45 71.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.026 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.1 81.91 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.065 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.14 -51.57 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 108.58 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -54.7 -47.82 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.109 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.66 96.29 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.599 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -56.82 -42.98 80.53 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.284 -1.127 . . . . 0.0 109.678 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 68' ' ' VAL . . . -69.82 -35.52 74.87 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -64.84 -46.76 80.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.96 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -69.46 -39.9 77.48 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.93 -1.106 . . . . 0.0 109.077 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 9.0 t80 -63.57 -46.6 85.17 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.659 -0.65 . . . . 0.0 110.126 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.54 -39.29 87.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.05 -38.47 79.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.2 mmm -62.86 -38.67 91.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.3 -27.64 65.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -35.1 59.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.45 4.37 43.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.052 -1.03 . . . . 0.0 109.595 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.47 80.12 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -121.04 92.11 48.31 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.574 -0.956 . . . . 0.0 109.091 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.78 136.65 51.08 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.14 1.893 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -23.31 67.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.25 -0.907 . . . . 0.0 108.653 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -62.2 -38.63 89.87 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.37 -33.09 74.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.144 -0.973 . . . . 0.0 108.79 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 67.0 t80 -59.37 -51.96 67.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 113' ' ' ALA . 1.6 p -57.99 -41.17 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.981 -1.074 . . . . 0.0 109.075 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -55.87 -38.29 69.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.1 p -65.79 -30.66 71.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.423 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.55 -26.47 67.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 110.399 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 171' ' ' LEU . 29.9 m -102.66 23.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 108.993 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 123' ' ' GLN . 40.7 t30 65.62 35.16 7.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 57.8 t-80 44.54 13.55 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -109.83 135.61 20.43 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.352 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.89 145.16 55.55 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.028 1.819 . . . . 0.0 111.616 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.617 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.9 mt-30 -110.69 143.82 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.22 153.13 52.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.522 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 5.8 t -136.45 157.68 46.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 43.79 2.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.545 -0.722 . . . . 0.0 109.203 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.2 46.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.31 -45.79 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.1 m -115.66 156.59 25.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.94 -35.66 69.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -32.23 73.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 0.0 109.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -64.23 -32.47 74.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 109.746 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.37 115.56 30.79 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 137.95 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.181 1.921 . . . . 0.0 112.234 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -96.44 4.7 51.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 t -114.09 101.19 8.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 109.402 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.1 p -123.08 149.71 57.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.15 -32.72 97.69 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.097 1.865 . . . . 0.0 112.353 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.48 57.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 109.61 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.5 p -63.5 -42.19 98.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.394 -0.816 . . . . 0.0 110.06 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.1 -44.03 81.01 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.797 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.01 80.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 109.705 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.9 tt -60.74 -41.4 95.27 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.234 -0.916 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 m -61.88 -41.3 97.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.48 -36.53 82.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.617 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.15 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 149' ' ' LEU . 81.8 mt -64.59 -37.64 88.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.281 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.15 -41.54 88.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.999 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -61.03 -39.62 90.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 18.7 mtt-85 -64.42 -20.23 66.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.842 . . . . 0.0 109.688 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.55 11.45 33.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.599 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 2.2 m-85 -71.84 141.28 49.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -111.16 161.61 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.555 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 68.11 46.07 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.572 -0.705 . . . . 0.0 109.413 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 20.8 m -112.3 24.17 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.559 -0.713 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.6 156.06 0.18 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.0 m -54.38 -31.3 54.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.332 -1.099 . . . . 0.0 109.196 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.8 p -67.79 -42.41 81.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.6 -34.56 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.936 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 20.6 t -66.39 -46.94 74.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.295 -0.878 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -61.81 -41.4 97.71 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.611 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 m -60.87 -34.74 75.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.416 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 74.6 t80 -60.28 -53.2 60.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -39.56 79.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.067 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CZ3' ' A' ' 6' ' ' TRP . 47.5 tt0 -60.78 -51.3 69.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.456 -0.778 . . . . 0.0 110.42 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.99 -42.86 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 71.3 m -59.03 -35.02 72.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.534 -0.729 . . . . 0.0 109.608 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.5 5.93 58.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.485 HD12 HG21 ' A' ' 120' ' ' VAL . 4.1 mm? -54.11 -39.71 66.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.938 -1.331 . . . . 0.0 108.774 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 125' ' ' GLN . 32.7 m -119.01 147.6 22.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -103.38 103.86 13.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.634 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -120.63 91.23 3.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.56 -0.712 . . . . 0.0 109.567 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.502 ' O ' ' O ' ' A' ' 176' ' ' VAL . 9.5 m-70 -132.04 40.73 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 178' ' ' GLY . 26.9 m 38.19 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.603 -0.685 . . . . 0.0 110.035 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.55 15.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 176' ' ' VAL . . . -121.14 26.31 6.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 181' ' ' CYS . 48.0 t -105.05 15.03 28.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -1.122 . . . . 0.0 110.037 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.17 -63.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.01 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 179' ' ' CYS . 78.6 m -52.11 -31.94 33.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.716 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 26.9 t80 -106.87 102.22 41.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.09 -63.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.314 2.01 . . . . 0.0 112.115 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.06 -2.62 66.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -173.35 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -1.183 . . . . 0.0 109.607 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -138.25 83.5 21.77 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.738 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.507 2.138 . . . . 0.0 112.35 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' NH1' ' A' ' 3' ' ' ARG . 13.4 ptp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -88.19 148.83 24.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.582 ' NH1' ' O ' ' A' ' 1' ' ' MET . 10.2 mpt_? -108.84 172.04 7.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -0.799 . . . . 0.0 109.81 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 151.15 47.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.91 71.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CE2' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -86.37 -1.76 57.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.355 . . . . 0.0 109.627 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 14' ' ' ILE . 38.3 t -91.92 128.49 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 110.196 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 9' ' ' GLN . 7.8 p -169.57 119.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 8' ' ' SER . 93.6 mm-40 38.69 -152.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.504 -0.748 . . . . 0.0 109.409 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' GLN . 2.4 m-20 44.75 74.66 0.76 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.89 -27.3 34.49 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.84 2.36 . . . . 0.0 112.479 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.68 -41.35 98.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.093 -1.005 . . . . 0.0 109.537 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -64.67 -46.45 82.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.046 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 7' ' ' VAL . 83.6 mt -61.39 -34.87 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.927 . . . . 0.0 109.909 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.08 93.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -67.44 -36.63 81.58 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 8.3 t-80 -57.89 -43.82 86.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -87.18 -22.74 25.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.984 . . . . 0.0 110.983 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.16 -73.69 0.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.836 -1.165 . . . . 0.0 110.132 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -136.1 106.18 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.591 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 38.4 t90 -175.74 99.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 109.564 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -15.94 58.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -78.6 133.34 63.12 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 108.554 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.96 129.94 15.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.594 1.53 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -115.57 131.05 57.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.429 -0.794 . . . . 0.0 108.946 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -122.88 3.65 9.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -86.49 109.94 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.118 -0.989 . . . . 0.0 108.992 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.1 p -63.84 -33.61 76.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -64.16 -49.17 73.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -71.83 -45.31 61.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.01 -1.056 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 165' ' ' PHE . 53.2 tp -57.89 -45.54 86.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.911 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CZ ' ' SG ' ' A' ' 36' ' ' CYS . 54.3 t80 -61.55 -40.86 96.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.96 -33.1 73.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 0.0 109.819 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.8 tpp -64.45 -50.87 65.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.742 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -33.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.879 -1.138 . . . . 0.0 111.041 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 32' ' ' PHE . 99.9 m -65.6 -51.18 61.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.242 . . . . 0.0 110.32 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.5 mp -75.24 -38.2 60.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.18 -34.96 64.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.94 -33.63 57.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' ALA . 50.9 tp60 -59.11 -33.61 71.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -1.079 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pt20 -45.57 -22.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.58 110.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.219 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.79 -35.67 4.29 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.5 mt -107.08 149.8 27.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.479 -1.012 . . . . 0.0 109.748 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 47' ' ' ILE . 82.1 p -72.5 162.19 29.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.462 -0.774 . . . . 0.0 109.216 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -63.99 -28.14 69.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 110.645 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.81 -38.19 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.922 -1.111 . . . . 0.0 109.96 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.5 m -69.17 -35.92 76.81 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.949 -1.094 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.04 -40.34 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.844 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.02 -53.11 59.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.665 -1.272 . . . . 0.0 109.747 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.8 -45.3 94.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.02 . . . . 0.0 108.828 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 55' ' ' ASN . 1.7 tpmt? -62.72 -35.57 80.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -52.97 -41.94 65.03 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.62 -39.29 93.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.473 HD22 ' HE2' ' A' ' 52' ' ' LYS . 89.4 m-20 -64.36 -35.72 81.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.119 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' A' ' 85' ' ' ILE . 1.4 m-85 -56.77 -45.98 81.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 108.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.1 mtp180 -60.54 -33.35 72.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.13 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.9 78.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.46 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.91 -28.53 16.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 63' ' ' PHE . 93.7 m-85 -112.99 29.18 8.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 111.432 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 23.8 t-80 -49.35 -29.43 6.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.431 -1.418 . . . . 0.0 108.202 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.6 mm-40 -85.84 20.04 2.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.71 -0.618 . . . . 0.0 109.772 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 71.5 t80 -54.72 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.438 -0.789 . . . . 0.0 111.889 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.94 132.25 39.26 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.213 -1.554 . . . . 0.0 108.59 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -43.59 -53.72 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.106 1.871 . . . . 0.0 112.778 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -41.41 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.724 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 10.8 tptt -62.22 -42.01 98.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.434 -0.791 . . . . 0.0 110.339 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.14 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -70.62 -29.53 65.94 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.955 -1.091 . . . . 0.0 108.627 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.25 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.514 -0.741 . . . . 0.0 109.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.39 171.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -120.07 158.33 27.07 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.534 . . . . 0.0 109.626 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.89 -34.24 74.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.122 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.66 -33.7 74.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.187 -0.946 . . . . 0.0 109.096 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.42 -39.61 84.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.748 HG21 ' NE2' ' A' ' 93' ' ' GLN . 69.9 t -64.02 -45.11 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -65.72 -34.2 77.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.3 ttm-85 -59.34 -46.2 89.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 82' ' ' ASP . 25.0 mt -71.68 -29.14 64.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 76' ' ' VAL . 47.0 t -51.09 -38.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.8 -1.188 . . . . 0.0 108.58 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -65.6 -45.51 82.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.249 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 79' ' ' LEU . 59.5 t0 -98.27 119.13 36.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.24 42.88 2.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.946 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.04 -29.09 6.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 56' ' ' TYR . 3.7 pt -120.7 167.92 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.87 91.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.681 -1.262 . . . . 0.0 109.982 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.725 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -108.6 149.3 29.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.519 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.623 ' O ' ' N ' ' A' ' 90' ' ' GLY . 83.3 t60 -148.25 34.06 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.847 . . . . 0.0 109.019 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 59.2 -65.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.716 -0.615 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.88 -41.03 97.55 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -60.79 -39.41 88.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.258 . . . . 0.0 109.772 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.435 HG12 ' NH1' ' A' ' 87' ' ' ARG . 61.1 mt -60.18 -41.3 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.938 -1.101 . . . . 0.0 108.57 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.748 ' NE2' HG21 ' A' ' 76' ' ' VAL . 92.0 mm-40 -59.29 -34.66 72.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.08 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -48.0 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 108.987 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.54 -49.75 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.51 96.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.5 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 22.8 m120 -58.73 -39.39 80.74 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.189 -1.183 . . . . 0.0 109.194 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -68.5 -45.5 72.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.08 -41.28 97.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.49 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.63 76.45 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 108.85 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -64.02 -44.99 90.89 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.513 -0.742 . . . . 0.0 109.861 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 103' ' ' LEU . 24.9 tp -62.78 -42.13 99.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -62.71 -42.01 99.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 22.1 ttt -63.03 -38.44 91.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 109.653 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.36 -29.94 71.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.786 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -53.66 -32.57 52.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 108.874 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.59 -18.47 58.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.301 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 22.09 60.22 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.96 84.31 44.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.397 -1.061 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.95 152.29 65.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.751 2.301 . . . . 0.0 112.429 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 75.0 m-85 -55.42 -39.23 69.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 108.828 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.96 80.27 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.141 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.8 -35.67 75.04 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.007 -1.058 . . . . 0.0 109.114 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 30.6 t80 -70.64 -51.81 25.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.662 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 112' ' ' PHE . 17.8 m -57.85 -42.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.769 -1.207 . . . . 0.0 109.517 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.498 ' N ' HG23 ' A' ' 116' ' ' VAL . 20.3 m95 -63.19 -31.16 72.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.1 p -64.12 -30.98 72.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.019 . . . . 0.0 110.078 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.28 -39.11 81.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.682 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 123' ' ' GLN . 18.6 m -97.11 14.14 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 109.324 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.46 39.85 31.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.469 -0.77 . . . . 0.0 110.292 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 9.8 m170 58.64 34.53 23.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.429 -0.794 . . . . 0.0 109.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.521 ' H ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -120.92 87.24 42.81 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 109.049 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.68 146.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.527 2.151 . . . . 0.0 112.166 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -114.22 152.61 30.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 84.6 mtp -134.22 156.16 48.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 108.766 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.42 157.43 31.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.206 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' A' ' 177' ' ' VAL . 62.8 tt0 -133.75 58.78 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -92.85 141.5 28.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.0 m -72.53 -36.66 68.37 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 133' ' ' SER . 12.7 t -134.73 173.74 11.35 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.73 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 6' ' ' TRP . 30.6 mt -66.13 -31.62 72.58 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.661 -0.65 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.431 ' H ' HG23 ' A' ' 131' ' ' THR . 53.5 p -59.89 -36.97 78.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.982 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -67.2 -29.59 69.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.759 -1.213 . . . . 0.0 110.184 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.89 123.01 88.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.011 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.65 137.31 14.32 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.307 2.005 . . . . 0.0 111.69 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.2 m -95.5 -6.69 40.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -120.1 98.93 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 109.657 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.2 p -108.87 152.42 42.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.792 . . . . 0.0 108.875 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -49.51 -38.12 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.066 1.844 . . . . 0.0 112.561 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.58 -42.02 71.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 166' ' ' MET . 22.4 m -60.6 -42.21 96.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.956 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.28 -44.39 95.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.996 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.86 83.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.716 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.1 tt -64.12 -41.2 97.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 110.721 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 -37.96 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.956 -1.09 . . . . 0.0 109.548 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.78 -38.65 91.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB1' ' NH2' ' A' ' 152' ' ' ARG . . . -63.65 -45.2 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 110.324 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 149' ' ' LEU . 96.2 mt -62.67 -38.45 90.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.02 -1.05 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -59.83 -40.05 87.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -61.96 -40.11 94.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 110.331 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 152' ' ' ARG . 3.4 mtt-85 -64.29 -20.72 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.43 12.0 20.43 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.5 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.3 m-85 -85.85 130.9 34.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -1.185 . . . . 0.0 109.692 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -101.46 175.71 5.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.436 -0.79 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 60.39 48.96 7.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.5 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.61 24.69 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.13 0.14 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.4 m -57.89 -28.92 64.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.445 -1.032 . . . . 0.0 109.824 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -67.19 -48.23 68.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.062 -1.024 . . . . 0.0 109.666 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.05 -34.73 71.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -0.95 . . . . 0.0 109.482 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -45.34 69.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.184 -0.948 . . . . 0.0 108.906 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.32 -43.65 98.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.839 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 t -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 108.879 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -61.28 -40.04 92.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.396 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.531 ' SD ' ' OG ' ' A' ' 142' ' ' SER . 65.8 mtp -62.38 -39.48 93.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.057 -1.027 . . . . 0.0 109.058 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.41 -43.52 98.63 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.48 -38.27 59.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.6 t -60.97 -37.66 83.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.709 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.49 3.5 59.77 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.3 mt -57.32 -34.94 69.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 108.734 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.92 141.51 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 127' ' ' THR . 65.0 t30 -91.54 104.22 16.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.975 -1.078 . . . . 0.0 109.552 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 20.6 p-10 -110.13 91.68 3.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.598 0.713 . . . . 0.0 109.607 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.591 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.9 m-70 -133.38 -117.76 0.2 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 178' ' ' GLY . 1.6 p -141.97 154.29 19.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 108.415 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 128' ' ' GLN . 8.0 p -45.18 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.908 -1.12 . . . . 0.0 109.947 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -128.63 81.25 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.947 -1.12 . . . . 0.0 110.342 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 2.7 t -104.9 156.75 17.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -1.149 . . . . 0.0 108.569 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 46.8 m -57.55 -44.13 84.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.979 -1.076 . . . . 0.0 109.143 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 89.6 m -76.11 -34.39 59.49 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 28.2 t80 -123.8 83.68 54.39 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.796 . . . . 0.0 110.251 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.6 Cg_endo -80.58 -63.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.739 2.293 . . . . 0.0 112.132 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.28 -14.59 2.27 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 183' ' ' PRO . 16.7 m120 -91.5 1.25 57.26 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.439 -1.036 . . . . 0.0 108.602 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -141.39 158.41 63.77 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.597 2.198 . . . . 0.0 112.224 179.901 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.435 0.636 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.9 152.41 45.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.923 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -123.17 152.08 41.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.559 -0.713 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -145.13 -162.32 1.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.1 -1.0 . . . . 0.0 109.529 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 115.23 -7.24 21.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.738 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 44.42 16.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.622 -0.928 . . . . 0.0 108.844 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 7' ' ' VAL . 8.7 m -46.2 120.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.7 t -62.19 -62.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.952 . . . . 0.0 109.927 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -175.4 69.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.11 137.06 9.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 0.0 109.182 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.31 -31.45 28.47 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.113 1.875 . . . . 0.0 112.414 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.6 mp -63.22 -37.46 87.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 109.208 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -65.25 -48.55 72.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.29 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 7' ' ' VAL . 82.7 mt -71.48 -38.03 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.578 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.913 -1.117 . . . . 0.0 108.393 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.54 -35.77 81.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.7 t-80 -57.27 -53.74 54.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.515 -0.74 . . . . 0.0 110.461 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 84.7 m-20 -71.16 -44.34 65.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 0.0 110.972 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.46 -40.47 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.032 . . . . 0.0 110.684 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -153.78 -124.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.049 . . . . 0.0 109.244 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.501 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.56 93.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.13 -9.23 46.16 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.19 139.52 75.84 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.117 -1.225 . . . . 0.0 108.468 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.5 125.01 14.17 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.048 1.832 . . . . 0.0 112.56 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -121.48 130.45 53.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.483 -0.76 . . . . 0.0 109.088 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -117.78 1.07 12.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 0.0 109.529 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -79.51 122.83 26.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.638 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -61.98 -37.69 85.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -60.46 -54.03 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 0.0 109.624 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -65.83 -41.53 91.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.572 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.626 HD12 ' SG ' ' A' ' 169' ' ' CYS . 6.8 tp -65.15 -43.87 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.51 -48.36 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.532 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' C ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.104 -0.997 . . . . 0.0 109.406 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.498 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 59.4 tpp -62.34 -41.23 98.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.916 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -67.86 -47.37 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.093 -1.005 . . . . 0.0 109.993 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.58 -33.2 75.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.011 -1.056 . . . . 0.0 109.91 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.2 tp -63.72 -38.29 90.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' O ' ' A' ' 34' ' ' MET . 0.5 OUTLIER -61.28 -32.8 72.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 110.706 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 156' ' ' PHE . . . -53.29 -33.56 46.34 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 52' ' ' LYS . 26.3 tt0 -60.37 -37.64 81.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.668 -0.901 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 42' ' ' ALA . 35.2 tt0 -58.22 -37.43 74.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.99 . . . . 0.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.93 118.03 1.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.965 . . . . 0.0 109.831 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.71 -26.94 13.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.7 mt -111.23 -141.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.159 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -141.57 154.79 45.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.084 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -54.08 -37.99 64.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.53 -39.4 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.077 -1.015 . . . . 0.0 109.87 -179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.1 m -66.48 -34.98 79.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.928 -1.107 . . . . 0.0 110.527 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.04 -41.43 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 111.61 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.2 mm? -56.87 -51.04 70.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.662 -1.274 . . . . 0.0 110.78 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HE3' HD22 ' A' ' 12' ' ' LEU . 80.2 mttt -60.42 -52.81 63.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.745 -1.222 . . . . 0.0 109.615 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' HE22 ' A' ' 40' ' ' GLN . 45.8 mmtm -62.74 -31.83 72.85 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -53.83 -41.79 67.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.969 . . . . 0.0 108.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.21 -43.62 81.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.583 ' CG ' HG22 ' A' ' 85' ' ' ILE . 43.9 t-20 -63.69 -38.32 90.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.086 -1.009 . . . . 0.0 109.12 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 73.2 t80 -56.68 -47.22 80.32 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.467 -0.771 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 57' ' ' ARG . 46.4 mtt-85 -63.41 -27.83 69.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 62' ' ' GLN . . . -60.64 -51.3 69.98 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.845 -1.159 . . . . 0.0 110.893 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 m -94.1 -35.62 12.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 112.641 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.475 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 65.8 m-85 -79.21 -52.36 8.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.581 -1.324 . . . . 0.0 112.887 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -59.38 -38.22 79.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.653 -1.279 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' A' ' 58' ' ' ALA . 93.6 mt-30 -58.71 -35.04 72.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.937 -1.102 . . . . 0.0 109.386 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 64' ' ' ASP . 10.8 m-85 -86.16 -4.01 59.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 62.8 148.33 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 108.818 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.98 -28.12 66.38 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.473 2.115 . . . . 0.0 113.119 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.98 -47.61 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 109.904 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' MET . 23.6 mttm -64.52 -32.46 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.363 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.4 -43.73 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.873 . . . . 0.0 109.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.73 -24.1 61.73 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.68 19.75 20.04 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.867 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.4 mtp -83.5 161.91 21.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.363 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.68 159.42 15.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.29 -30.93 68.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.302 -0.874 . . . . 0.0 109.306 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.92 -37.38 79.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.067 -1.021 . . . . 0.0 108.851 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.69 -38.18 77.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 108.847 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.17 -39.88 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.587 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -59.61 -38.59 81.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.4 -41.41 93.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.173 -0.955 . . . . 0.0 109.331 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.5 mt -67.22 -32.48 73.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.911 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.58 -39.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.174 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -107.04 -41.56 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -0.813 . . . . 0.0 109.777 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 52.5 t0 -85.65 160.8 19.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 92.29 -31.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.22 0.533 . . . . 0.0 109.693 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.56 32.55 78.96 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.583 HG22 ' CG ' ' A' ' 55' ' ' ASN . 34.0 pt -106.94 166.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.315 -1.109 . . . . 0.0 109.205 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ILE . 74.9 mt -46.11 125.85 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 108.695 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.83 131.73 54.7 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.468 -179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.659 ' O ' ' N ' ' A' ' 90' ' ' GLY . 1.3 t-80 -164.25 14.77 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.474 -0.766 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 89' ' ' ARG . 8.3 ttt-85 53.3 -70.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.93 -45.25 96.18 Favored Glycine 0 N--CA 1.493 2.453 0 O-C-N 121.251 -0.906 . . . . 0.0 111.282 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.54 -42.14 95.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.771 -1.429 . . . . 0.0 109.834 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.89 -41.71 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.077 . . . . 0.0 108.672 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.08 -36.13 74.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.73 87.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.346 -0.846 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.92 -49.34 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.838 . . . . 0.0 109.351 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.2 mt -57.38 -42.15 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.94 -37.59 91.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -59.7 -41.04 89.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.032 -1.275 . . . . 0.0 109.336 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.8 79.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.271 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.45 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 17.5 mmm-85 -60.78 -42.33 97.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.87 -42.36 66.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.307 -0.871 . . . . 0.0 109.884 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -60.31 -43.6 96.2 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.389 -0.82 . . . . 0.0 110.285 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.41 -40.66 97.81 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.875 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -60.71 -39.55 88.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.106 -0.996 . . . . 0.0 109.858 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.2 ttt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.44 -28.24 69.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.168 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -53.49 -31.63 46.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.985 -1.072 . . . . 0.0 109.263 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -80.35 -6.91 58.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.53 29.03 66.42 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -111.29 113.51 54.01 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.38 -1.071 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.09 133.83 47.97 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.613 1.542 . . . . 0.0 112.175 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -64.44 -42.72 95.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.724 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.57 98.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.368 -0.833 . . . . 0.0 110.496 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -56.37 -38.41 71.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.904 -1.123 . . . . 0.0 109.17 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 76.1 t80 -61.18 -47.97 83.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.4 -44.12 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -59.73 -36.91 77.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.779 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.7 m -61.93 -36.92 82.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 m-85 -65.1 -28.61 69.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 110.613 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.7 m -101.93 21.36 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 0.0 109.011 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 25.0 t-20 62.65 34.94 14.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.51 -0.744 . . . . 0.0 109.723 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 50.1 t-80 42.95 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.49 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' ASN . 9.2 tt0 -112.98 108.8 52.98 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.557 -0.714 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.12 146.91 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.04 1.827 . . . . 0.0 111.668 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -115.07 143.96 44.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.812 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.9 ptp -136.22 154.18 51.0 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -131.38 159.06 39.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -124.09 52.57 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.9 123.93 27.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 109.815 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.2 m -65.89 -39.58 90.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.921 -1.112 . . . . 0.0 108.843 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -133.24 171.02 14.59 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.585 0.707 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.53 -33.44 73.84 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.6 t -56.99 -36.67 70.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -64.7 -31.28 72.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.278 -0.889 . . . . 0.0 109.971 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.23 124.05 89.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 138' ' ' SER . 52.1 Cg_endo -74.29 -12.9 23.19 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.045 1.83 . . . . 0.0 112.34 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -2.03 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.805 -0.56 . . . . 0.0 110.457 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 136' ' ' PRO . 25.2 p -131.5 93.95 3.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.842 . . . . 0.0 109.651 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.86 155.47 36.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.53 -29.01 77.96 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.473 2.115 . . . . 0.0 112.291 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.31 74.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.74 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -61.43 -44.86 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.778 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -64.26 -45.55 87.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.29 86.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 149' ' ' LEU . 7.1 tt -63.71 -39.05 93.35 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.347 -0.845 . . . . 0.0 109.739 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.8 m -58.73 -44.93 90.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.345 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -63.25 -36.58 84.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.896 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.12 69.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.859 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 145' ' ' LEU . 52.9 mt -64.46 -37.42 87.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.074 -1.016 . . . . 0.0 108.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -58.26 -40.63 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.67 -40.26 94.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -64.34 -20.78 66.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.13 24.81 8.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.39 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -85.31 138.95 31.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.981 -1.305 . . . . 0.0 109.309 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.622 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 31.8 mttt -97.77 177.29 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.907 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.622 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 22.6 p90 44.43 48.18 8.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.602 0.715 . . . . 0.0 109.927 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.2 m -104.31 24.49 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 109.424 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.44 158.86 0.53 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 38.5 m -56.78 -30.06 63.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.414 -1.051 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 160' ' ' THR . 0.1 OUTLIER -68.62 -45.59 71.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.744 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.29 -42.62 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.051 -1.031 . . . . 0.0 109.224 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.17 -46.32 87.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -61.0 -43.76 98.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.757 -1.214 . . . . 0.0 109.779 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.2 t -62.84 -40.97 99.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.038 -1.039 . . . . 0.0 109.649 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.35 89.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.9 mtp -66.91 -38.84 86.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.039 -1.038 . . . . 0.0 110.239 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.26 -42.5 65.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.442 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 31' ' ' LEU . 79.9 m -63.24 -37.08 85.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.529 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.96 6.01 56.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -54.89 -34.45 63.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.268 . . . . 0.0 108.23 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.14 139.17 51.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 127' ' ' THR . 80.3 m-20 -99.74 101.4 12.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.151 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.0 p30 -121.35 90.31 3.29 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.635 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 12.3 m170 -122.52 -67.45 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -159.57 -89.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -35.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.99 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -143.93 47.9 0.76 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 181' ' ' CYS . 3.9 t -64.74 79.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 109.722 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.528 ' C ' ' O ' ' A' ' 179' ' ' CYS . 1.6 p 25.44 -83.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.432 0.634 . . . . 0.0 111.247 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 179' ' ' CYS . 25.4 m -48.84 -29.07 4.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 110.036 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 12.1 t80 -118.92 80.05 17.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 109.717 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.78 -20.48 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.662 2.241 . . . . 0.0 111.932 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.27 71.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.33 42.65 24.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 0.0 109.439 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -128.74 80.72 72.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.515 -0.741 . . . . 0.0 109.217 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.794 2.329 . . . . 0.0 111.997 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 24.4 pt-20 -104.62 162.42 13.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.691 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 1.1 ptt-85 -140.36 179.0 6.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 109.639 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 153.87 7.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.644 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.8 -3.62 54.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE2' HD22 ' A' ' 132' ' ' LEU . 97.6 m95 -57.11 -44.52 83.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.762 HG11 ' CD1' ' A' ' 13' ' ' TYR . 31.1 m -126.76 161.39 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.427 -0.796 . . . . 0.0 110.09 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 t -149.9 -61.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 109.603 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.46 25.66 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -120.26 82.5 30.97 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.899 . . . . 0.0 109.733 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.96 -37.74 97.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 112.181 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 12' ' ' LEU . 9.2 tt -64.12 -42.74 96.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 108.746 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CD1' HG11 ' A' ' 7' ' ' VAL . 13.5 t80 -67.62 -46.57 72.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 109.175 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.25 -37.34 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.493 -0.755 . . . . 0.0 110.016 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.14 -44.8 94.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.973 -1.079 . . . . 0.0 108.659 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 75.7 t80 -67.16 -37.51 83.9 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.381 -0.824 . . . . 0.0 108.96 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.0 t-80 -55.13 -49.7 71.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -69.97 -39.53 75.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -56.03 -39.75 72.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 21' ' ' TRP . 5.2 pt-20 -168.89 -104.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 108.834 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.509 ' CZ3' ' CD2' ' A' ' 17' ' ' HIS . 18.3 t90 52.03 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 109.677 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.28 8.67 40.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' CYS . 64.8 t -101.29 107.0 48.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.34 -1.094 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.69 123.41 12.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.166 1.911 . . . . 0.0 112.449 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 25.5 tp10 -115.4 141.98 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 0.0 108.987 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.8 p -103.94 3.11 33.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.175 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 86.4 m-20 -79.84 116.35 19.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 19.8 m -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -59.37 -43.59 92.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.15 -0.969 . . . . 0.0 110.129 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tttp -64.26 -47.77 78.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.908 -1.12 . . . . 0.0 109.931 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 mp -64.05 -39.19 93.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.466 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 57.7 t80 -62.53 -46.44 88.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.605 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.74 -31.65 70.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.043 -1.036 . . . . 0.0 109.779 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.438 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 1.5 tpt -62.76 -52.66 62.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.8 tp -62.7 -32.49 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.844 -1.16 . . . . 0.0 109.852 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.74 -45.38 78.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.29 -38.69 78.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.359 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 72.7 mm-40 -61.81 -35.79 79.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.984 -1.072 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.59 61.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -62.23 -32.63 73.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -1.011 . . . . 0.0 109.144 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.6 pp0? -54.13 -23.27 13.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.549 -0.719 . . . . 0.0 110.424 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.64 108.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.65 -30.23 4.65 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 mt -106.2 145.92 30.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.128 . . . . 0.0 110.342 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.9 m -77.93 157.28 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.872 . . . . 0.0 109.517 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.782 ' NE1' HD21 ' A' ' 50' ' ' LEU . 75.7 t-105 -55.04 -31.04 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -52.93 -42.04 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.91 . . . . 0.0 109.378 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 90.0 m -71.27 -35.96 71.56 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.123 -0.986 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 72.7 t -59.8 -39.23 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 111.023 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.782 HD21 ' NE1' ' A' ' 46' ' ' TRP . 80.3 mt -54.57 -48.53 71.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.225 . . . . 0.0 109.646 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -57.9 -38.65 76.21 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -23.24 59.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.264 -0.898 . . . . 0.0 109.104 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 36.2 ttm180 -55.9 -49.51 73.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 108.879 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -72.88 -43.74 62.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.313 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.83 -38.92 92.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.817 -1.177 . . . . 0.0 109.482 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 73.0 t80 -57.26 -44.05 83.56 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.728 HH12 ' CD2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -61.7 -33.33 73.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.961 . . . . 0.0 109.089 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.96 -39.03 80.48 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.765 -1.21 . . . . 0.0 110.163 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -93.02 -40.11 10.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.877 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 96.1 m-85 -93.28 -28.85 15.98 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.817 -1.177 . . . . 0.0 112.85 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.728 ' CD2' HH12 ' A' ' 57' ' ' ARG . 56.1 t60 -57.59 -42.59 83.49 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.462 -1.399 . . . . 0.0 110.614 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.34 -40.74 91.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 109.588 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 39.8 m-85 -75.1 -35.26 61.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 72.35 159.22 0.16 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.818 -179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.48 -35.2 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.4 2.066 . . . . 0.0 112.26 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.7 t -62.87 -48.8 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.728 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' PHE . 13.5 tttm -67.08 -34.54 77.89 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.096 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.1 t -55.77 -43.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.85 -21.54 61.66 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.05 10.58 40.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.55 -0.719 . . . . 0.0 111.094 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.5 mtm -86.4 164.81 16.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.477 -1.39 . . . . 0.0 110.086 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.7 164.74 12.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.53 -32.97 63.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 109.453 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.24 -37.26 69.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.942 . . . . 0.0 109.363 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.29 -38.83 81.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.188 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.8 t -60.74 -42.75 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -59.43 -38.66 81.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -61.68 -45.54 93.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 82' ' ' ASP . 82.9 mt -71.35 -32.98 69.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 110.42 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.6 t -53.15 -36.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.74 -62.16 1.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-20 -100.19 141.42 33.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -177.05 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 109.827 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.4 6.45 86.52 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 83' ' ' ALA . 40.3 pt -125.65 173.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.782 -0.834 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' ILE . 73.1 mt -44.35 142.83 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 39.2 mtt-85 -107.63 149.98 27.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.6 m-70 166.06 105.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' HG21 ' A' ' 80' ' ' VAL . 98.6 mtt180 -51.88 -34.49 41.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 108.939 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.36 -39.31 61.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 88' ' ' HIS . 19.4 tttt -60.61 -47.61 85.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.422 -1.046 . . . . 0.0 110.411 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 76' ' ' VAL . 80.5 mt -64.17 -45.34 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.928 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -60.43 -33.07 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.099 -1.001 . . . . 0.0 109.114 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.83 85.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.063 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.41 -44.48 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.038 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.13 -37.76 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.838 . . . . 0.0 109.614 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.92 -45.49 96.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.694 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 20.5 m120 -62.41 -41.02 98.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.272 . . . . 0.0 109.8 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -43.71 81.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.142 -0.974 . . . . 0.0 109.27 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.63 -44.28 97.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.48 -40.74 63.89 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.413 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 58.5 t80 -61.63 -48.99 78.39 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.12 -40.48 90.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.205 -0.934 . . . . 0.0 109.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 61.4 tp60 -60.9 -40.24 92.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.283 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.449 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 6.6 ttt -63.1 -42.96 99.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.344 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.31 -29.85 71.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.255 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.532 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 54.0 tt0 -53.29 -31.79 45.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -76.44 -15.57 59.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 109.463 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.56 22.43 43.57 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -113.72 105.14 55.0 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -51.68 136.28 49.85 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.107 1.871 . . . . 0.0 112.702 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.76 -44.19 94.19 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.52 0.676 . . . . 0.0 109.521 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.06 -40.19 96.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.784 . . . . 0.0 109.996 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -63.49 -34.74 78.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.992 -1.068 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.14 -50.31 73.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.61 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.65 -40.34 86.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.9 -1.125 . . . . 0.0 109.566 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -55.78 -37.33 68.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.055 . . . . 0.0 108.92 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -62.9 -34.87 78.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.007 -1.058 . . . . 0.0 109.325 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.61 -31.55 72.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 111.181 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.89 22.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 0.0 109.359 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 123' ' ' GLN . 8.9 t-20 59.89 32.06 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.543 -0.723 . . . . 0.0 109.639 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.95 -7.27 0.07 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 110.085 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -97.94 131.31 26.89 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.55 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.75 154.74 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.336 2.024 . . . . 0.0 112.213 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 172' ' ' VAL . 75.8 mt-30 -98.96 147.58 24.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 108.92 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.95 147.57 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.964 . . . . 0.0 109.688 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -87.38 154.75 20.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -158.56 46.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.45 -127.0 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.403 -0.81 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.7 m -164.73 -30.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -113.45 151.46 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.149 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 6' ' ' TRP . 76.9 mt -61.68 -32.8 73.01 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.358 -0.839 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.5 p -67.12 -33.7 76.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.339 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.23 -27.71 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.74 124.77 90.18 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 0.0 109.274 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.17 138.71 28.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 2.81 39.24 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.306 -0.872 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 159' ' ' THR . 6.9 m -143.77 82.86 1.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.77 159.6 60.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 108.991 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -49.07 -37.58 38.23 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.923 1.749 . . . . 0.0 111.747 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.39 81.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.837 . . . . 0.0 109.547 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -61.86 -47.55 84.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.047 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.95 -42.58 99.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.891 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.27 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.938 . . . . 0.0 110.107 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.474 HD21 HD11 ' A' ' 149' ' ' LEU . 8.2 tt -65.38 -41.69 93.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.4 p -60.46 -41.09 93.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.0 109.1 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -64.05 -37.74 88.55 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.172 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.63 -49.44 71.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.781 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 145' ' ' LEU . 47.6 mt -61.2 -38.57 87.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.018 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.45 -44.9 92.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.864 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.61 -39.11 92.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.058 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 31.4 mmt180 -64.16 -20.63 66.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.32 28.79 6.27 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.694 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 2.7 m-85 -91.38 133.8 35.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -1.119 . . . . 0.0 109.728 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -99.65 162.04 13.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 161' ' ' ILE . 70.9 m-85 60.36 54.61 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.509 -0.744 . . . . 0.0 109.863 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 158' ' ' GLY . 34.9 m -118.18 24.85 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 109.679 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.38 159.53 0.08 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.515 HG21 ' OG ' ' A' ' 138' ' ' SER . 51.7 m -57.15 -30.37 64.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.39 -1.065 . . . . 0.0 109.678 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.9 p -71.34 -41.26 70.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.411 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 156' ' ' PHE . 90.2 mt -66.0 -39.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.81 . . . . 0.0 109.904 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 108.975 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.493 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.1 t80 -62.5 -43.44 98.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 t -61.11 -40.85 95.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -46.69 89.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 88.1 mtp -59.31 -39.87 84.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.0 109.065 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.96 -42.44 89.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.381 -0.825 . . . . 0.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.24 -47.63 56.01 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' CD2' ' A' ' 171' ' ' LEU . 3.9 t -64.74 -51.63 61.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.79 9.56 4.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.614 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mm? -57.53 -36.34 71.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.83 -1.394 . . . . 0.0 108.682 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 125' ' ' GLN . 14.8 p -132.01 142.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.017 . . . . 0.0 109.179 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.493 ' OD2' ' OH ' ' A' ' 163' ' ' TYR . 84.5 m-20 -119.25 92.04 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -125.68 -81.61 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.84 HG22 ' H ' ' A' ' 177' ' ' VAL . 12.8 p -174.8 -125.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.457 -0.777 . . . . 0.0 109.332 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.84 ' H ' HG22 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -128.21 -32.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.247 -0.908 . . . . 0.0 109.875 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . -124.22 43.96 1.34 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 181' ' ' CYS . 44.4 t -74.65 28.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.239 . . . . 0.0 109.105 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 178' ' ' GLY . 2.9 m 62.57 -66.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 179' ' ' CYS . 72.3 m -54.34 -32.18 56.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.916 . . . . 0.0 109.962 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.8 t80 -123.37 82.23 52.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.404 -0.81 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.64 -69.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.64 65.29 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -135.31 19.27 3.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -1.084 . . . . 0.0 109.393 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -132.38 151.12 77.7 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.651 -0.656 . . . . 0.0 109.297 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.561 2.174 . . . . 0.0 112.282 179.736 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 178' ' ' GLY . 1.1 pt-20 -103.8 154.5 19.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.557 ' HG3' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -103.9 163.51 12.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.096 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' HG12 ' A' ' 7' ' ' VAL . 1.9 m -66.17 153.73 41.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.603 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.71 -19.35 71.17 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.595 ' CE2' HD22 ' A' ' 132' ' ' LEU . 90.2 m95 -52.66 -40.0 62.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.405 . . . . 0.0 109.912 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG13 ' N ' ' A' ' 8' ' ' SER . 11.0 p -66.02 -127.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.453 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.801 ' N ' HG13 ' A' ' 7' ' ' VAL . 1.5 p 79.62 113.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 109.203 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 55.02 39.04 31.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 108.756 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -160.96 62.63 1.64 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.441 -0.787 . . . . 0.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.71 -32.46 45.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.137 1.892 . . . . 0.0 111.837 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.22 -39.77 94.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 0.0 108.507 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -65.25 -42.37 93.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -56.66 -42.62 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.197 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -58.99 -44.17 91.55 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.9 -39.25 93.91 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CD2' ' CE3' ' A' ' 21' ' ' TRP . 11.8 t-80 -58.92 -48.21 82.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.5 -41.25 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -55.03 -43.01 73.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 110.486 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.39 104.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.65 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 35.6 t90 -163.71 107.62 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 0.0 109.577 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.85 -2.66 57.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 116.51 55.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -1.117 . . . . 0.0 109.098 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.67 125.63 14.61 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.832 1.688 . . . . 0.0 112.426 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -115.04 129.25 56.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' HE1' ' A' ' 117' ' ' TRP . 67.1 p -113.67 -0.69 14.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 109.793 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -84.03 125.35 32.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.2 p -63.49 -32.27 73.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.25 -54.11 42.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.001 . . . . 0.0 109.452 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.35 -38.04 89.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.449 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.558 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.5 tp -63.56 -47.49 81.34 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.458 -0.777 . . . . 0.0 109.928 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.579 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 76.7 t80 -61.73 -41.87 98.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.128 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 45.9 tp10 -61.01 -31.93 71.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.847 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 52.2 tpp -67.08 -49.05 66.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 0.0 111.39 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tp -65.1 -32.56 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.786 -1.196 . . . . 0.0 111.247 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 33' ' ' GLU . 19.3 p -69.09 -43.02 75.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 0.0 110.425 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD13 ' HG3' ' A' ' 53' ' ' ARG . 82.3 mt -63.74 -37.55 87.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.01 -29.17 70.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.24 -37.84 31.96 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.99 -31.63 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.24 . . . . 0.0 109.584 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 44' ' ' LEU . 48.0 tt0 -51.99 -33.55 38.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.841 . . . . 0.0 109.827 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.27 109.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.024 -1.047 . . . . 0.0 109.406 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -18.52 54.44 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.2 mt -119.21 -163.56 0.98 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.542 -0.975 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -124.76 153.07 43.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.572 -0.705 . . . . 0.0 109.524 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 42.9 p90 -57.21 -33.06 67.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.078 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -59.44 -40.97 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.01 -1.057 . . . . 0.0 109.054 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.0 m -72.03 -35.14 69.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.179 -0.951 . . . . 0.0 109.589 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 t -59.85 -36.81 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.523 -0.736 . . . . 0.0 110.765 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.7 mt -55.87 -45.32 78.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.617 -1.302 . . . . 0.0 110.041 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -50.83 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.253 . . . . 0.0 109.098 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -64.12 -31.4 72.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 108.936 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 37' ' ' LEU . 67.9 ttt180 -54.38 -44.15 72.01 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.489 -0.757 . . . . 0.0 109.643 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.37 -43.13 74.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.164 -0.96 . . . . 0.0 109.338 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.0 -39.58 90.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.46 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.896 ' OH ' HG21 ' A' ' 95' ' ' ILE . 64.8 t80 -58.38 -44.19 88.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.275 -0.891 . . . . 0.0 109.366 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.486 HH21 ' CE1' ' A' ' 61' ' ' HIS . 48.6 mtp180 -62.99 -32.23 73.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.089 -1.007 . . . . 0.0 109.514 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.11 -41.58 92.88 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.87 -1.144 . . . . 0.0 110.446 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.98 -41.68 9.87 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 111.743 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 92.3 m-85 -85.99 -37.95 18.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.991 -1.068 . . . . 0.0 113.14 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' CE1' HH21 ' A' ' 57' ' ' ARG . 33.5 t60 -52.24 -40.36 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.657 -1.277 . . . . 0.0 110.856 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 63' ' ' PHE . 13.6 pt20 -58.93 -40.48 84.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.186 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 68.1 m-85 -67.62 -24.91 65.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.016 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 71.13 147.59 0.12 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.812 -1.18 . . . . 0.0 108.203 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.19 -30.04 85.78 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.362 2.041 . . . . 0.0 113.429 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.48 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.747 -1.22 . . . . 0.0 109.417 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' MET . 19.4 mtpp -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 109.586 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 96' ' ' ILE . 62.6 t -56.02 -44.1 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.204 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.06 58.35 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.5 8.78 44.46 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 109.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' LYS . 22.9 mtp -75.61 146.29 40.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.385 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -99.05 166.38 11.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.847 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 54.7 mp0 -61.87 -35.02 77.08 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.57 -33.21 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.898 -1.126 . . . . 0.0 109.177 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -61.65 -40.26 94.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -63.47 -42.74 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.788 -1.195 . . . . 0.0 109.046 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 97.1 mt-10 -55.58 -36.35 66.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -65.47 -46.97 77.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.431 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.2 mt -72.26 -27.76 62.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -51.71 -35.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.75 -1.219 . . . . 0.0 109.021 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.76 -60.82 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.973 . . . . 0.0 109.81 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.732 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.8 m-20 -75.33 166.41 23.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.76 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 86.6 86.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.768 0.794 . . . . 0.0 109.548 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -57.91 1.47 0.22 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 83' ' ' ALA . 22.6 pt -57.1 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -1.18 . . . . 0.0 109.341 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.9 mt -79.78 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.932 -1.105 . . . . 0.0 109.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 26.8 mtt-85 -94.9 129.52 41.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.35 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m170 179.56 92.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -50.63 -35.64 31.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.83 -47.56 81.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.51 -40.14 96.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.102 -1.234 . . . . 0.0 110.512 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.8 mt -58.25 -49.51 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.002 -1.061 . . . . 0.0 109.335 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.61 -32.9 73.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.655 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.91 88.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.967 . . . . 0.0 109.728 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.896 HG21 ' OH ' ' A' ' 56' ' ' TYR . 16.5 mt -58.66 -44.36 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 108.989 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' VAL . 82.4 mt -58.14 -49.3 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.459 -0.775 . . . . 0.0 110.017 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.32 95.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.579 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 54.5 t30 -57.37 -45.22 84.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -1.113 . . . . 0.0 109.873 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.23 85.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.049 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.626 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -62.5 -43.88 97.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.277 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.99 -41.41 77.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.17 -0.956 . . . . 0.0 108.788 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -66.4 -47.81 72.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 103' ' ' LEU . 28.5 tp -63.88 -38.76 92.29 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -61.11 -42.38 98.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.6 ttt -67.18 -42.76 83.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.506 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.56 -28.32 68.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -52.79 -32.05 41.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.89 . . . . 0.0 109.313 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.47 -17.12 60.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.2 -0.937 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.25 5.6 60.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -89.1 113.44 56.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.296 -1.12 . . . . 0.0 108.931 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -53.75 129.36 33.62 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.566 1.511 . . . . 0.0 112.079 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -68.76 -45.51 71.22 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.969 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.65 92.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.596 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -55.73 -38.66 70.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.814 -1.179 . . . . 0.0 109.195 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.33 -50.8 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.9 -42.67 93.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 26' ' ' THR . 45.5 m95 -59.5 -39.11 82.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.86 . . . . 0.0 110.123 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.6 m -60.84 -36.61 79.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.193 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -61.12 -28.76 69.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.137 -0.977 . . . . 0.0 110.656 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.2 23.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 17.3 t-20 68.96 33.68 3.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.595 -0.691 . . . . 0.0 109.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 51.6 t-80 42.92 23.19 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.775 -0.578 . . . . 0.0 110.241 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 121' ' ' ASN . 3.5 pt20 -133.09 149.89 73.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.164 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.52 148.36 59.97 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.52 2.147 . . . . 0.0 112.31 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -110.38 143.78 40.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.761 . . . . 0.0 109.222 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -131.64 152.55 50.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 109.209 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 t -136.48 159.15 42.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 0.0 110.013 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -120.27 50.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 142.11 58.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.399 -0.813 . . . . 0.0 109.937 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 -46.67 8.19 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -124.08 154.97 39.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 6' ' ' TRP . 69.2 mt -58.6 -33.55 70.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.591 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -32.42 73.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.598 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CD ' ' C ' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 109.944 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 137' ' ' THR . 53.1 mt -68.09 128.88 93.25 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 51.4 Cg_endo -72.96 -10.14 24.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.347 2.031 . . . . 0.0 112.81 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER 54.49 -4.03 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.112 0 O-C-N 121.834 -0.541 . . . . 0.0 110.281 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 22.6 t -134.4 91.37 2.78 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -86.02 149.67 50.89 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 108.801 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.11 -34.56 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.698 1.599 . . . . 0.0 111.798 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.59 -36.2 70.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.5 t -60.92 -46.46 90.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 110.053 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.66 -43.96 95.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.078 -1.014 . . . . 0.0 109.782 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 149' ' ' LEU . 7.8 tt -61.82 -43.01 99.71 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.037 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 20.4 t -59.96 -44.7 94.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.481 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.58 -38.09 88.76 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.99 76.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 157' ' ' VAL . 37.6 mt -65.99 -41.82 90.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 109.144 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -61.21 -35.12 76.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.09 -41.05 95.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 110.801 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 152' ' ' ARG . 23.5 ttm-85 -67.69 -22.29 65.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 0.0 109.816 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 123.03 9.16 6.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 50.3 m-85 -76.09 136.68 39.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.376 . . . . 0.0 109.513 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 2.1 mptm? -107.84 -172.28 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.104 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 40.2 p90 41.31 32.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 157' ' ' VAL . 14.5 p -110.03 25.23 3.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.565 -0.709 . . . . 0.0 109.507 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.82 165.46 0.27 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.5 m -55.98 -33.14 64.55 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.4 -1.059 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.1 p -66.48 -44.66 82.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.04 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -67.47 -39.37 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -0.998 . . . . 0.0 109.441 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -40.41 94.92 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.3 -44.37 95.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.161 -0.962 . . . . 0.0 109.776 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.6 m -60.75 -35.73 77.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.031 -1.043 . . . . 0.0 108.98 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -69.79 -37.97 76.49 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 109.662 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.705 ' SD ' HD12 ' A' ' 171' ' ' LEU . 95.2 mmm -60.87 -40.78 94.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.039 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.1 -41.05 29.55 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -65.59 -39.72 91.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' SG ' ' CD1' ' A' ' 31' ' ' LEU . 8.3 t -69.35 -34.34 74.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 109.809 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.06 8.22 45.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.705 HD12 ' SD ' ' A' ' 166' ' ' MET . 84.2 mt -58.31 -35.18 71.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.181 -1.188 . . . . 0.0 108.961 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -129.96 140.28 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -96.17 101.5 13.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.401 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -120.89 92.13 3.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.728 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.65 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 7.3 m170 -121.5 -90.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.97 138.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 177' ' ' VAL . 10.8 p -64.52 36.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -0.976 . . . . 0.0 110.086 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -149.97 -2.72 0.28 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.28 163.12 18.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.662 -0.905 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -39.81 91.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.302 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.83 -29.87 70.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.53 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -122.25 83.79 46.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.563 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.3 -9.69 26.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.182 1.921 . . . . 0.0 112.18 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.54 24.12 37.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 57.14 44.7 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.491 -1.005 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -128.06 151.57 76.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.534 -0.729 . . . . 0.0 109.041 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 C-N-CA 122.37 2.047 . . . . 0.0 112.249 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.223 0.535 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -104.75 154.41 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 109.059 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.898 ' NH2' HD13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -148.66 166.68 27.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.45 154.9 20.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.47 -18.52 15.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CE2' HD22 ' A' ' 132' ' ' LEU . 53.4 m95 -50.54 -35.48 29.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -1.13 . . . . 0.0 110.353 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 9' ' ' GLN . 94.6 t -60.0 130.52 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.086 -1.009 . . . . 0.0 110.03 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 9' ' ' GLN . 7.5 t -92.08 8.08 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.482 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.876 ' H ' HG12 ' A' ' 7' ' ' VAL . 33.8 tp60 86.19 35.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.57 137.17 25.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.91 -38.52 9.63 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.035 1.823 . . . . 0.0 112.303 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.06 -40.63 96.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.4 t80 -65.3 -45.81 82.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.358 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.898 HD13 ' NH2' ' A' ' 3' ' ' ARG . 89.9 mt -62.21 -38.59 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.221 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.95 89.08 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.896 -1.128 . . . . 0.0 108.294 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -71.13 -33.32 69.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.528 -0.732 . . . . 0.0 109.307 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 11.0 t-80 -55.63 -49.56 72.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 -42.28 68.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.338 -0.851 . . . . 0.0 111.081 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -57.34 -48.8 78.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.071 . . . . 0.0 110.517 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.75 -117.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.462 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 23.9 t90 55.16 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.925 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' OD1' ' A' ' 173' ' ' ASN . . . 104.79 -3.59 42.03 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.99 134.94 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.307 -1.114 . . . . 0.0 108.329 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.37 127.51 25.04 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.677 1.584 . . . . 0.0 112.478 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -109.78 134.03 52.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.768 . . . . 0.0 109.133 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -113.3 4.98 16.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -85.18 111.3 19.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.548 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.58 -37.47 86.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -59.55 -44.66 93.17 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.122 -0.986 . . . . 0.0 108.699 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -66.72 -45.34 79.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.805 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 31' ' ' LEU . 82.5 mt -66.45 -41.64 88.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 36.9 t80 -61.18 -49.36 77.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.413 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.34 -31.56 72.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.571 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.6 tpp -59.38 -45.83 90.37 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.468 -0.77 . . . . 0.0 110.127 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -46.93 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.879 -1.138 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.219 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 13.6 tp -65.37 -38.73 90.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.522 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 161' ' ' ILE . 89.6 mt-10 -60.01 -24.11 64.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 110.496 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.02 -41.32 21.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.563 ' OE1' ' CZ ' ' A' ' 87' ' ' ARG . 26.3 mt-30 -63.46 -33.75 76.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -1.189 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.8 tt0 -52.45 -35.63 52.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 110.378 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 109.79 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.916 -1.115 . . . . 0.0 109.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -122.43 -161.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.478 -1.013 . . . . 0.0 109.692 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.7 m -125.04 152.0 44.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.471 -0.768 . . . . 0.0 109.506 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.655 ' CE2' HD21 ' A' ' 50' ' ' LEU . 68.1 t-105 -56.4 -39.02 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 13' ' ' TYR . 10.3 tp -57.46 -43.29 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 0.0 110.337 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 34.6 m -64.33 -39.03 93.09 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.1 t -63.31 -39.51 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.712 -0.618 . . . . 0.0 111.026 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.655 HD21 ' CE2' ' A' ' 46' ' ' TRP . 86.2 mt -54.35 -52.22 62.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.719 -1.238 . . . . 0.0 110.44 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.9 -45.5 86.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.362 -1.461 . . . . 0.0 108.009 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 24.7 mttm -63.53 -27.85 69.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 53' ' ' ARG . 15.9 ttt-85 -53.22 -44.8 68.34 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.76 -42.82 97.74 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.361 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -64.4 -38.96 92.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.368 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.683 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 75.6 t80 -59.47 -44.49 93.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -0.819 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 57.5 mtp180 -59.04 -35.56 73.51 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.85 68.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -92.65 -20.39 20.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 111.577 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 73.8 m-85 -122.24 -34.56 3.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.996 -1.065 . . . . 0.0 111.342 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 48.7 t-80 -57.83 -42.87 85.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.0 109.655 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.83 -34.45 75.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 88.8 m-85 -78.79 -2.73 40.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 110.379 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 64.96 151.27 0.12 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.631 -1.293 . . . . 0.0 109.228 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -43.3 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.746 2.297 . . . . 0.0 113.623 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.42 -45.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.877 -1.139 . . . . 0.0 110.151 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mttm -62.73 -33.5 75.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 64' ' ' ASP . 79.6 t -57.71 -41.84 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.54 -26.88 63.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.07 24.81 11.67 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.772 -0.58 . . . . 0.0 110.388 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.598 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.3 mtp -69.34 151.26 46.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -99.64 167.01 10.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.11 -0.994 . . . . 0.0 108.962 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.8 mt-10 -63.14 -35.43 80.27 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.37 -0.831 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.0 -39.96 66.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.166 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.48 -37.63 81.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.269 -0.894 . . . . 0.0 109.229 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 80' ' ' VAL . 90.3 t -58.58 -45.53 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.02 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.0 mp0 -59.89 -36.17 76.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.601 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 78' ' ' ARG . 29.0 ttm-85 -61.25 -45.2 95.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.048 -1.033 . . . . 0.0 109.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 82' ' ' ASP . 75.4 mt -73.95 -30.16 62.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.409 -0.807 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' VAL . 43.1 t -54.42 -38.72 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.923 -1.11 . . . . 0.0 109.403 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -84.94 -51.45 6.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 20.6 t70 -96.87 146.06 25.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 109.777 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 88.25 83.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.713 0.768 . . . . 0.0 109.596 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -83.09 31.36 3.14 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 85' ' ' ILE . 4.3 pt -62.58 38.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.94 . . . . 0.0 110.461 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 86' ' ' ILE . 83.5 mt 58.01 6.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.796 . . . . 0.0 111.469 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 35.5 mtt-85 -95.69 126.39 40.93 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -106.25 174.37 5.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 32.4 ptt180 -45.89 -40.74 10.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 0.0 110.2 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -71.84 -48.18 28.9 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 32.5 mttm -63.7 -41.62 98.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.062 -1.258 . . . . 0.0 109.767 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.11 -39.08 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 108.809 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.36 -36.97 76.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.064 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.66 -37.27 85.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.47 -48.31 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.52 -47.12 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.762 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.61 93.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -61.54 -42.44 98.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.247 . . . . 0.0 110.053 -179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.37 91.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.55 -43.71 98.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 110.43 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.37 84.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.918 -1.114 . . . . 0.0 110.129 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 67.2 t80 -65.15 -43.89 90.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.379 -0.825 . . . . 0.0 111.13 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.5 -42.29 98.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 110.505 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.98 -37.63 88.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.902 -1.124 . . . . 0.0 110.085 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.73 -37.94 86.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.87 -1.144 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.55 -30.07 70.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.34 -30.95 42.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.04 -10.33 59.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.81 21.03 72.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.45 106.73 55.43 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.375 -1.074 . . . . 0.0 108.971 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -50.54 130.05 28.54 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.794 1.662 . . . . 0.0 112.24 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.11 -42.3 99.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 109.215 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.62 87.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.16 -35.57 79.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 77.1 t80 -61.03 -52.56 64.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 110.407 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 116' ' ' VAL . 2.3 p -61.32 -40.01 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.988 -1.07 . . . . 0.0 109.591 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -56.75 -36.32 69.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 109.359 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.6 p -66.22 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.85 -27.58 68.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.087 -1.008 . . . . 0.0 110.36 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.77 23.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 123' ' ' GLN . 64.9 m-20 63.82 33.33 12.8 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.522 0.677 . . . . 0.0 109.698 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 45.42 11.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.927 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.3 mt-30 -108.48 127.09 28.12 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.352 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.24 147.72 54.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.897 1.731 . . . . 0.0 111.91 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -113.7 145.18 41.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.7 ttp -125.6 137.16 53.89 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.38 143.02 27.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.93 -1.106 . . . . 0.0 110.276 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.94 43.18 3.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.05 157.24 16.91 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 110.256 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.36 -26.59 12.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.185 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 m -120.42 151.93 38.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.513 -0.742 . . . . 0.0 109.205 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 6' ' ' TRP . 67.3 mt -60.63 -33.05 72.21 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.483 -0.761 . . . . 0.0 109.366 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.8 t -58.65 -37.69 76.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 110.375 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 98.1 mt-10 -63.84 -31.96 73.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.331 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mt -72.11 119.08 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.993 -1.067 . . . . 0.0 109.623 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.53 135.78 16.71 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.008 1.805 . . . . 0.0 112.083 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -89.68 -12.86 38.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.86 . . . . 0.0 108.851 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.8 m -112.02 98.13 7.14 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 155.52 41.13 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.66 -32.58 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.433 2.088 . . . . 0.0 112.39 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.26 -37.41 69.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.736 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.427 ' CB ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -62.42 -48.93 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.63 -42.16 98.49 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.24 -0.913 . . . . 0.0 109.863 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.71 71.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.131 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 145' ' ' LEU . 9.6 tt -62.85 -44.07 97.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.258 -0.901 . . . . 0.0 110.255 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 25.1 m -61.49 -42.82 99.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.944 -1.097 . . . . 0.0 109.454 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -63.33 -37.31 86.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.814 . . . . 0.0 109.998 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 145' ' ' LEU . 49.0 mt -62.58 -36.6 83.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 108.747 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -58.82 -40.11 83.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.764 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -60.98 -40.89 95.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.949 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.518 ' NH2' ' CZ ' ' A' ' 115' ' ' PHE . 47.1 mtt-85 -65.79 -21.17 66.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.907 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.75 21.46 6.77 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.757 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.1 135.1 33.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.772 -1.428 . . . . 0.0 109.687 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' HG13 ' A' ' 157' ' ' VAL . 63.5 mttt -104.24 -170.63 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 155' ' ' LYS . 45.5 p90 42.97 45.02 4.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 109.124 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 155' ' ' LYS . 26.6 m -110.94 25.09 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.438 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.58 155.85 0.05 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.7 m -58.5 -26.82 63.86 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.419 -1.047 . . . . 0.0 109.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -48.02 71.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 38' ' ' GLU . 96.6 mt -63.58 -34.21 66.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 109.596 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.669 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -64.82 -45.16 87.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.669 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 43.4 t80 -63.58 -41.95 98.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 109.127 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.4 m -59.86 -39.87 86.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.01 -43.55 98.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.617 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.9 mtp -60.63 -37.98 83.26 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.049 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.572 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 15.8 mm100 -63.02 -44.35 96.19 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.906 . . . . 0.0 109.352 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.55 -41.16 24.6 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 t -55.07 -38.53 68.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.53 1.02 59.13 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.82 -34.66 67.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.865 -1.374 . . . . 0.0 108.437 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.0 140.45 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' GLY . 67.1 m-20 -98.75 115.83 29.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 0.0 109.502 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.572 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 82.4 m-20 -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.293 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.462 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 22.2 m-70 -140.95 -176.7 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 179' ' ' CYS . 8.9 m -124.39 158.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.424 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 69.9 t -54.7 -37.05 38.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.028 -1.045 . . . . 0.0 108.529 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.2 -33.45 70.12 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.47 ' H ' HG23 ' A' ' 176' ' ' VAL . 34.3 t -56.08 134.27 52.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.061 -1.258 . . . . 0.0 109.586 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -35.76 78.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.193 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.5 t -55.81 -34.8 65.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.336 -0.852 . . . . 0.0 109.129 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 177' ' ' VAL . 27.1 t80 -91.98 115.72 65.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.46 -63.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.18 1.92 . . . . 0.0 112.564 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.37 25.54 56.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.0 t30 59.36 44.82 14.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.115 . . . . 0.0 109.385 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -105.43 151.61 39.75 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.585 2.19 . . . . 0.0 112.208 179.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -102.49 150.37 23.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.913 . . . . 0.0 109.517 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -143.48 168.92 18.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.587 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -46.21 127.52 8.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.85 -34.04 85.62 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.579 ' CE2' HD22 ' A' ' 132' ' ' LEU . 12.5 m95 -51.6 -26.28 8.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.26 . . . . 0.0 109.422 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG11 ' CG1' ' A' ' 14' ' ' ILE . 21.7 t -99.04 132.09 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -122.52 -45.06 2.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.756 . . . . 0.0 109.703 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 4.6 tp60 -159.21 -168.43 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.064 -1.023 . . . . 0.0 109.916 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER 60.99 132.13 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.0 109.446 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.41 -21.75 25.9 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.182 1.922 . . . . 0.0 112.584 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 47' ' ' ILE . 30.8 tp -63.58 -37.62 88.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.974 -1.079 . . . . 0.0 109.492 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -62.32 -47.43 84.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 109.526 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG11 ' A' ' 7' ' ' VAL . 83.3 mt -68.0 -34.98 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.15 -46.5 79.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.776 -1.203 . . . . 0.0 108.024 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.36 -36.41 83.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 36.3 t-80 -58.42 -42.73 87.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 110.039 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -96.49 -38.76 9.87 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.047 -1.033 . . . . 0.0 110.964 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -54.67 -42.21 71.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -178.68 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 0.0 108.944 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.635 ' CZ3' ' NE2' ' A' ' 175' ' ' HIS . 53.2 t90 -169.67 106.31 0.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.762 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.54 -11.93 59.69 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.5 151.61 62.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 0.0 108.789 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.2 126.47 11.77 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.415 2.077 . . . . 0.0 112.964 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 169' ' ' CYS . 58.4 mp0 -122.54 128.94 51.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -115.17 6.35 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -78.73 119.4 21.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 20.3 m -60.85 -42.15 97.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.0 110.123 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -61.94 -44.79 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.08 -40.66 96.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 25' ' ' GLU . 9.0 mp -72.7 -38.71 67.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.998 -1.064 . . . . 0.0 110.517 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 102' ' ' TYR . 78.6 t80 -61.46 -45.85 92.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.823 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -70.77 -30.78 67.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.842 -1.161 . . . . 0.0 110.267 -179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 61.4 tpp -60.03 -53.37 58.63 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.535 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 tt -66.06 -32.83 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.765 -1.21 . . . . 0.0 110.281 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -49.05 73.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' OE1' ' A' ' 33' ' ' GLU . 81.2 mt -68.4 -38.38 81.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.537 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.85 -35.5 74.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.143 . . . . 0.0 110.069 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.17 -36.14 61.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.31 -32.2 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.476 -1.014 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.585 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.5 pt20 -57.75 -34.18 69.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 109.764 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.95 112.82 0.4 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.843 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.55 69.44 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 48' ' ' THR . 0.8 OUTLIER -121.64 -170.86 2.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.375 -1.073 . . . . 0.0 109.905 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 t -87.88 155.5 19.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.914 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.89 -40.0 69.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 111.008 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 12' ' ' LEU . 17.9 tt -87.91 -19.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.859 -1.15 . . . . 0.0 112.127 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 44' ' ' LEU . 94.2 m -51.67 -37.87 52.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.512 -1.367 . . . . 0.0 108.934 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 41' ' ' GLN . 81.7 t -68.62 -37.49 77.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.496 -0.752 . . . . 0.0 110.745 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 47' ' ' ILE . 70.4 mt -61.34 -50.58 72.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.643 -1.285 . . . . 0.0 109.754 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -58.28 -42.15 85.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 86' ' ' ILE . 18.1 tttp -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -50.68 -42.28 56.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.918 -1.114 . . . . 0.0 108.676 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.09 -44.39 72.6 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.56 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -67.47 -37.41 82.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.951 -1.093 . . . . 0.0 109.178 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 58.5 t80 -58.35 -45.18 88.66 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.536 0.684 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.752 ' HE ' ' CE1' ' A' ' 61' ' ' HIS . 26.6 ttm180 -59.91 -33.85 72.42 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.41 -41.37 96.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.902 -1.124 . . . . 0.0 110.8 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -37.06 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.951 -1.093 . . . . 0.0 112.449 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.696 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 61.4 m-85 -81.1 -52.04 7.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.533 -1.354 . . . . 0.0 113.097 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.752 ' CE1' ' HE ' ' A' ' 57' ' ' ARG . 37.1 m80 -57.67 -37.02 72.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.496 -1.378 . . . . 0.0 110.394 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -55.83 -32.52 63.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' ASP . 21.0 m-85 -92.23 14.11 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.33 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 52.22 169.74 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.977 -1.077 . . . . 0.0 110.09 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.415 ' O ' HG22 ' A' ' 68' ' ' VAL . 77.0 Cg_endo -82.25 -53.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.97 2.446 . . . . 0.0 113.518 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.06 -41.35 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.869 -1.145 . . . . 0.0 110.335 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -62.94 -35.39 79.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 111.241 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -61.18 -44.18 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.477 -1.389 . . . . 0.0 108.597 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -65.17 -30.01 70.89 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 27.94 7.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.681 -0.637 . . . . 0.0 109.364 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.32 164.62 26.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.035 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -109.81 155.04 22.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.84 -34.2 71.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 109.498 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -38.16 89.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 108.718 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.01 -38.62 86.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' OE1' ' A' ' 93' ' ' GLN . 69.4 t -60.55 -41.11 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.396 -0.815 . . . . 0.0 109.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.27 -39.71 93.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.355 -0.841 . . . . 0.0 110.002 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -61.62 -42.53 99.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.681 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' ASP . 27.0 mt -65.97 -35.42 80.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.12 -33.05 49.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -84.74 -57.49 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.422 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 86.5 m-20 -85.37 146.99 26.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.92 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.782 0.801 . . . . 0.0 109.066 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -66.19 15.3 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' H ' ' C ' ' A' ' 83' ' ' ALA . 9.0 pt -57.87 76.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.075 -1.25 . . . . 0.0 109.794 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.1 mt 56.01 150.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.557 ' HG2' HH11 ' A' ' 87' ' ' ARG . 20.8 mtt-85 -107.44 127.96 54.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 109.156 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.658 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.31 75.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -50.69 -35.31 30.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.404 -0.81 . . . . 0.0 108.995 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.62 98.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -66.28 -39.83 89.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.061 -1.259 . . . . 0.0 110.167 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.18 -45.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.945 -1.097 . . . . 0.0 109.171 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.653 ' OE1' HG21 ' A' ' 76' ' ' VAL . 15.6 mm100 -60.92 -33.2 72.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.295 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -61.2 -44.24 97.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.3 mp -59.48 -45.53 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 68' ' ' VAL . 97.8 mt -56.28 -50.78 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.469 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.73 92.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 22.9 m120 -60.77 -38.54 85.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -1.225 . . . . 0.0 109.957 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -66.76 -40.96 88.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -59.27 -41.35 88.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.67 87.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 75.8 t80 -59.69 -43.18 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 103' ' ' LEU . 89.3 mt -62.13 -35.71 79.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 0.0 109.508 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -57.96 -42.94 86.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.961 . . . . 0.0 109.425 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.7 mmm -66.09 -44.07 85.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.647 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.67 -30.49 64.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.97 -36.17 59.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 108' ' ' ASN . 3.0 m120 -88.2 2.85 51.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.73 57.44 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -110.18 105.58 57.3 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.398 -1.06 . . . . 0.0 109.36 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -52.95 133.15 50.52 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.712 1.608 . . . . 0.0 112.036 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.75 -43.44 96.42 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.959 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -61.88 -45.17 94.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -58.71 -37.68 76.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 0.0 109.748 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.27 -46.86 82.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.11 -46.48 88.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.518 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CH2' HD23 ' A' ' 171' ' ' LEU . 72.9 m95 -58.87 -36.1 74.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.3 m -59.37 -36.26 75.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -62.92 -35.87 81.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 110.7 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.53 11.99 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.154 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.5 t30 62.83 34.98 13.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.788 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 51.51 24.98 2.47 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.534 -0.729 . . . . 0.0 109.672 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -111.42 113.06 54.03 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.351 -0.843 . . . . 0.0 109.631 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.39 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.61 1.54 . . . . 0.0 111.667 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -115.49 149.31 38.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.2 ttm -126.63 147.96 49.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 t -133.81 155.64 49.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 110.11 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.483 HE21 ' HB ' ' A' ' 177' ' ' VAL . 20.0 tp60 -128.99 46.12 2.68 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -70.39 147.08 49.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.426 -0.796 . . . . 0.0 109.996 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 -38.52 11.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -121.46 156.21 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.505 -0.747 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.579 HD22 ' CE2' ' A' ' 6' ' ' TRP . 72.2 mt -56.95 -34.88 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 109.503 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.8 m -58.52 -34.54 71.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.668 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.3 mm-40 -62.13 -33.7 74.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 109.764 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.517 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -80.54 123.41 82.78 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.81 140.97 21.15 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.202 1.935 . . . . 0.0 112.138 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -85.79 -2.24 58.03 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.238 -0.914 . . . . 0.0 109.072 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -136.87 90.69 2.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 109.335 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -90.73 161.15 36.94 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.107 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -49.95 -40.29 49.39 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.017 1.812 . . . . 0.0 112.264 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.42 -40.63 61.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -61.08 -43.85 98.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 110.058 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -64.22 -44.71 91.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.678 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.01 76.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.7 tt -60.41 -41.51 94.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -63.86 -38.36 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.435 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -63.92 -37.09 86.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.66 -51.4 56.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.7 mt -63.28 -36.42 83.6 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 108.684 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.49 -43.88 93.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -60.81 -38.36 85.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -20.34 65.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.782 . . . . 0.0 109.494 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.03 28.12 6.3 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.547 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.52 134.33 35.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.359 . . . . 0.0 109.654 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -93.72 -177.24 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 27.4 p90 42.41 41.79 2.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 149' ' ' LEU . 6.2 p -105.82 24.52 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.48 -0.762 . . . . 0.0 109.469 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.93 155.43 4.34 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -32.36 54.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.227 -1.16 . . . . 0.0 109.287 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.1 m -63.73 -44.05 94.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.668 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.46 -42.72 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -41.38 97.16 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.86 -43.97 97.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.67 -42.05 92.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.802 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -60.9 -41.56 96.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.565 -0.709 . . . . 0.0 109.715 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.445 ' SD ' HG11 ' A' ' 172' ' ' VAL . 60.4 ttm -59.39 -37.35 77.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.26 -40.89 97.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 109.727 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' O ' ' OE1' ' A' ' 25' ' ' GLU . . . -77.18 -42.92 35.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.271 -0.893 . . . . 0.0 110.48 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.511 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 53.4 t -58.31 -35.71 72.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.122 -0.986 . . . . 0.0 109.947 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.32 65.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.77 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD23 ' CH2' ' A' ' 117' ' ' TRP . 68.6 mt -56.15 -34.52 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.746 -1.444 . . . . 0.0 107.933 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.445 HG11 ' SD ' ' A' ' 166' ' ' MET . 19.8 m -111.45 139.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.422 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 18.1 m120 -96.73 102.55 14.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.061 -1.025 . . . . 0.0 108.963 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.623 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 51.0 t0 -121.03 -178.49 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.663 -0.648 . . . . 0.0 109.929 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.635 ' NE2' ' CZ3' ' A' ' 21' ' ' TRP . 6.5 m170 137.28 38.13 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 175' ' ' HIS . 4.1 m 34.02 111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.67 0.748 . . . . 0.0 111.931 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -42.01 120.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.88 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 115.42 -7.15 20.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.4 OUTLIER -59.12 79.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.098 -1.236 . . . . 0.0 108.527 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.0 t 64.4 -42.71 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.388 -0.82 . . . . 0.0 109.131 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 179' ' ' CYS . 7.1 t 179.91 69.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.433 -0.792 . . . . 0.0 109.873 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 173' ' ' ASN . 26.3 t80 -122.59 78.64 47.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.98 -13.29 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.889 2.392 . . . . 0.0 112.712 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 84.11 23.28 52.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 58.97 43.73 17.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -1.051 . . . . 0.0 109.617 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -131.03 79.79 70.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.346 -0.846 . . . . 0.0 109.367 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.929 2.42 . . . . 0.0 112.249 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.764 0.792 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 178' ' ' GLY . 39.7 mm-40 -142.0 162.22 36.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.723 ' NH2' HG23 ' A' ' 14' ' ' ILE . 3.5 ttt-85 -123.95 153.25 41.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -48.14 130.51 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.05 -30.6 69.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -51.97 -31.43 29.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.0 -1.294 . . . . 0.0 109.403 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 4' ' ' CYS . 4.5 m -58.13 135.82 22.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 9' ' ' GLN . 21.1 m -146.48 -171.16 3.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.389 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.8 tp60 -42.12 164.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.31 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER 75.8 82.09 0.12 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.26 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.64 -10.73 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.896 2.397 . . . . 0.0 112.559 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.53 -37.32 85.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.531 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CE1' ' NE1' ' A' ' 46' ' ' TRP . 74.9 t80 -62.87 -47.15 84.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 110.462 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.723 HG23 ' NH2' ' A' ' 3' ' ' ARG . 77.4 mt -57.4 -40.58 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.092 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.96 81.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.19 -39.05 86.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.51 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 4.4 t-80 -60.6 -50.42 73.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -72.34 -35.61 68.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.01 -70.96 0.33 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.015 -1.053 . . . . 0.0 110.352 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.78 121.03 13.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.713 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 27.5 t90 -175.79 103.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.379 -0.826 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.22 -4.79 58.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 23' ' ' VAL . 5.2 m -71.37 149.85 93.97 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.154 -1.203 . . . . 0.0 108.747 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.04 122.01 9.66 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.125 1.883 . . . . 0.0 112.02 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.04 129.95 53.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.184 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.7 p -123.49 1.44 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -85.68 118.37 25.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.198 -0.939 . . . . 0.0 109.29 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.7 m -60.8 -36.76 79.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.166 -0.959 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -63.6 -55.3 24.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 110.159 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.61 -39.37 91.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -47.39 78.81 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 46.7 t80 -64.67 -40.12 94.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.679 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.49 -31.24 71.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.505 -1.372 . . . . 0.0 109.759 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.7 tpp -68.06 -49.09 63.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 111.194 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -63.54 -35.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.712 -1.243 . . . . 0.0 110.403 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 12.4 m -73.18 -49.1 29.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.243 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.47 -35.2 75.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.576 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -53.34 -34.0 55.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.042 -1.036 . . . . 0.0 109.826 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.47 -31.23 51.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.652 HE21 ' NZ ' ' A' ' 91' ' ' LYS . 40.4 tt0 -55.87 -37.88 69.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -1.083 . . . . 0.0 110.029 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.2 -23.88 57.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.127 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.44 110.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.15 -34.64 4.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 41' ' ' GLN . 25.7 mt -103.1 152.15 21.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.383 -1.069 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -69.55 151.07 46.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.089 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.497 ' NE1' ' CE1' ' A' ' 13' ' ' TYR . 36.9 p90 -55.53 -29.78 59.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -62.06 -37.07 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.6 m -63.52 -35.9 82.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.088 -1.008 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 41' ' ' GLN . 96.8 t -60.17 -39.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.7 mt -55.8 -52.69 63.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.614 -1.304 . . . . 0.0 110.484 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -62.39 -49.76 74.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.031 -1.043 . . . . 0.0 109.609 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -65.59 -31.53 72.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttp180 -53.4 -45.12 69.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.968 . . . . 0.0 109.05 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.12 -41.36 90.61 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -65.52 -41.64 92.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.803 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 2.1 t80 -63.3 -44.21 95.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 19.5 mmm180 -59.26 -34.51 72.32 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 109.393 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.92 95.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.285 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.4 m -92.59 -33.86 14.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 95.9 m-85 -102.55 15.59 28.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 110.86 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -49.58 -23.46 1.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.738 -1.226 . . . . 0.0 108.293 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.586 ' C ' ' H ' ' A' ' 64' ' ' ASP . 12.0 tp60 -82.85 18.06 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 88.0 t80 -55.38 8.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 111.275 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -44.07 150.16 0.63 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.196 . . . . 0.0 108.496 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.7 -54.25 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.233 1.955 . . . . 0.0 112.596 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.7 t -73.62 -41.61 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -65.22 -48.36 73.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.897 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 2.8 p -65.74 -45.13 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.915 -1.116 . . . . 0.0 110.625 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . . . -67.89 -27.33 66.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.016 -1.053 . . . . 0.0 108.27 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.05 -15.02 63.46 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 109.254 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mtm -73.71 160.82 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.99 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -115.12 173.77 6.33 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.95 -33.03 55.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.135 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.94 -36.5 65.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 109.012 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.528 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 21.9 t70 -59.68 -38.67 82.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.157 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 80' ' ' VAL . 93.8 t -61.44 -42.79 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.78 -38.79 92.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.454 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 78' ' ' ARG . 31.1 ttm-85 -63.29 -48.23 79.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.525 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 80.8 mt -70.51 -34.19 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -54.53 -38.93 43.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 108.593 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -82.56 -17.75 43.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.561 -0.712 . . . . 0.0 109.834 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' GLY . 56.5 t0 -81.65 105.4 12.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 110.597 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 84' ' ' GLY . . . 48.0 3.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 110.984 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . . . 44.4 45.53 8.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -39.97 112.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.973 . . . . 0.0 110.31 -178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.3 tt 33.79 -155.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 0.0 110.304 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.68 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 60.2 mtp180 -52.64 149.55 5.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.012 -1.055 . . . . 0.0 109.145 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.8 p-80 -142.99 180.0 6.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.908 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 61.22 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.642 -0.661 . . . . 0.0 110.437 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -63.89 -48.54 75.36 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.732 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.652 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 20.4 ttpt -66.89 -45.31 78.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.863 -1.374 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.658 HG22 HG22 ' A' ' 76' ' ' VAL . 84.4 mt -61.31 -38.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.26 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.27 -40.21 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.86 77.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.657 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' OH ' ' A' ' 56' ' ' TYR . 10.7 mt -57.55 -50.85 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 110.231 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.86 -46.84 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.939 -1.1 . . . . 0.0 109.463 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.53 86.43 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.656 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 23.2 m120 -59.7 -41.38 90.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.15 . . . . 0.0 110.196 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -68.64 -38.64 80.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.107 -0.995 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -58.35 -44.17 88.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.481 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.87 73.15 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -58.61 -44.44 89.91 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.461 -0.774 . . . . 0.0 109.062 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.4 -38.05 88.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -0.819 . . . . 0.0 109.318 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -59.64 -38.61 81.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.614 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 86.6 mmm -62.06 -40.28 95.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 109' ' ' GLY . 39.9 tp10 -68.71 -36.91 79.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.862 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -53.25 -33.82 54.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.12 -4.8 59.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 108.839 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.58 33.46 84.6 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.84 84.67 60.53 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.389 -1.066 . . . . 0.0 110.057 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.67 151.06 72.79 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.911 2.407 . . . . 0.0 112.507 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 116' ' ' VAL . 61.3 m-85 -57.97 -43.85 86.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.303 -0.873 . . . . 0.0 109.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.46 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.767 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.65 -42.49 74.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.649 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 77.8 t80 -64.58 -46.84 80.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 110.35 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' PHE . 55.5 t -57.73 -45.93 86.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' CH2' HD23 ' A' ' 171' ' ' LEU . 35.9 m95 -61.78 -35.92 79.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.943 -1.098 . . . . 0.0 109.7 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.8 m -58.89 -36.94 75.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 110.278 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.2 m-85 -62.06 -35.57 79.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 110.471 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.38 10.57 5.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.064 -1.023 . . . . 0.0 108.895 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.06 35.82 21.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.832 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.11 31.08 13.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 109.223 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -121.02 90.05 46.7 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.653 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.51 148.89 10.62 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.332 2.022 . . . . 0.0 111.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -108.44 154.05 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 110.166 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -130.64 153.32 49.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.2 t -136.4 156.2 48.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -127.8 49.77 2.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -71.86 126.47 29.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 110.089 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.7 m -75.45 -37.72 60.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.4 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 132' ' ' LEU . 32.4 m -122.56 161.05 24.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.615 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.466 ' N ' HG22 ' A' ' 131' ' ' THR . 79.5 mt -54.92 -37.42 66.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.815 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.7 p -62.52 -32.06 72.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.737 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.8 mm-40 -66.08 -25.68 67.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.59 119.37 62.5 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.208 -0.932 . . . . 0.0 109.472 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.11 132.11 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.921 1.748 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 t -105.03 5.36 32.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.172 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.6 t -135.95 94.01 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 109.447 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 156.74 39.91 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.9 -38.9 79.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.406 2.07 . . . . 0.0 111.968 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -40.7 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 33.1 t -60.79 -44.37 96.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.11 -46.74 85.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.15 81.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.305 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.765 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.6 tm? -61.16 -43.3 99.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.438 -0.789 . . . . 0.0 109.478 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.6 m -63.75 -42.33 97.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.121 -0.987 . . . . 0.0 109.857 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -62.42 -35.75 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.833 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.04 96.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.799 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.17 -38.9 93.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.774 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.08 -38.65 86.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.875 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -60.47 -37.69 81.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.614 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.5 mmt180 -63.91 -20.18 65.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.344 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.52 26.8 7.94 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.656 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 3.0 m-85 -91.86 131.18 37.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -1.218 . . . . 0.0 110.116 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -95.7 164.32 12.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 59.36 50.27 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -120.89 24.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.473 -0.767 . . . . 0.0 109.508 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.64 155.23 0.14 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.9 m -56.21 -28.04 56.92 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.43 -1.041 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 47.0 p -64.3 -43.34 95.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.91 -35.26 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.31 -0.868 . . . . 0.0 109.382 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.565 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -65.81 -42.71 90.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.565 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 65.6 t80 -62.3 -44.83 95.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.298 -0.876 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.8 p -61.29 -36.98 81.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.019 -1.051 . . . . 0.0 108.809 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' ' CD1' ' A' ' 165' ' ' PHE . 1.3 t80 -61.41 -39.72 91.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.0 mtt -61.22 -37.98 84.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.4 -0.813 . . . . 0.0 109.594 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -59.57 -40.26 86.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.19 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.66 -41.97 68.08 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.671 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 10.9 t -67.05 -40.08 87.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.37 55.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' CH2' ' A' ' 117' ' ' TRP . 33.9 mt -55.86 -37.47 68.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -1.204 . . . . 0.0 109.074 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.95 139.46 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.74 100.77 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.985 -1.072 . . . . 0.0 109.357 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 52.6 p30 -121.87 -177.27 3.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.753 -0.592 . . . . 0.0 109.669 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.713 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 3.5 m170 142.74 -1.23 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 74.07 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 109.216 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 129' ' ' ALA . 34.4 t -64.45 136.57 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 102.15 -6.21 53.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.8 t -63.11 3.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.959 -1.319 . . . . 0.0 108.631 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.579 ' H ' ' C ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER 65.86 -53.68 0.38 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.9 m -62.24 -23.61 66.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.492 -0.755 . . . . 0.0 109.842 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -119.8 84.93 32.69 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 0.0 109.958 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.85 -138.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.32 -7.07 59.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -135.69 26.75 3.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -1.082 . . . . 0.0 109.564 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -97.79 155.53 37.04 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 109.284 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.188 0.518 . . . . 0.0 109.64 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 78.9 mm-40 -130.63 155.09 47.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -127.27 150.78 49.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 20.9 m -58.87 124.41 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 108.302 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.77 -5.71 61.13 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 p-90 -87.4 -4.24 59.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.339 . . . . 0.0 109.548 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.48 141.78 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.172 -0.955 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -60.15 157.35 13.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 108.964 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -84.47 99.83 10.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 109.39 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.02 144.74 0.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.67 -35.81 44.98 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.228 1.952 . . . . 0.0 112.23 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -43.25 95.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.835 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' CZ2' ' A' ' 6' ' ' TRP . 35.5 t80 -65.19 -48.03 74.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.636 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -60.96 -32.92 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.928 . . . . 0.0 109.674 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.62 91.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 20' ' ' GLU . 51.6 t80 -66.78 -37.82 85.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.512 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.2 t-80 -57.31 -43.65 83.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -90.12 -27.12 19.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -78.72 -74.49 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.73 -1.232 . . . . 0.0 110.467 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.496 ' O ' ' CZ ' ' A' ' 16' ' ' TYR . 96.6 mt-10 -128.73 102.71 6.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 109.425 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.773 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 33.0 t90 -176.62 101.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.81 4.14 63.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -99.22 116.21 65.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -1.081 . . . . 0.0 108.983 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.59 127.62 14.13 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.824 1.682 . . . . 0.0 112.456 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 29.0 tt0 -116.68 137.17 52.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.3 p -117.63 8.64 12.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.343 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 91.3 m-20 -85.28 117.75 24.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.7 m -63.23 -38.89 92.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HZ2' ' HG3' ' A' ' 30' ' ' LYS . 21.5 pttp -63.1 -44.16 96.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.846 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CD ' ' OE2' ' A' ' 25' ' ' GLU . 96.6 mttt -66.69 -45.0 80.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.0 109.993 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 113' ' ' ALA . 95.9 mt -61.41 -43.59 98.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.992 -1.068 . . . . 0.0 109.8 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.66 -43.33 97.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' OE2' ' CE2' ' A' ' 32' ' ' PHE . 74.3 mm-40 -64.32 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.83 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 8.1 tpt -60.86 -49.9 75.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.425 -0.797 . . . . 0.0 110.429 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.16 -47.41 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 0.0 110.756 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.46 -49.31 67.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.568 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 53' ' ' ARG . 79.4 mt -70.7 -39.79 73.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.115 -0.991 . . . . 0.0 110.405 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 34' ' ' MET . 34.7 tt0 -63.08 -36.38 83.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.979 -1.076 . . . . 0.0 110.113 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.31 -28.98 44.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 88' ' ' HIS . 61.1 tp60 -55.42 -33.7 63.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -1.042 . . . . 0.0 109.997 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -53.07 -30.9 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.112 -0.993 . . . . 0.0 110.55 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' N ' HE21 ' A' ' 41' ' ' GLN . . . -44.27 109.54 0.16 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.885 -1.134 . . . . 0.0 108.907 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.73 48.04 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -117.65 156.34 28.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.577 -0.955 . . . . 0.0 109.943 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.7 m -81.58 159.23 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.487 -0.758 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.478 ' NE1' HD21 ' A' ' 50' ' ' LEU . 43.3 t-105 -58.33 -39.56 79.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.37 -0.831 . . . . 0.0 110.397 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 48' ' ' THR . 10.1 tp -57.55 -43.41 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.052 -1.03 . . . . 0.0 110.088 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 47' ' ' ILE . 67.3 m -66.93 -38.6 86.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 41' ' ' GLN . 75.0 t -61.57 -42.65 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 111.3 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.478 HD21 ' NE1' ' A' ' 46' ' ' TRP . 84.3 mt -56.91 -47.98 79.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.722 -1.237 . . . . 0.0 109.995 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.68 -49.63 72.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.374 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HZ2' HG13 ' A' ' 86' ' ' ILE . 31.7 mmtp -63.62 -32.69 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.021 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG3' HD13 ' A' ' 37' ' ' LEU . 43.6 ttp180 -53.15 -43.06 66.73 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.85 . . . . 0.0 108.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -67.62 -41.64 83.63 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.42 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.16 96.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.856 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HH ' ' CD ' ' A' ' 40' ' ' GLN . 4.7 m-85 -56.98 -45.98 82.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 108.889 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 57' ' ' ARG . 52.7 mtt-85 -59.37 -29.35 67.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.264 -0.898 . . . . 0.0 109.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.13 87.25 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.783 -1.198 . . . . 0.0 109.72 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 69.4 m -94.52 -38.17 11.03 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 112.005 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.74 -48.07 60.74 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.839 -1.163 . . . . 0.0 112.847 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -51.93 -30.05 22.84 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.254 -1.529 . . . . 0.0 108.869 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -54.11 -36.85 63.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 96.2 m-85 -99.39 67.17 1.53 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -35.15 158.67 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.846 -0.534 . . . . 0.0 110.391 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -40.58 -43.85 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.843 2.362 . . . . 0.0 112.697 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -73.05 -44.55 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.925 -1.109 . . . . 0.0 109.593 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -63.15 -46.14 88.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 69' ' ' ALA . 15.0 p -62.44 -38.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.015 -1.053 . . . . 0.0 109.565 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -62.34 -23.69 66.92 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.17 21.3 17.54 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.079 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 3.9 mtp -80.67 158.83 25.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -106.11 159.34 16.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.528 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.4 mt-10 -58.05 -33.73 69.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.47 -32.16 71.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.81 -1.181 . . . . 0.0 109.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.24 -39.55 93.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 0.0 110.672 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -65.48 -43.38 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.83 -1.169 . . . . 0.0 109.487 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt-10 -56.09 -39.7 72.54 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.508 -0.745 . . . . 0.0 109.268 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.04 -41.33 99.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.726 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 82' ' ' ASP . 87.9 mt -67.63 -30.72 70.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.362 -0.836 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 87' ' ' ARG . 53.3 t -51.8 -39.44 24.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.108 -0.995 . . . . 0.0 108.989 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.39 -54.51 3.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 85.7 m-20 -74.18 168.02 20.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.449 -0.782 . . . . 0.0 110.147 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 90.93 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.161 0.505 . . . . 0.0 109.67 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.41 32.36 82.7 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' ILE . 1.2 pp -112.01 165.95 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.47 -1.018 . . . . 0.0 109.776 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' HZ2' ' A' ' 52' ' ' LYS . 79.2 mt -41.81 146.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.628 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 87' ' ' ARG . 7.9 mtt-85 -107.36 146.74 31.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.652 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -167.87 -21.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? 57.81 -66.65 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.1 0.476 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.25 -38.94 93.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' ' CG ' ' A' ' 156' ' ' PHE . 44.1 tptt -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.27 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.04 -43.56 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.151 -0.968 . . . . 0.0 109.253 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.02 -36.78 73.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.212 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.09 82.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.45 -44.28 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.326 -0.859 . . . . 0.0 109.388 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 90.7 mt -56.84 -45.37 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.16 94.63 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -59.74 -44.24 93.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -1.205 . . . . 0.0 109.897 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' N ' HD22 ' A' ' 98' ' ' ASN . . . -64.99 -46.34 81.87 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.103 -0.998 . . . . 0.0 109.454 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -60.16 -42.54 95.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.45 -41.19 63.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.352 -0.843 . . . . 0.0 109.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 6.4 t80 -63.67 -46.34 85.99 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.496 -0.752 . . . . 0.0 110.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.7 tp -62.8 -38.57 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.949 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.18 -41.35 92.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.951 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.6 ttt -63.19 -42.38 99.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.627 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.59 -30.06 69.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 109.909 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.427 HE21 ' CA ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -52.92 -32.11 43.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 109.152 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -84.01 2.49 38.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.2 57.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.03 93.45 30.07 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.0 109.126 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.54 132.26 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.015 1.81 . . . . 0.0 111.95 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -61.05 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.501 -0.749 . . . . 0.0 109.736 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -63.45 -43.94 95.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.538 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -56.92 -37.99 72.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.815 -1.178 . . . . 0.0 108.914 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -57.91 -45.35 86.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 108.915 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 145' ' ' LEU . 3.5 t -63.62 -49.03 84.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.399 -0.813 . . . . 0.0 109.177 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.44 -34.02 74.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.261 -0.899 . . . . 0.0 109.103 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.0 t -57.01 -36.49 70.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 109.661 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.89 -35.2 74.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.008 -1.057 . . . . 0.0 109.827 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.4 13.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 108.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.0 t30 59.22 34.62 23.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.545 -0.722 . . . . 0.0 110.121 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.88 37.84 29.05 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -121.51 91.99 48.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.951 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.71 144.81 25.0 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.304 2.003 . . . . 0.0 111.853 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -117.61 152.22 35.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.7 mtt -126.96 155.33 43.3 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 t -88.5 150.64 23.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.846 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.64 47.05 1.67 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.386 -0.821 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.2 -169.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -30.43 7.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.731 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 m -127.09 153.53 45.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.332 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 132' ' ' LEU . 3.8 mp -62.01 -32.5 72.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.2 p -60.51 -31.8 70.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.676 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.26 -30.29 70.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.734 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.12 130.02 92.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.32 137.86 31.84 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.94 1.76 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 137' ' ' THR . 1.1 m -97.16 -8.42 30.14 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -123.56 77.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.1 p -79.7 150.07 72.16 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 108.636 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -54.53 -30.43 64.76 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.939 1.759 . . . . 0.0 111.744 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.41 -40.81 66.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.295 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -62.09 -45.58 92.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -63.53 -45.1 92.17 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.904 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -38.21 78.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 116' ' ' VAL . 7.8 tt -59.89 -47.61 85.04 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.7 t -57.33 -40.23 77.51 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.017 -1.052 . . . . 0.0 109.028 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.02 -37.87 86.54 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.97 -52.32 44.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.2 mp -61.87 -34.06 75.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.026 -1.046 . . . . 0.0 109.239 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.49 -41.03 84.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 109.504 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -61.03 -39.63 90.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 109.943 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 12.1 mpt_? -64.77 -20.34 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.52 28.08 5.86 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -89.61 131.06 35.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.157 . . . . 0.0 110.11 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -101.38 167.88 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 41.9 m-85 61.56 44.19 9.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' GLY . 26.8 m -109.86 24.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.469 -0.769 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.33 152.4 0.22 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.2 m -56.96 -25.71 58.46 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.382 -1.07 . . . . 0.0 109.626 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 160' ' ' THR . 0.9 OUTLIER -69.23 -47.85 63.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 0.0 109.713 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.74 -35.1 74.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.197 -0.939 . . . . 0.0 109.31 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 97.9 m -65.74 -45.67 81.76 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -64.88 -44.92 88.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.148 -0.97 . . . . 0.0 109.504 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.1 m -60.89 -36.24 78.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.256 -0.903 . . . . 0.0 108.941 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 16.5 t80 -60.25 -42.07 94.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.495 -0.753 . . . . 0.0 109.329 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 42.4 mmm -63.69 -37.81 88.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.307 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.773 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 31.3 tt0 -59.96 -46.26 90.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.322 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.26 67.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.185 -0.947 . . . . 0.0 110.134 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.675 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 74.3 m -60.99 -37.73 83.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.396 -0.815 . . . . 0.0 110.104 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.33 0.47 47.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.8 mp -57.86 -36.87 72.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.906 -1.349 . . . . 0.0 108.205 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.21 137.25 54.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -99.53 109.9 22.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.108 -0.995 . . . . 0.0 109.94 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -118.15 90.71 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.0 109.297 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.6 m170 -129.04 -25.2 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.461 -0.774 . . . . 0.0 108.954 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 175' ' ' HIS . 0.8 OUTLIER 99.85 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -59.61 130.99 23.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.149 -0.969 . . . . 0.0 109.756 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 106.83 -89.0 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.57 ' C ' ' H ' ' A' ' 181' ' ' CYS . 42.2 t 39.69 22.63 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 109.192 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 2' ' ' GLU . 22.2 m 53.41 -1.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.57 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.0 t -130.0 -25.35 2.53 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.173 -0.955 . . . . 0.0 110.012 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 21.4 t80 -124.32 82.57 57.71 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.12 -69.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.63 2.22 . . . . 0.0 111.762 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.56 -11.62 71.69 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -143.71 20.83 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -1.202 . . . . 0.0 110.079 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -136.18 154.49 77.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.522 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 122.594 2.196 . . . . 0.0 112.187 179.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.04 141.76 43.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -144.27 155.8 44.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.05 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 134.8 56.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.61 -36.87 93.67 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 1.7 m95 -59.93 -30.12 68.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.917 -1.343 . . . . 0.0 109.645 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.724 HG13 ' CG1' ' A' ' 14' ' ' ILE . 55.1 t -51.36 -43.95 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.451 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 59.9 p 40.59 -130.12 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 10' ' ' ASP . 98.4 mt-30 -105.33 -47.52 3.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 9' ' ' GLN . 63.1 m-20 -31.74 95.86 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.924 -0.485 . . . . 0.0 110.782 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLN . 25.4 Cg_exo -59.8 -32.12 95.01 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.33 2.02 . . . . 0.0 112.262 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.9 -38.14 89.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.83 -42.85 90.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.301 -0.874 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.724 ' CG1' HG13 ' A' ' 7' ' ' VAL . 74.0 mt -59.36 -38.36 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.863 . . . . 0.0 110.087 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.9 89.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 108.275 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -68.19 -38.69 82.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.764 . . . . 0.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 11.5 t-80 -60.19 -49.37 77.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.434 -0.791 . . . . 0.0 109.877 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.36 -42.07 59.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 111.21 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -56.25 -48.92 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.089 . . . . 0.0 110.408 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 12.8 pt-20 -176.42 120.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.443 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 58.5 t90 -173.37 109.83 0.17 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.044 -1.035 . . . . 0.0 110.061 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.27 -18.26 57.73 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.99 146.24 87.23 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.211 -1.17 . . . . 0.0 108.689 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.61 126.58 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.12 1.88 . . . . 0.0 112.187 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 47.6 tp10 -112.38 136.17 52.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.487 -0.758 . . . . 0.0 109.581 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.8 p -127.09 15.17 7.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 87.6 m-20 -83.5 118.94 24.11 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.619 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 90.4 p -55.26 -57.6 11.15 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.599 -0.688 . . . . 0.0 110.951 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 8.9 mtpm? -62.95 -39.41 94.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.028 -1.045 . . . . 0.0 112.719 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -60.98 -43.12 99.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.404 -1.435 . . . . 0.0 111.279 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 169' ' ' CYS . 9.4 mp -65.35 -38.91 91.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.9 -1.125 . . . . 0.0 110.912 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.4 m-30 -65.38 -46.4 80.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' OE1' ' O ' ' A' ' 29' ' ' LYS . 4.1 mp0 -64.78 -34.01 77.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 168' ' ' ALA . 6.6 tpt -62.73 -41.3 99.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.183 -0.948 . . . . 0.0 109.91 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -72.48 -35.65 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.001 -1.062 . . . . 0.0 110.379 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.39 -49.7 65.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.016 -1.052 . . . . 0.0 111.126 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.2 mp -70.32 -36.51 74.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.025 -1.047 . . . . 0.0 110.948 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -60.11 -32.21 70.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.824 -1.172 . . . . 0.0 110.074 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.61 67.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' ' CZ ' ' A' ' 56' ' ' TYR . 96.1 mt-30 -64.15 -29.0 70.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 109.661 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 46' ' ' TRP . 32.0 tt0 -48.99 -36.5 17.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.42 114.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.175 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.29 -26.15 25.45 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' GLN . 21.0 mt -106.79 -144.11 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.793 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -142.91 151.05 40.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.485 ' HA ' HE21 ' A' ' 41' ' ' GLN . 48.7 p90 -53.85 -39.31 65.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 110.195 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.5 tp -60.74 -36.2 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 109.964 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.411 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.2 m -64.36 -39.41 93.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.943 -1.098 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.4 t -65.02 -38.43 82.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.551 -0.718 . . . . 0.0 110.941 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.5 -55.19 38.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.736 -1.228 . . . . 0.0 111.194 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.72 -47.6 84.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.344 -1.473 . . . . 0.0 108.235 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -64.6 -30.29 71.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.475 -0.766 . . . . 0.0 109.066 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' VAL . 62.6 ttt180 -51.12 -41.63 60.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.07 -39.98 86.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -66.93 -46.04 75.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' OE1' ' A' ' 40' ' ' GLN . 18.7 m-85 -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.999 . . . . 0.0 108.898 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.617 HH11 ' CD2' ' A' ' 61' ' ' HIS . 12.6 tpp180 -59.32 -34.14 71.97 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.556 -0.715 . . . . 0.0 109.553 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -46.08 76.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 111.742 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.4 -39.99 11.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 112.11 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -80.41 -44.47 19.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.909 -1.119 . . . . 0.0 112.384 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.617 ' CD2' HH11 ' A' ' 57' ' ' ARG . 5.7 t-80 -58.45 -42.77 88.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.681 -1.262 . . . . 0.0 110.48 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.35 -35.16 75.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.022 . . . . 0.0 109.627 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -78.42 -0.23 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 54.09 168.31 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 120.864 -1.148 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -81.16 -35.45 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.634 2.223 . . . . 0.0 113.462 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.63 -47.77 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 0.0 110.5 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 71' ' ' MET . 63.9 mttp -64.19 -33.87 76.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.043 . . . . 0.0 109.542 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.1 t -59.19 -38.74 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.71 -16.33 51.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.367 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.08 16.76 9.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 110.959 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.3 ptp -73.93 179.96 4.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.726 -1.234 . . . . 0.0 109.156 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.22 154.92 20.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.79 -31.75 66.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.187 -0.945 . . . . 0.0 108.964 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.26 -36.96 71.63 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.304 -0.873 . . . . 0.0 108.942 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.01 -38.34 72.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.23 -0.919 . . . . 0.0 108.867 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.59 -42.97 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 109.252 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.98 -37.69 88.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.11 -45.3 95.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.996 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 82' ' ' ASP . 85.7 mt -65.16 -33.48 76.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.746 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.74 -35.89 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.208 -0.932 . . . . 0.0 108.901 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -80.3 -60.13 2.44 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.186 -0.946 . . . . 0.0 108.948 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 26.6 p-10 -100.17 138.54 37.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.388 -0.82 . . . . 0.0 109.157 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . 179.4 -72.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 109.955 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 2.8 70.5 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.64 HG12 ' HB1' ' A' ' 83' ' ' ALA . 9.0 pt -98.59 -118.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -1.052 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.23 137.34 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' O ' ' ND1' ' A' ' 88' ' ' HIS . 98.1 mtt180 -86.83 118.16 26.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 171.84 86.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -47.14 -33.17 4.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.97 -38.52 94.31 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ ' ' A' ' 156' ' ' PHE . 2.4 mptp? -65.01 -45.28 86.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 109.905 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.4 mt -56.13 -41.8 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.548 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.81 -35.47 76.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.431 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.51 97.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.438 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 95' ' ' ILE . 1.7 mp -58.14 -48.05 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.08 -41.86 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.48 -41.97 98.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.34 90.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.0 109.849 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.98 88.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 108.834 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 37.4 ttm-85 -63.44 -46.62 85.43 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.451 -0.78 . . . . 0.0 109.791 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.33 89.78 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.035 -1.041 . . . . 0.0 108.892 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 20.2 t80 -63.49 -44.94 92.94 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.663 -0.648 . . . . 0.0 109.954 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.82 -37.71 79.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.13 -40.32 89.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.612 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 88.4 mtp -61.72 -38.6 88.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.102 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.6 -32.05 73.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 109.714 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.9 -32.39 53.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.263 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.83 -1.04 53.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.91 23.87 77.61 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.33 109.85 63.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 109.227 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.79 127.12 24.22 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.657 1.571 . . . . 0.0 111.98 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 10.8 t80 -66.16 -42.88 88.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 109.531 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.95 -40.37 84.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.02 -33.96 75.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.857 -1.152 . . . . 0.0 109.748 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.93 -52.35 65.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.888 . . . . 0.0 110.139 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.16 -40.03 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.055 -1.028 . . . . 0.0 109.577 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.503 ' CH2' HD23 ' A' ' 171' ' ' LEU . 17.6 m95 -62.4 -37.69 86.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.101 -1.0 . . . . 0.0 109.712 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.2 p -61.47 -32.4 72.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.907 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -62.24 -31.72 72.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.17 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.12 23.09 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 109.244 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.524 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 4.5 t-20 68.13 26.72 7.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 52.96 26.0 4.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.582 -0.699 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 121' ' ' ASN . 1.4 mp0 -132.54 138.21 31.58 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.47 149.28 49.79 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.26 1.973 . . . . 0.0 111.797 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.3 mm-40 -114.76 154.94 27.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.415 -0.803 . . . . 0.0 109.546 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.19 154.36 44.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.033 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -129.49 160.28 33.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 109.841 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -127.91 52.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -85.11 127.48 34.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.348 -0.845 . . . . 0.0 110.038 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.0 m -73.5 -39.03 65.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 108.863 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 156.23 37.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.455 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.7 mt -55.83 -31.8 63.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 109.737 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.9 m -57.78 -37.9 74.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.295 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.9 mm-40 -64.57 -30.56 71.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.89 -1.131 . . . . 0.0 109.882 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 72.2 mt -68.84 124.27 89.86 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 110.42 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.73 140.43 16.5 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.337 2.025 . . . . 0.0 111.857 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.7 t -98.99 5.16 47.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.195 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.35 90.1 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 109.785 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 155.29 36.48 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.181 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -49.61 -38.86 46.19 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.117 1.878 . . . . 0.0 112.35 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.41 81.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.635 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -63.96 -38.08 89.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.542 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.89 -45.67 77.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.2 -0.937 . . . . 0.0 109.701 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.79 -39.01 84.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 149' ' ' LEU . 7.9 tt -62.81 -38.6 91.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.232 -0.917 . . . . 0.0 109.257 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -59.8 -43.82 94.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.389 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -63.34 -34.96 78.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.63 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.99 64.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.321 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 145' ' ' LEU . 56.3 mt -67.27 -36.43 81.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.267 -0.895 . . . . 0.0 108.676 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -59.69 -41.87 91.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.463 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -61.66 -37.1 82.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.612 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 42.9 mtt-85 -63.81 -20.65 65.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.724 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.0 5.86 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -88.6 129.99 35.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.276 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -93.1 158.76 15.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CZ ' ' NZ ' ' A' ' 91' ' ' LYS . 93.5 m-85 56.51 45.81 21.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.814 . . . . 0.0 109.068 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.6 p -116.21 24.64 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.3 161.68 0.08 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 46.7 m -53.79 -32.8 53.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.221 -1.164 . . . . 0.0 109.403 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -61.94 -45.68 92.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.892 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.22 -40.36 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.953 . . . . 0.0 109.611 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.71 -42.45 97.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.784 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -59.6 -39.07 82.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.133 -0.98 . . . . 0.0 109.09 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.404 ' CD1' HG12 ' A' ' 35' ' ' ILE . 59.3 t80 -61.32 -42.63 99.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 110.269 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 77.9 mtp -59.45 -38.1 79.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.5 -43.73 96.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.932 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 34' ' ' MET . . . -76.74 -42.13 42.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.2 t -58.18 -36.51 73.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.31 57.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.503 HD23 ' CH2' ' A' ' 117' ' ' TRP . 80.4 mt -56.04 -36.55 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.055 -1.262 . . . . 0.0 108.871 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.6 m -128.23 149.88 33.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.494 -0.754 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.25 109.98 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 108.753 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -119.22 92.53 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.703 . . . . 0.0 110.673 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.443 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 11.3 m-70 -125.87 -121.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 178' ' ' GLY . 25.4 t -144.17 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.812 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.5 p -57.73 78.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 134.38 14.03 1.25 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.622 ' O ' ' N ' ' A' ' 181' ' ' CYS . 35.6 t -64.68 40.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.239 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 178' ' ' GLY . 0.8 OUTLIER 57.57 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -59.68 -25.77 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 110.322 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -123.67 81.03 54.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.189 -0.945 . . . . 0.0 110.049 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -69.68 -23.04 31.58 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.79 2.326 . . . . 0.0 111.93 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 93.2 8.64 61.28 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 0.2 OUTLIER 69.44 19.07 7.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -1.011 . . . . 0.0 109.459 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -130.04 80.49 70.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.713 0 C-N-CA 122.851 2.368 . . . . 0.0 112.22 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.417 0.627 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -105.19 149.79 25.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.517 -0.739 . . . . 0.0 109.135 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -131.26 155.25 47.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 0.0 109.213 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -123.67 -155.84 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.798 . . . . 0.0 109.633 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 102.26 -2.66 50.72 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.753 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 52.26 5.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.712 -0.875 . . . . 0.0 109.077 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 14' ' ' ILE . 33.2 m -68.11 128.39 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 -51.89 4.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.121 -0.987 . . . . 0.0 109.72 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 mt-30 -139.74 174.09 10.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.5 t70 84.6 86.13 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.62 -17.61 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.702 2.268 . . . . 0.0 112.647 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -62.54 -40.03 95.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.002 -1.061 . . . . 0.0 108.557 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -66.37 -45.42 80.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -64.44 -42.63 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.03 -1.044 . . . . 0.0 109.726 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.06 73.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.041 -1.037 . . . . 0.0 108.644 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -67.18 -41.57 85.68 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 108.897 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.549 ' C ' ' HD1' ' A' ' 17' ' ' HIS . 3.3 t-80 -61.61 -49.57 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.399 -0.813 . . . . 0.0 109.499 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.19 -36.14 74.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.636 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.36 -73.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.994 -1.066 . . . . 0.0 109.838 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.61 130.92 25.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.795 ' HE1' HE21 ' A' ' 167' ' ' GLN . 28.0 t90 -177.17 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.241 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 169' ' ' CYS . . . 100.75 -3.67 56.09 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.2 m -69.9 125.92 92.22 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.176 -1.19 . . . . 0.0 108.894 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.87 126.73 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.748 1.632 . . . . 0.0 112.265 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.0 tp10 -117.19 136.23 53.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 0.0 109.05 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -110.83 3.44 18.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 109.256 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 94.9 m-20 -87.68 115.35 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.821 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 m -62.78 -34.27 76.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.87 -51.49 69.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 109.325 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.08 -41.96 97.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.857 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.43 -42.57 87.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 102' ' ' TYR . 19.7 t80 -60.92 -47.09 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.91 -31.03 72.01 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.005 -1.06 . . . . 0.0 109.244 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 9.7 tpt -59.37 -53.47 57.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.446 -0.784 . . . . 0.0 110.916 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.52 -32.51 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.628 -1.295 . . . . 0.0 109.9 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.4 m -65.66 -49.06 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.042 . . . . 0.0 110.205 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.1 mp -72.08 -31.55 66.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.951 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 161' ' ' ILE . 51.8 mm-40 -53.43 -34.45 57.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.792 -1.193 . . . . 0.0 109.609 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.29 -32.0 50.87 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -61.53 -39.7 91.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.958 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 28.7 tt0 -49.02 -37.75 21.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.88 108.3 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.34 -31.29 4.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -89.74 -166.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.966 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.3 t -133.44 152.47 51.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.555 -0.715 . . . . 0.0 109.722 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 57.9 t-105 -48.17 -44.67 32.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 48' ' ' THR . 10.5 tp -61.25 -39.44 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 110.103 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.692 HG21 HD12 ' A' ' 44' ' ' LEU . 97.1 m -67.21 -38.82 85.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.57 -42.44 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 0.0 110.94 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.2 mt -59.46 -42.72 92.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.765 -1.21 . . . . 0.0 110.633 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.91 -58.34 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.618 -1.301 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.09 -30.91 71.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.032 -1.042 . . . . 0.0 109.061 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -51.33 -41.54 60.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -64.5 -40.46 95.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' ILE . 22.3 m120 -65.22 -39.03 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.0 109.273 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.692 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 51.8 t80 -56.72 -44.48 81.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.511 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.0 mtp180 -62.84 -31.75 72.83 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.15 94.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.928 -1.107 . . . . 0.0 110.24 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -42.32 9.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.989 . . . . 0.0 111.394 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 80.4 m-85 -81.43 -37.09 28.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.032 . . . . 0.0 112.643 -177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' HH21 ' A' ' 57' ' ' ARG . 1.0 OUTLIER -54.11 -43.19 70.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.419 -1.426 . . . . 0.0 109.48 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.41 -34.77 79.09 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 64' ' ' ASP . 23.8 m-85 -94.21 67.43 3.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -35.03 158.77 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 121.321 0.582 . . . . 0.0 110.267 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.61 -31.17 48.54 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.959 2.439 . . . . 0.0 112.856 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.1 -47.48 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.92 -1.112 . . . . 0.0 109.275 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 71' ' ' MET . 33.7 mttp -65.79 -35.89 81.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 109.434 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 96' ' ' ILE . 82.8 t -62.37 -37.44 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.559 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.35 58.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.019 -1.051 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.12 23.99 10.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.56 -0.712 . . . . 0.0 110.76 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ptp -80.34 179.67 7.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.742 -1.224 . . . . 0.0 109.312 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -113.7 155.73 25.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.28 -31.65 67.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 0.0 109.011 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.54 -36.77 64.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.93 . . . . 0.0 108.523 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.5 -38.69 88.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.265 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 75.0 t -57.95 -42.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.13 -40.03 96.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.982 . . . . 0.0 109.12 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.82 -42.6 94.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.467 -0.771 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.9 mt -66.69 -32.87 74.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.399 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 76' ' ' VAL . 58.4 t -55.17 -36.67 40.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.13 6.03 46.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.142 -0.974 . . . . 0.0 110.79 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 78.7 m-20 -92.75 126.86 38.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.234 . . . . 0.0 110.331 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 85' ' ' ILE . . . 52.82 -0.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 43.89 38.85 4.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 55' ' ' ASN . 39.2 pt -54.19 -162.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.41 -1.053 . . . . 0.0 109.932 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 9.1 tt -49.38 -177.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.915 . . . . 0.0 109.801 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HG2' HH11 ' A' ' 87' ' ' ARG . 23.5 mtt-85 -51.93 152.72 2.91 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB2' HG22 ' A' ' 80' ' ' VAL . 5.9 m80 -122.41 -165.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.532 -0.73 . . . . 0.0 110.375 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 59.57 -80.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.789 -0.569 . . . . 0.0 110.24 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.95 -48.32 84.31 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.353 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 mttt -72.26 -51.73 19.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.928 -1.337 . . . . 0.0 110.591 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 95' ' ' ILE . 77.2 mt -57.27 -41.89 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.649 -1.282 . . . . 0.0 109.912 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.88 -40.14 72.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.948 -1.095 . . . . 0.0 108.662 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.38 -40.07 89.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 92' ' ' ILE . 98.7 mt -58.81 -46.74 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 109.997 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 68' ' ' VAL . 89.7 mt -57.31 -44.06 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.728 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.07 96.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 95' ' ' ILE . 86.0 m-20 -57.9 -38.96 76.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -1.146 . . . . 0.0 109.986 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.93 92.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 109.704 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.5 OUTLIER -64.25 -42.18 96.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.71 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.09 72.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.064 -1.023 . . . . 0.0 109.179 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 49.9 t80 -68.0 -49.07 63.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.503 -0.748 . . . . 0.0 110.149 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 103' ' ' LEU . 30.6 tp -61.71 -40.15 94.04 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.221 -0.925 . . . . 0.0 109.799 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -62.54 -40.16 95.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.489 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 24.0 ttt -62.58 -44.28 96.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.97 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -65.99 -30.1 70.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.082 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -52.97 -30.83 37.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.226 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -81.89 0.59 38.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.37 26.28 63.98 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -108.78 101.44 43.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -1.09 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -51.06 129.59 28.83 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.871 1.714 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.94 -42.15 97.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.822 . . . . 0.0 109.508 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.37 98.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.82 -33.8 70.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.831 -1.168 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.51 -51.43 68.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.0 110.562 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -61.37 -41.41 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.12 . . . . 0.0 109.54 -179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.563 ' CH2' HD23 ' A' ' 171' ' ' LEU . 67.0 m95 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.152 -0.967 . . . . 0.0 109.276 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -62.93 -35.19 79.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 3.5 m-85 -63.05 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.858 -1.151 . . . . 0.0 110.002 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.7 13.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 122' ' ' HIS . 17.7 t-20 61.29 39.58 15.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.745 . . . . 0.0 110.025 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.2 t-80 43.28 31.52 0.39 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.486 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.65 95.02 43.51 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.459 -0.776 . . . . 0.0 109.422 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.0 145.9 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.231 1.954 . . . . 0.0 112.157 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -113.33 155.56 24.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.975 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -135.29 155.18 51.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.06 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.2 t -128.86 155.63 44.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.01 40.35 3.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.554 -0.716 . . . . 0.0 109.347 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.02 136.66 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 4.2 m -98.65 -26.92 14.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 m -122.5 155.76 35.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.516 -0.74 . . . . 0.0 109.13 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.3 mt -57.14 -37.11 71.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.873 . . . . 0.0 109.939 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -60.18 -35.58 75.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.714 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.526 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.6 mt-10 -64.96 -28.31 69.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.29 121.64 79.48 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.039 -1.038 . . . . 0.0 109.818 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.47 142.37 20.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.323 2.016 . . . . 0.0 112.287 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.52 0.73 22.9 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.3 86.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.469 -0.77 . . . . 0.0 109.739 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -88.01 161.53 43.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.841 . . . . 0.0 108.946 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.86 -35.32 88.5 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.478 2.119 . . . . 0.0 112.262 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.83 80.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.062 -1.024 . . . . 0.0 109.199 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.6 m -61.06 -43.98 98.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 109.832 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.39 -45.91 88.86 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.23 -40.25 78.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.91 . . . . 0.0 109.517 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 39.0 tp -57.89 -48.59 79.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.438 -0.789 . . . . 0.0 110.196 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.9 t -57.89 -38.98 76.8 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.172 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -61.68 -41.69 97.9 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.773 . . . . 0.0 109.461 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -69.16 -48.38 62.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.06 -37.95 86.91 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 108.842 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -62.24 -47.05 86.12 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.9 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -64.14 -37.44 87.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.618 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 10.9 tpp180 -63.76 -21.29 66.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.299 -0.876 . . . . 0.0 109.711 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.38 15.09 11.8 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -88.73 135.61 33.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.951 -1.323 . . . . 0.0 109.9 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 61.5 mttt -103.89 -172.04 2.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.474 -0.766 . . . . 0.0 109.405 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 43.73 50.93 6.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 108.887 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 155' ' ' LYS . 35.3 m -110.96 24.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.15 162.59 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 t -62.26 -27.0 68.7 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 27.2 p -70.89 -43.26 68.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 38' ' ' GLU . 2.9 mt -66.92 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.4 m -64.43 -46.94 81.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.248 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' OH ' ' OD2' ' A' ' 174' ' ' ASP . 61.0 t80 -63.28 -42.88 99.16 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.0 109.238 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.7 m -59.73 -38.07 80.67 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.883 . . . . 0.0 108.909 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -60.95 -46.58 90.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.154 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.816 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.4 mmm -64.47 -40.0 94.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.089 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.795 HE21 ' HE1' ' A' ' 21' ' ' TRP . 33.8 tt0 -66.93 -38.75 86.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.605 -0.685 . . . . 0.0 110.894 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -61.28 -54.5 43.2 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.114 -0.991 . . . . 0.0 110.135 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -79.33 -60.87 2.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 108.955 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 153.85 -102.98 0.23 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.816 HD12 ' SD ' ' A' ' 166' ' ' MET . 15.8 mt 64.43 -37.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.66 ' H ' ' C ' ' A' ' 170' ' ' GLY . 10.5 m -135.37 146.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 127' ' ' THR . 37.2 t30 -104.18 100.57 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.273 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p30 -121.99 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.608 -0.683 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.691 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.7 m170 -125.24 -75.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.1 t 167.98 134.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 129' ' ' ALA . 31.1 t -56.53 129.29 17.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.0 109.128 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 27.27 36.15 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.029 -1.082 . . . . 0.0 110.405 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 181' ' ' CYS . 2.0 t -92.35 111.29 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.743 -1.445 . . . . 0.0 109.57 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.61 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.889 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 179' ' ' CYS . 4.8 p -156.76 59.47 0.54 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.342 -0.849 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.1 t80 -124.04 81.82 56.69 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -69.9 -58.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.618 2.212 . . . . 0.0 112.034 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.4 -9.07 67.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -171.98 16.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -147.28 80.02 9.48 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.236 179.905 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.622 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.41 158.83 16.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.741 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 3' ' ' ARG . 24.3 mtt-85 -113.49 160.05 18.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.128 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.2 p -51.18 141.97 13.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.821 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.13 33.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -47.01 -33.34 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.346 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 4' ' ' CYS . 28.4 m -59.88 126.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -79.5 -88.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -164.12 -33.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 145.31 98.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.22 -31.71 22.34 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.325 2.017 . . . . 0.0 112.421 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 12' ' ' LEU . 7.3 tt -63.77 -39.74 94.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.501 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.12 -48.76 74.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.8 mt -66.12 -35.32 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.48 91.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.84 -38.09 87.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.1 t-80 -56.85 -46.96 81.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.24 -31.92 66.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 110.842 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -69.42 -72.51 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.124 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -148.77 116.69 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.206 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 51.3 t90 -176.44 92.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.318 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -8.9 51.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.53 132.16 53.11 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.375 -1.074 . . . . 0.0 108.633 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.64 124.7 11.36 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.571 . . . . 0.0 112.468 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -116.09 133.91 55.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 109.19 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.7 p -113.87 2.8 15.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 109.281 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.97 119.22 26.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.771 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -63.18 -38.07 89.72 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 110.262 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -58.42 -45.63 88.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 110.188 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -66.01 -43.92 86.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.35 -41.45 89.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.984 -1.072 . . . . 0.0 110.486 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -61.57 -47.47 85.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 96.3 mt-10 -65.72 -31.84 73.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.426 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.568 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 5.0 tpt -62.24 -52.57 63.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 111.242 -178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.43 -34.21 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.657 -1.277 . . . . 0.0 109.983 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -72.26 -43.75 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 23.3 tp -65.48 -42.5 92.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.565 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 2.8 mp0 -65.67 -28.31 68.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.846 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.74 -34.15 43.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.276 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.63 ' OE1' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -82.3 -13.78 56.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.974 -1.309 . . . . 0.0 110.414 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 9.4 pt20 -58.69 -36.05 73.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.0 109.58 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.45 119.5 1.88 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.063 -1.023 . . . . 0.0 109.383 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.46 -12.87 68.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.587 HD23 HG21 ' A' ' 48' ' ' THR . 2.2 mp -116.69 -169.43 1.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -1.023 . . . . 0.0 109.731 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -117.84 152.91 34.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.586 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -52.9 -40.75 63.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.968 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 48' ' ' THR . 11.2 tp -61.65 -37.77 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.965 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.587 HG21 HD23 ' A' ' 44' ' ' LEU . 86.2 m -66.86 -39.01 87.43 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.2 -45.21 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 110.431 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -58.0 -46.58 84.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.92 -1.112 . . . . 0.0 109.065 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.94 -42.49 84.99 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.561 ' HZ3' HD12 ' A' ' 86' ' ' ILE . 7.4 tptm -64.23 -32.5 74.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.07 -46.16 68.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 58.3 mp0 -72.3 -43.8 63.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.914 -1.116 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -65.48 -38.61 90.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.973 -1.08 . . . . 0.0 109.649 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 80.9 t80 -57.42 -44.98 85.06 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.745 HH22 ' CE1' ' A' ' 61' ' ' HIS . 21.2 mmm180 -62.33 -30.31 71.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.225 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.83 99.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.882 -1.136 . . . . 0.0 110.997 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -42.57 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.959 -1.088 . . . . 0.0 111.613 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 78.8 m-85 -78.49 -48.37 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 112.225 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.745 ' CE1' HH22 ' A' ' 57' ' ' ARG . 38.6 t60 -58.82 -32.07 69.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.724 -1.235 . . . . 0.0 110.06 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.84 -36.8 59.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -95.92 -6.69 38.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.998 . . . . 0.0 110.029 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 66.12 151.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.835 -1.166 . . . . 0.0 109.24 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.77 -38.04 25.45 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.73 2.287 . . . . 0.0 113.262 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.55 -46.06 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.663 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -63.29 -35.04 79.04 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 64' ' ' ASP . 69.5 t -57.78 -41.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.531 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -66.81 -31.04 71.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.67 17.79 17.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 75' ' ' ASP . 50.3 ttp -100.09 159.84 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.959 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -107.15 164.69 11.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.091 -1.006 . . . . 0.0 109.544 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -23.9 54.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 15.8 pt-20 -52.14 -37.69 55.16 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.112 -0.992 . . . . 0.0 108.701 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 19.2 t70 -58.75 -38.48 78.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 80' ' ' VAL . 97.5 t -57.07 -42.72 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 108.69 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -59.04 -35.22 72.94 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -69.15 -48.93 60.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.498 -0.751 . . . . 0.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.9 mt -64.06 -33.87 76.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.47 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 76' ' ' VAL . 77.5 t -62.86 -37.51 79.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.839 -1.163 . . . . 0.0 108.318 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.97 -49.7 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.868 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.733 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.3 m-20 -99.01 151.75 20.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 83.93 85.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -67.75 17.22 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 83' ' ' ALA . 1.2 pt -46.43 -99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.257 -1.143 . . . . 0.0 109.578 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 93.5 mt -123.82 143.49 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.927 . . . . 0.0 109.614 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' NH1' ' O ' ' A' ' 80' ' ' VAL . 17.7 tpt180 -93.32 116.01 28.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.08 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.096 -1.003 . . . . 0.0 108.67 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 80' ' ' VAL . 81.8 mtm180 -52.43 -36.49 54.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.033 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.59 97.67 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.504 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -66.76 -45.67 77.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.723 -1.457 . . . . 0.0 110.741 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 76' ' ' VAL . 59.1 mt -60.62 -44.61 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.34 -37.65 75.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.98 85.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.77 -45.78 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.956 . . . . 0.0 108.985 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.92 -41.91 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.92 94.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -59.94 -40.77 90.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.098 . . . . 0.0 110.063 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.01 -42.65 97.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.67 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -63.39 -41.8 98.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.01 -42.11 60.84 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.27 -0.893 . . . . 0.0 109.496 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.51 -45.69 91.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -65.84 -37.89 87.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.158 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -57.92 -42.49 84.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.87 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 36.5 ttm -63.23 -40.16 96.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.104 . . . . 0.0 109.369 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -58.75 -28.04 65.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.331 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -52.81 -35.16 56.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.09 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -83.42 -1.06 52.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.32 23.71 77.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 109.66 63.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.126 . . . . 0.0 109.236 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.79 137.11 42.95 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.857 1.705 . . . . 0.0 112.231 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.22 -42.6 99.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.301 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.13 73.54 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.185 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.09 -34.81 79.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.175 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.02 -51.76 68.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.747 . . . . 0.0 109.987 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.74 -40.45 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.034 -1.041 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 171' ' ' LEU . 27.7 m95 -60.58 -36.1 77.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 0.0 109.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.5 p -64.15 -33.56 76.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 7.1 m-85 -65.17 -26.71 68.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.866 -1.146 . . . . 0.0 110.342 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.34 23.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 108.909 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 73.6 m-20 57.77 38.07 27.29 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.527 0.68 . . . . 0.0 109.883 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 45.24 13.11 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.593 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' ASN . 11.1 mt-30 -103.51 127.35 29.76 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.076 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.01 145.5 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.871 1.714 . . . . 0.0 111.763 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -108.5 141.51 40.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 78.3 mtp -132.19 151.48 51.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.0 t -132.15 151.81 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.15 -0.969 . . . . 0.0 110.133 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -119.87 47.36 1.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -67.55 142.47 56.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.6 -35.35 15.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 155.27 37.77 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.6 -33.33 69.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.0 m -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.763 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.9 mt-10 -64.24 -29.33 70.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.01 119.91 70.43 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.103 -0.998 . . . . 0.0 109.449 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.62 141.48 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.198 1.932 . . . . 0.0 112.06 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 t -102.96 4.2 37.18 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.387 -0.821 . . . . 0.0 109.076 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -137.69 78.42 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 109.675 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.1 p -79.94 150.74 72.52 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.19 -0.944 . . . . 0.0 108.953 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.71 -30.74 68.13 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.154 1.903 . . . . 0.0 111.966 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.07 61.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.9 p -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -63.8 -45.94 87.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.13 82.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.06 -47.54 77.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.358 -0.839 . . . . 0.0 109.754 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.558 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 29.0 m -59.6 -41.64 90.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.42 -0.8 . . . . 0.0 109.48 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.54 -36.86 85.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 119' ' ' PHE . . . -67.17 -51.48 53.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 0.0 109.694 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.17 -33.64 74.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -42.43 88.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.707 -0.62 . . . . 0.0 109.798 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -62.54 -39.26 93.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.991 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -63.67 -20.19 65.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.96 18.27 14.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -81.27 132.97 35.37 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.393 -1.063 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.23 165.65 10.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.477 -0.765 . . . . 0.0 109.144 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.94 53.52 4.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 158' ' ' GLY . 27.1 m -115.94 24.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.805 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.1 153.91 0.36 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 39.7 m -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.41 -1.053 . . . . 0.0 109.727 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.6 m -64.13 -47.49 79.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.432 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 38' ' ' GLU . 89.6 mt -66.39 -36.66 77.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.377 -0.827 . . . . 0.0 109.344 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.558 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 82.4 m -64.38 -46.4 83.5 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.43 -0.794 . . . . 0.0 109.327 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -60.94 -45.26 95.41 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.5 m -59.39 -38.72 81.26 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.127 -0.983 . . . . 0.0 108.83 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.02 -41.47 96.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.512 -0.743 . . . . 0.0 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.6 mtp -59.37 -37.3 77.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.18 -42.86 95.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.14 -0.975 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.568 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.69 -42.1 59.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.78 -37.05 86.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.019 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.05 7.15 57.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.504 HD23 ' CH2' ' A' ' 117' ' ' TRP . 74.9 mt -59.02 -32.83 70.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.916 -1.343 . . . . 0.0 108.982 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.08 140.73 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 109.044 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 127' ' ' THR . 0.7 OUTLIER -106.03 102.59 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.817 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.8 p-10 -120.45 91.11 3.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.59 -0.694 . . . . 0.0 109.787 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.571 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 9.2 m-70 -132.74 27.44 4.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.202 -0.936 . . . . 0.0 108.777 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 58.11 160.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.798 -1.189 . . . . 0.0 108.334 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 177' ' ' VAL . 7.2 p -88.51 92.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.007 -1.058 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 159.72 -12.35 0.18 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 19.6 t -70.5 30.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.283 . . . . 0.0 109.714 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 64.82 -65.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.298 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 30.6 m -52.03 -22.75 4.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 109.046 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.83 80.67 56.17 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.0 109.659 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.67 -25.09 24.77 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.751 2.301 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.32 65.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 58.9 42.06 20.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.44 -1.035 . . . . 0.0 109.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -87.86 150.02 47.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.209 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 C-N-CA 122.337 2.025 . . . . 0.0 112.163 179.908 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.12 162.03 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.533 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -144.06 158.57 43.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.2 m -59.17 138.37 57.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.097 -1.002 . . . . 0.0 108.622 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.83 -18.83 9.62 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.136 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' NE1' ' CH2' ' A' ' 21' ' ' TRP . 69.7 p-90 -53.65 -28.99 36.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.753 -1.439 . . . . 0.0 109.493 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -52.72 132.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.36 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 p -73.6 170.4 15.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 1.3 mp0 -56.06 -29.78 60.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.27 133.54 24.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.025 . . . . 0.0 109.149 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.26 -26.56 20.76 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.241 1.961 . . . . 0.0 112.757 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 12' ' ' LEU . 33.4 tp -62.93 -36.72 84.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 108.806 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' CE2' HD13 ' A' ' 47' ' ' ILE . 3.2 m-85 -57.26 -55.57 33.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.04 -36.95 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -59.01 -43.5 91.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.084 -1.01 . . . . 0.0 108.398 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -66.33 -39.74 89.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 6.2 t-80 -60.55 -51.64 68.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.741 . . . . 0.0 109.595 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.09 -33.84 70.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 88.3 m-20 -72.26 -71.23 0.29 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.078 -1.013 . . . . 0.0 110.037 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' OE1' HG21 ' A' ' 23' ' ' VAL . 78.4 mm-40 -143.14 119.08 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.692 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 26.7 t90 -175.32 103.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -0.893 . . . . 0.0 109.918 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.12 -13.79 60.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG21 ' OE1' ' A' ' 20' ' ' GLU . 2.7 m -73.84 138.15 76.62 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.067 -1.255 . . . . 0.0 108.382 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.73 131.66 34.23 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.817 1.678 . . . . 0.0 112.433 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 35.3 tp10 -113.02 134.32 54.57 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.9 p -113.66 6.14 16.77 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 109.298 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 62.4 t0 -86.0 115.72 23.78 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 m -65.5 -35.72 81.72 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.659 -0.651 . . . . 0.0 109.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -60.99 -43.81 98.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.128 -0.982 . . . . 0.0 110.343 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -63.23 -38.54 91.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.872 -1.143 . . . . 0.0 109.811 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 75.2 mt -65.04 -38.21 90.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 110.119 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE2' ' OH ' ' A' ' 102' ' ' TYR . 6.7 m-30 -59.51 -50.27 74.56 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.41 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.39 -33.52 76.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.1 tpp -59.64 -49.65 76.92 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.408 -0.808 . . . . 0.0 109.937 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mm -59.92 -39.89 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 71.4 m -59.94 -46.43 89.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.086 -1.009 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -73.75 -42.35 61.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.425 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.19 -38.87 84.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.787 -1.196 . . . . 0.0 109.756 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -65.64 -33.69 76.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.466 -1.02 . . . . 0.0 110.201 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' ' 41' ' ' GLN . 1.6 pp0? -49.87 -29.7 8.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.999 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.72 109.89 0.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.152 -0.967 . . . . 0.0 110.048 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.62 -37.43 3.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 2.9 mm? -77.94 -165.38 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 49' ' ' VAL . 89.8 p -122.55 153.61 39.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.315 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.487 ' NE1' HD11 ' A' ' 50' ' ' LEU . 56.9 t-105 -58.31 -41.8 85.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.17 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.589 HD13 ' CE2' ' A' ' 13' ' ' TYR . 8.0 tp -61.66 -40.88 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.172 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 85.4 m -66.14 -39.3 89.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.051 -1.03 . . . . 0.0 109.629 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 81.4 t -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -0.773 . . . . 0.0 110.871 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 ' NE1' ' A' ' 46' ' ' TRP . 84.7 mt -62.55 -54.99 31.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.765 -1.21 . . . . 0.0 110.103 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.99 -44.2 91.56 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -64.4 -32.3 73.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.705 -0.622 . . . . 0.0 109.353 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' VAL . 42.7 ttm180 -54.14 -43.43 70.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.078 -1.014 . . . . 0.0 109.618 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -69.69 -45.47 68.22 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.343 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -65.52 -38.02 88.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 8.6 t80 -57.61 -42.61 83.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -58.11 -40.91 82.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.301 -0.874 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.59 -22.73 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.93 -46.12 8.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 0.0 112.779 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.27 -17.83 12.22 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.768 -1.208 . . . . 0.0 112.9 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -58.61 -39.61 80.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.165 -1.584 . . . . 0.0 108.869 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.23 -33.32 70.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.6 m-85 -101.37 68.24 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.11 162.25 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 CA-C-O 121.355 0.598 . . . . 0.0 110.632 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 72.9 Cg_exo -41.51 -53.0 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.901 2.4 . . . . 0.0 113.166 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 3.5 p -59.41 -40.53 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.806 -1.184 . . . . 0.0 110.234 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 23.9 mttm -62.57 -41.8 99.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.447 -0.783 . . . . 0.0 111.215 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 99' ' ' ALA . 13.9 m -73.82 -34.17 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.59 -1.319 . . . . 0.0 109.741 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.95 -24.57 67.94 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.836 -1.165 . . . . 0.0 108.441 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.07 19.58 18.29 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.807 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.98 178.77 7.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.642 -1.286 . . . . 0.0 109.485 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -110.37 154.82 23.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.866 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.93 -32.36 67.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.98 -35.77 75.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -0.911 . . . . 0.0 108.835 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.02 -38.21 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.0 109.018 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 96' ' ' ILE . 69.3 t -60.03 -42.42 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 109.542 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.77 -35.19 79.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -58.79 -44.43 90.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.534 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 82' ' ' ASP . 60.0 mt -67.87 -33.34 74.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 109.66 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.63 -36.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 108.891 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -75.86 -57.42 3.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 108.873 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 90.7 m-20 -98.96 127.77 44.96 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 82' ' ' ASP . . . 164.09 82.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 109.789 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -51.4 -26.98 15.6 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 84' ' ' GLY . 46.9 pt -58.14 -147.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 109.831 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.29 143.78 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.507 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -104.16 114.5 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.869 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -178.34 101.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -52.53 -31.5 35.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.06 -47.62 87.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -61.16 -43.27 99.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.746 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 95' ' ' ILE . 74.4 mt -62.05 -37.66 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.173 -0.954 . . . . 0.0 109.164 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -38.99 71.17 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.326 -0.859 . . . . 0.0 109.06 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.48 87.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.836 . . . . 0.0 109.439 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 92' ' ' ILE . 90.0 mt -58.06 -46.88 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.624 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.7 mt -58.24 -42.14 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -34.21 88.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -60.38 -42.42 95.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.265 . . . . 0.0 109.857 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -66.86 -45.52 77.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.688 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 100' ' ' ARG . 32.0 ttm-85 -60.16 -43.2 95.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 108.776 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -69.75 -33.2 72.11 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.348 -0.845 . . . . 0.0 108.789 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 81.2 t80 -59.29 -43.4 92.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.6 mt -66.61 -36.93 83.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -59.02 -45.33 90.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.093 -1.004 . . . . 0.0 109.661 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.84 -44.43 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.163 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.78 -28.02 68.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.588 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.68 -35.06 54.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.232 -0.918 . . . . 0.0 109.099 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.49 0.49 54.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.12 65.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -123.42 84.95 52.4 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.02 145.24 92.55 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.639 2.226 . . . . 0.0 112.153 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 116' ' ' VAL . 71.4 m-85 -57.02 -40.47 76.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 108.983 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.05 -47.75 84.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.761 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.57 -42.84 73.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 67.9 t80 -62.77 -44.33 96.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.561 -0.712 . . . . 0.0 110.172 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 171' ' ' LEU . 38.6 t -59.63 -45.78 93.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.23 -38.71 71.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.015 -1.053 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -60.47 -37.08 79.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.3 m-85 -62.27 -29.48 70.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.13 22.47 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' C ' ' N ' ' A' ' 123' ' ' GLN . 37.8 t30 61.66 32.18 18.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m80 51.97 11.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 109.981 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -109.87 134.29 20.7 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.88 . . . . 0.0 109.451 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.36 150.54 58.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.171 1.914 . . . . 0.0 112.19 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.658 ' HB2' HG12 ' A' ' 172' ' ' VAL . 25.8 mt-30 -112.53 147.99 35.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.44 -0.788 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.7 ttm -125.69 146.86 49.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 0.0 109.513 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -131.04 150.18 52.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.32 53.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -65.57 130.12 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.453 -0.779 . . . . 0.0 109.17 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.549 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.3 m -63.9 -38.55 91.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -134.75 172.79 12.47 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.647 0.737 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.77 -35.49 74.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.735 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.9 m -60.09 -38.33 82.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.955 . . . . 0.0 110.428 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 94.4 mt-10 -65.7 -20.95 66.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 110.402 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.44 119.1 59.97 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 120.796 -1.19 . . . . 0.0 109.243 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.48 138.67 17.64 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.095 1.863 . . . . 0.0 112.263 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 0.55 30.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.7 t -132.34 94.82 3.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.261 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.0 p -105.58 152.14 39.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 108.799 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.14 -39.6 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.757 1.638 . . . . 0.0 111.912 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.22 70.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.1 p -62.21 -38.48 89.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.24 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.01 -46.37 84.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 109.314 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.52 67.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -58.73 -49.28 78.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.444 -0.785 . . . . 0.0 109.313 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.4 p -64.46 -35.53 81.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 0.0 109.744 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.86 -37.07 85.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.874 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.81 -52.25 52.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 110.471 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.5 mp -66.72 -34.36 77.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.922 -1.111 . . . . 0.0 109.171 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -59.06 -41.13 87.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.294 -0.879 . . . . 0.0 109.178 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.99 -38.75 87.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 109.202 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 27.9 mmt180 -64.16 -19.97 65.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.36 40.4 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -67.13 144.2 56.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.953 -1.322 . . . . 0.0 109.624 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -102.7 161.42 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.501 -0.749 . . . . 0.0 109.586 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 57.36 52.85 8.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 110.163 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 158' ' ' GLY . 6.9 m -116.87 24.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.438 -0.789 . . . . 0.0 109.34 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.04 159.35 0.12 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.8 t -54.82 -29.8 55.72 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.0 p -66.36 -38.23 87.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.03 -47.02 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.276 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.15 -40.39 89.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -62.85 -41.85 99.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.917 -1.114 . . . . 0.0 109.371 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -62.94 -35.12 79.05 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 108.609 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.514 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 67.9 t80 -62.73 -44.58 95.84 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.675 -0.64 . . . . 0.0 109.546 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.5 mtp -65.49 -38.08 88.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.402 -0.811 . . . . 0.0 109.506 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 174' ' ' ASP . 69.8 tp60 -62.48 -47.09 85.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.0 76.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.956 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 171' ' ' LEU . 38.9 t -65.6 -38.06 88.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.12 56.58 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.426 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 116' ' ' VAL . 70.6 mt -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.895 -1.356 . . . . 0.0 108.71 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 125' ' ' GLN . 4.0 m -114.75 136.67 50.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 127' ' ' THR . 78.1 m-20 -83.33 109.55 17.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.645 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 77.5 m-20 -119.68 -176.89 3.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.7 . . . . 0.0 110.663 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.692 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 21.0 m170 123.67 -119.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -144.56 155.09 14.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 182' ' ' TYR . 97.9 t -52.59 -36.25 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -104.66 15.3 49.31 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.906 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.615 ' O ' ' N ' ' A' ' 181' ' ' CYS . 24.4 t -69.9 61.25 0.18 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.244 -1.739 . . . . 0.0 109.9 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 1.5 t 34.31 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.685 -0.635 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -41.48 -25.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 180' ' ' CYS . 10.4 t80 -101.44 108.23 54.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.399 -0.813 . . . . 0.0 108.948 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 185' ' ' ASN . 96.3 Cg_endo -82.26 -102.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.364 2.043 . . . . 0.0 112.158 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.22 -13.67 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 183' ' ' PRO . 19.9 t-20 -85.18 7.01 23.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 108.932 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.9 81.57 65.71 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 121.483 0.659 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.667 2.244 . . . . 0.0 112.2 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 62.7 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.372 0.606 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -110.49 149.84 29.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.531 -0.731 . . . . 0.0 109.614 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.96 151.92 44.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.187 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 175' ' ' HIS . 28.3 m -74.69 128.23 35.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.373 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.807 ' C ' HD11 ' A' ' 132' ' ' LEU . . . -68.45 -17.5 70.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.611 ' CE2' HD22 ' A' ' 132' ' ' LEU . 56.4 m95 -53.96 -38.22 64.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.307 . . . . 0.0 109.679 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 13' ' ' TYR . 15.2 m -122.91 156.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.456 -0.778 . . . . 0.0 110.075 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -149.06 -56.88 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 110.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 58.6 tp60 -101.9 149.91 23.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 2.1 t70 85.59 89.28 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.7 -0.625 . . . . 0.0 109.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.09 -13.6 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.005 2.47 . . . . 0.0 113.146 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.2 -35.11 77.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.822 -1.174 . . . . 0.0 108.563 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' HB3' HG11 ' A' ' 7' ' ' VAL . 50.6 m-85 -55.77 -69.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.885 0.85 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OD2' ' A' ' 18' ' ' ASP . 97.5 mt -52.57 -41.6 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.872 -0.518 . . . . 0.0 111.427 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.75 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.669 -1.269 . . . . 0.0 109.284 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CD1' ' CD2' ' A' ' 50' ' ' LEU . 7.1 t80 -75.21 -44.98 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.388 -0.82 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.596 ' HD1' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -70.1 -18.85 63.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.316 -178.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.596 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 83.5 m-20 -77.56 -50.8 11.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.901 -1.124 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -75.77 -65.9 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.844 . . . . 0.0 110.485 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.2 mt-10 -101.79 -174.6 2.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.3 -0.875 . . . . 0.0 109.6 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.889 ' CE3' ' HB2' ' A' ' 168' ' ' ALA . 3.7 t-105 57.44 117.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.056 0.931 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 103.41 -8.94 52.94 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.78 149.7 37.8 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.378 -1.072 . . . . 0.0 108.957 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.86 124.14 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.118 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.67 132.49 55.76 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.451 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.0 p -121.75 6.35 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.527 -0.733 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -85.36 116.61 23.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.292 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -61.56 -36.97 82.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -62.36 -54.54 38.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -39.25 82.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 169' ' ' CYS . 11.9 tp -58.13 -44.7 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -63.06 -43.04 99.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.348 -0.845 . . . . 0.0 109.524 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.35 -35.01 74.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.6 tpt -62.76 -43.65 98.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -69.83 -47.36 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.072 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -48.64 66.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.357 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.66 -40.47 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.416 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' A' ' 161' ' ' ILE . 50.0 tp10 -62.15 -35.1 77.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.017 -1.052 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.11 -31.09 40.15 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.59 -33.33 72.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -1.052 . . . . 0.0 110.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.17 -26.52 28.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.977 -1.077 . . . . 0.0 109.929 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.74 114.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 109.382 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.67 -27.87 12.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -121.49 161.45 22.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.599 -0.942 . . . . 0.0 109.951 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 m -79.94 159.54 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 49' ' ' VAL . 16.3 p90 -60.92 -34.76 75.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -44.16 -41.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.98 -1.075 . . . . 0.0 108.926 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 89.6 m -66.01 -36.36 83.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 46' ' ' TRP . 44.4 t -67.21 -49.61 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.589 -0.694 . . . . 0.0 110.152 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 16' ' ' TYR . 6.9 mp -54.38 -55.58 27.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.891 -1.13 . . . . 0.0 109.728 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -56.8 -43.96 81.45 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 86' ' ' ILE . 12.4 tttm -63.96 -32.55 74.13 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.069 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.5 tmm_? -48.02 -41.43 25.57 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.815 -1.178 . . . . 0.0 107.83 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.01 -44.05 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.184 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.03 -40.25 94.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 109.672 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.695 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 60.0 t80 -57.02 -43.22 81.63 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.418 -0.801 . . . . 0.0 108.987 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.719 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 40.7 ttm-85 -58.38 -36.74 73.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.398 -0.814 . . . . 0.0 109.777 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.78 78.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.01 -1.056 . . . . 0.0 111.359 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -42.4 9.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.836 -1.165 . . . . 0.0 112.749 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 97.0 m-85 -92.82 -52.25 4.7 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.733 -1.229 . . . . 0.0 112.603 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.719 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 43.5 t60 -54.65 -32.95 59.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.008 -1.057 . . . . 0.0 110.027 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -53.96 -36.66 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 109.402 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 89.9 m-85 -96.66 3.88 52.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 60.61 153.26 0.1 Allowed Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 109.179 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.08 -29.14 56.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.764 2.31 . . . . 0.0 113.264 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.77 -47.83 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.936 -1.102 . . . . 0.0 110.141 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' MET . 32.8 mttp -65.61 -32.34 73.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.275 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 64' ' ' ASP . 74.0 t -57.39 -43.19 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -72.12 -28.87 63.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.109 -0.994 . . . . 0.0 108.415 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.61 19.47 20.32 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.561 -0.712 . . . . 0.0 110.029 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 mtp -77.77 150.51 34.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.974 -1.078 . . . . 0.0 109.158 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -99.49 159.6 14.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.298 -0.877 . . . . 0.0 109.564 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.02 -34.3 69.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.347 -0.846 . . . . 0.0 109.188 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.15 -38.9 84.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 109.072 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.35 -38.58 90.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.83 . . . . 0.0 109.348 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.407 ' CG2' HD11 ' A' ' 96' ' ' ILE . 81.1 t -60.95 -40.66 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 109.624 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.89 -37.56 87.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -60.7 -42.68 97.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 82' ' ' ASP . 40.3 mt -66.93 -33.14 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.059 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.92 -37.61 26.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.132 -0.98 . . . . 0.0 109.1 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.15 -51.94 66.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 108.35 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 79' ' ' LEU . 58.7 t0 -99.76 111.05 23.41 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.89 -84.39 0.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 110.062 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.47 10.2 35.04 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' ILE . 39.0 pt -126.4 178.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.908 -0.76 . . . . 0.0 109.313 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.629 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 1.5 tt -52.13 -159.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.777 0.799 . . . . 0.0 110.664 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.629 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 5.5 tpp180 -51.84 152.2 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' O ' ' N ' ' A' ' 90' ' ' GLY . 20.3 p80 -121.25 177.68 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.635 0.731 . . . . 0.0 110.347 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.639 ' H ' HD12 ' A' ' 92' ' ' ILE . 0.2 OUTLIER 60.07 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.595 -0.691 . . . . 0.0 110.462 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -61.4 -49.0 81.89 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.345 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -45.46 62.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.841 -1.388 . . . . 0.0 109.68 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.639 HD12 ' H ' ' A' ' 89' ' ' ARG . 95.9 mt -55.28 -42.75 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.976 -1.078 . . . . 0.0 109.308 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -58.0 -39.5 78.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.198 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.23 -37.12 85.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.717 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.5 -44.2 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 76' ' ' VAL . 89.4 mt -59.23 -41.68 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.83 -42.97 99.74 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.685 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -41.74 93.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.007 -1.29 . . . . 0.0 110.312 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -65.11 -40.35 94.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.9 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.3 mtt-85 -64.48 -42.26 95.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.878 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.85 70.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 109.529 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.86 -46.71 86.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 110.487 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 103' ' ' LEU . 95.1 mt -65.31 -38.94 91.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.15 -41.59 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.98 . . . . 0.0 109.885 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.0 ttt -64.27 -39.41 93.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.002 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.75 -34.94 79.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -53.91 -23.07 11.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 0.0 108.827 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -77.12 -8.97 58.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.371 -0.831 . . . . 0.0 109.363 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.09 17.43 69.63 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.64 106.25 55.61 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.408 -1.054 . . . . 0.0 109.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.11 134.63 36.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.96 1.773 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -63.63 -43.92 95.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.477 -0.765 . . . . 0.0 109.656 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.89 99.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.212 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -59.54 -36.53 76.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.105 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -57.25 -46.68 82.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.89 -46.5 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.433 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.421 ' CH2' HD23 ' A' ' 171' ' ' LEU . 83.2 m95 -62.08 -35.12 77.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.882 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -59.22 -36.42 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.94 . . . . 0.0 110.232 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.39 -28.85 70.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.968 -1.082 . . . . 0.0 110.333 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.9 18.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.6 34.14 20.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 109.74 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 46.24 29.56 0.85 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.495 -0.753 . . . . 0.0 109.619 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -115.69 100.37 53.48 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.468 -0.77 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -51.77 144.84 33.31 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.287 1.992 . . . . 0.0 112.123 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -117.04 155.93 28.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.791 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.0 mtm -136.34 155.66 49.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -118.85 154.91 32.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.235 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -148.11 61.56 1.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.312 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -106.23 -131.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -33.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.666 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -119.81 152.91 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.051 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.807 HD11 ' C ' ' A' ' 5' ' ' GLY . 46.3 mt -60.31 -34.17 73.41 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.405 -0.809 . . . . 0.0 109.594 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 t -57.73 -37.18 73.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.828 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.46 -32.3 73.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 4.5 mt -85.79 115.75 62.94 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.35 128.14 9.48 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.973 1.782 . . . . 0.0 112.06 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -77.85 -17.87 56.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.277 -0.889 . . . . 0.0 109.055 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.3 t -97.89 103.17 15.09 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.353 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.8 p -116.79 150.52 45.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.88 -32.37 97.17 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.27 -43.0 61.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.248 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 t -60.8 -47.37 86.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.37 -0.831 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.4 -42.26 99.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.284 -0.885 . . . . 0.0 109.637 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.11 77.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.3 tt -62.1 -42.44 99.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.411 -0.806 . . . . 0.0 109.728 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.559 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 15.8 m -59.73 -45.41 92.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -60.86 -34.98 75.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.819 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.58 80.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.926 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 145' ' ' LEU . 84.3 mt -63.46 -35.36 80.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -57.91 -33.03 68.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.14 -40.72 90.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.0 109.413 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 152' ' ' ARG . 19.4 mtt-85 -67.9 -20.41 65.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.681 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.95 33.52 7.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -79.65 139.97 37.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -1.099 . . . . 0.0 110.162 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -105.85 165.94 10.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 109.096 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 161' ' ' ILE . 97.4 m-85 56.13 48.7 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -0.896 . . . . 0.0 109.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 15.0 p -122.14 26.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.552 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -37.01 151.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.9 m -55.89 -28.42 56.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.494 -1.004 . . . . 0.0 109.185 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.6 p -64.7 -40.51 95.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.164 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 158' ' ' GLY . 8.3 mt -64.49 -35.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 0.0 109.446 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.559 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.9 m -63.28 -48.1 79.55 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.431 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 58.5 t80 -63.59 -45.82 88.66 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.008 -1.058 . . . . 0.0 109.441 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 m -59.33 -37.37 77.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.905 . . . . 0.0 108.853 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.64 -40.46 92.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.507 -0.746 . . . . 0.0 109.376 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtp -63.71 -36.21 83.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.927 . . . . 0.0 109.247 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -59.19 -43.08 92.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.316 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.889 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . . . -82.02 -51.42 8.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.927 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 31' ' ' LEU . 40.5 t -49.48 -39.63 34.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.41 4.44 58.3 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD23 ' CH2' ' A' ' 117' ' ' TRP . 42.3 mt -53.81 -36.22 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.806 -1.409 . . . . 0.0 107.529 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.99 137.74 56.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 57.2 t30 -81.49 101.54 9.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.714 -1.241 . . . . 0.0 109.249 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -119.57 91.55 3.58 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.595 0.712 . . . . 0.0 109.442 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.54 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 1.5 m-70 -141.21 -75.19 0.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.4 OUTLIER 177.61 177.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.612 ' N ' HG13 ' A' ' 176' ' ' VAL . 95.5 t -64.94 -46.56 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.571 -1.331 . . . . 0.0 112.352 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . -112.02 -40.71 1.15 Allowed Glycine 0 N--CA 1.498 2.789 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.666 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.592 ' C ' ' H ' ' A' ' 181' ' ' CYS . 44.3 t 42.28 19.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -1.047 . . . . 0.0 109.018 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 57.48 -4.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.977 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 179' ' ' CYS . 16.4 m -119.72 -52.57 2.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -103.06 113.47 65.85 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 109.623 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.05 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.051 1.834 . . . . 0.0 112.187 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . 94.66 -1.24 65.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 11.7 m-20 -177.77 28.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.292 . . . . 0.0 110.037 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.34 80.4 58.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.296 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.821 2.347 . . . . 0.0 112.325 -179.955 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 6.4 tpp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.294 0.569 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.408 ' H ' ' CG ' ' A' ' 1' ' ' MET . 83.2 tt0 -96.44 147.51 23.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.235 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.7 mtm-85 -100.53 156.86 17.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER -52.71 135.28 35.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.514 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.37 78.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 26.9 m95 -53.91 -27.48 30.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.971 -1.311 . . . . 0.0 109.027 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 9' ' ' GLN . 53.9 t -52.52 -43.38 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' VAL . 66.5 m 38.71 -90.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 110.268 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 13.6 pt20 -140.58 169.14 18.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 1.1 t70 83.7 90.66 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.56 -18.91 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.643 2.229 . . . . 0.0 112.412 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 12' ' ' LEU . 48.1 tp -62.76 -36.83 84.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.9 t80 -60.24 -44.01 95.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.714 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.46 -36.99 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.97 . . . . 0.0 110.025 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.65 98.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.08 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -72.57 -32.98 66.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.9 t-80 -53.49 -42.73 67.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 110.204 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -96.82 -20.92 17.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.069 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -45.58 89.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.518 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 176.45 63.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 63.3 t90 -131.79 121.67 24.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 99.53 -20.91 47.69 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.3 140.82 65.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.243 -1.151 . . . . 0.0 108.678 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.54 125.62 15.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.933 1.755 . . . . 0.0 112.173 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.13 129.22 54.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.044 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.4 p -112.97 3.3 16.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -81.27 121.88 26.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.489 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 20.6 t -60.31 -36.89 78.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -59.57 -45.82 90.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -66.02 -38.22 87.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -66.07 -42.37 89.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.47 -52.4 63.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 111.161 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.8 -33.36 75.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.859 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 43.7 ttm -62.11 -52.51 63.58 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.976 -1.078 . . . . 0.0 110.958 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.54 -33.46 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.027 . . . . 0.0 110.706 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.04 -49.22 68.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.121 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.9 mp -68.14 -30.01 69.04 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.669 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.595 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 12.3 tp10 -53.49 -38.14 63.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 110.1 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -31.75 78.09 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -56.55 -32.16 64.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' LEU . 56.4 mt-30 -56.25 -27.39 54.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.984 -1.072 . . . . 0.0 110.63 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 108.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 108.982 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 -22.37 34.47 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.1 mt -120.85 155.12 34.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.032 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.7 p -88.75 164.3 15.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.0 110.164 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.755 ' NE1' HD21 ' A' ' 50' ' ' LEU . 62.7 t-105 -59.84 -40.29 88.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.512 -0.743 . . . . 0.0 111.573 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.526 HD12 HD12 ' A' ' 50' ' ' LEU . 8.6 tp -56.6 -40.07 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 0.0 110.531 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.7 m -66.38 -40.38 89.66 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.492 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 82.4 t -63.85 -33.79 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.578 -0.701 . . . . 0.0 110.812 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.755 HD21 ' NE1' ' A' ' 46' ' ' TRP . 94.3 mt -53.73 -47.25 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.577 -1.327 . . . . 0.0 109.264 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mppp? -61.47 -46.65 89.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.475 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -65.84 -30.47 71.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.561 -0.712 . . . . 0.0 109.192 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -55.47 -43.58 75.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.61 -43.62 80.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 108.88 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.434 ' HB2' HG22 ' A' ' 85' ' ' ILE . 19.8 m120 -65.22 -35.74 82.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.878 . . . . 0.0 109.246 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 33.7 t80 -59.87 -42.9 94.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.825 . . . . 0.0 109.746 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.492 HH21 ' CD2' ' A' ' 61' ' ' HIS . 61.2 mtp180 -60.42 -38.31 83.67 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.54 72.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.2 m -91.18 -23.26 20.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.022 -1.049 . . . . 0.0 111.413 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.649 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 93.4 m-85 -119.15 -46.03 2.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.976 -1.078 . . . . 0.0 111.789 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' CD2' HH21 ' A' ' 57' ' ' ARG . 51.8 t-80 -53.06 -39.03 62.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.759 -1.213 . . . . 0.0 109.361 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.01 -34.14 65.54 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.483 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 64' ' ' ASP . 91.4 m-85 -95.82 2.55 53.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.432 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.06 163.25 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.138 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 -30.19 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.94 2.427 . . . . 0.0 113.419 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' N ' ' A' ' 67' ' ' LYS . 4.1 p -60.94 -47.48 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.879 -1.138 . . . . 0.0 110.434 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG13 ' A' ' 66' ' ' VAL . 24.8 mttt -66.06 -33.39 75.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 109.896 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 64' ' ' ASP . 60.6 t -57.56 -43.54 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.213 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.17 61.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.47 18.59 21.99 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.609 -0.682 . . . . 0.0 110.152 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' LYS . 3.4 mtp -80.79 154.73 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.993 -1.067 . . . . 0.0 109.144 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -104.87 161.33 14.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -57.94 -29.62 65.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.752 . . . . 0.0 109.516 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.78 -38.34 78.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.021 -1.049 . . . . 0.0 108.93 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.4 -38.63 87.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.084 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 96' ' ' ILE . 63.7 t -59.54 -41.97 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -60.85 -36.15 78.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.323 -0.861 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.5 ttm-85 -59.52 -44.27 93.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 82' ' ' ASP . 83.2 mt -68.17 -32.62 73.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.1 t -52.68 -37.79 25.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 108.551 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -68.37 -51.44 44.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.333 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 79' ' ' LEU . 61.5 t0 -97.12 118.77 34.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 108.769 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' C ' ' N ' ' A' ' 85' ' ' ILE . . . -121.2 47.53 1.82 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.69 -23.73 3.58 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 55' ' ' ASN . 32.7 pt -118.95 168.56 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.676 -0.897 . . . . 0.0 108.927 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.07 107.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.099 . . . . 0.0 109.742 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 87' ' ' ARG . 36.4 mtt-85 -110.43 152.27 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.51 0.671 . . . . 0.0 110.543 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -151.57 27.62 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 54.72 -75.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.816 -0.552 . . . . 0.0 110.091 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.08 -40.06 95.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -40.64 94.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.088 -1.243 . . . . 0.0 108.759 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.54 -43.09 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.174 -0.954 . . . . 0.0 108.901 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.56 -35.64 68.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.342 -0.849 . . . . 0.0 108.807 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.0 87.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.067 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.61 -46.72 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 108.867 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 76' ' ' VAL . 85.6 mt -60.63 -41.28 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.442 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.71 -43.3 99.24 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.31 -39.53 87.33 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.237 . . . . 0.0 109.197 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.13 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -60.51 -44.44 96.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.34 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.05 76.33 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.318 -0.864 . . . . 0.0 108.839 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.489 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 61.0 t80 -63.51 -47.56 81.18 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.521 -0.737 . . . . 0.0 110.301 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.43 -41.45 93.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -61.12 -39.15 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.333 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.507 ' CE ' ' NH2' ' A' ' 152' ' ' ARG . 25.0 ttt -61.82 -38.76 89.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 0.0 109.268 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -53.41 -29.1 33.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.137 -0.977 . . . . 0.0 108.592 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.81 -13.65 59.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.87 18.82 69.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -108.87 106.9 59.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.279 -1.13 . . . . 0.0 109.228 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.91 137.5 43.52 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.939 1.759 . . . . 0.0 112.188 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.07 -45.55 88.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.464 -0.772 . . . . 0.0 109.582 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.9 98.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.04 -34.5 77.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.072 . . . . 0.0 109.045 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.98 -50.61 73.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 110.388 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' VAL . 17.0 m -67.33 -38.49 80.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.06 -1.025 . . . . 0.0 109.578 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -60.4 -37.85 82.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.04 . . . . 0.0 109.291 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.2 p -64.51 -33.44 75.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.57 -30.75 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 109.87 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.8 20.9 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.134 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 m120 57.27 37.91 28.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.727 . . . . 0.0 109.99 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 46.05 29.85 0.84 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.05 103.69 44.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.68 151.25 77.62 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.789 1.659 . . . . 0.0 111.629 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.8 mt-30 -106.61 147.48 29.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.892 . . . . 0.0 109.734 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 10.4 ptm -116.22 155.57 28.08 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -103.44 149.7 24.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 0.0 110.647 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -143.04 39.28 1.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -105.09 166.98 10.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.686 -0.633 . . . . 0.0 109.634 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -101.25 -27.56 13.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -124.72 152.09 44.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.571 -0.706 . . . . 0.0 109.231 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 47.0 mt -60.98 -32.83 72.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.0 p -63.21 -31.95 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.6 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.6 mt-10 -63.73 -31.21 72.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.831 -1.168 . . . . 0.0 109.729 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -70.91 127.65 91.51 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.07 138.11 33.01 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.86 1.707 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -96.35 -0.73 49.05 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.312 -0.868 . . . . 0.0 109.009 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -131.48 93.3 3.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.525 -0.734 . . . . 0.0 109.389 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 48.4 p -96.86 151.54 37.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 108.903 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -36.75 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.853 1.702 . . . . 0.0 112.066 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.29 81.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -64.63 -40.66 95.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -65.66 -47.62 74.88 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.285 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.02 -38.92 72.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.823 . . . . 0.0 109.444 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 tp -58.35 -48.25 81.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.544 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 16.5 m -59.87 -40.5 88.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.26 -0.9 . . . . 0.0 109.641 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -62.12 -38.57 89.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.355 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.36 53.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 157' ' ' VAL . 68.8 mt -62.42 -33.49 74.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 108.695 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -58.26 -44.27 88.3 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.191 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -63.88 -34.32 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.205 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.507 ' NH2' ' CE ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -63.71 -19.89 65.3 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -0.831 . . . . 0.0 109.528 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.38 29.77 6.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.38 128.6 41.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.343 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -96.11 155.56 16.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 66.5 38.91 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.761 0.791 . . . . 0.0 108.921 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 149' ' ' LEU . 9.5 p -106.6 25.08 2.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.748 -0.595 . . . . 0.0 109.574 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 156.64 0.06 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -56.22 -27.75 55.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.8 p -69.44 -38.11 77.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.1 -44.08 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.235 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.544 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 97.1 m -59.79 -45.02 93.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.74 -42.3 97.09 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 4.9 t -61.29 -40.67 95.0 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -60.85 -40.97 94.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.942 . . . . 0.0 109.112 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 165' ' ' PHE . 49.8 mmm -58.14 -38.25 76.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 108.914 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -70.13 -46.77 64.08 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.591 -0.693 . . . . 0.0 110.684 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.607 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -68.46 -46.14 70.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.123 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD13 ' A' ' 171' ' ' LEU . 23.9 p -61.34 -35.11 76.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.093 -1.004 . . . . 0.0 110.132 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 100.55 7.02 52.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.852 HD13 ' SG ' ' A' ' 169' ' ' CYS . 4.8 mp -53.13 -34.02 54.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.938 -1.331 . . . . 0.0 108.637 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 125' ' ' GLN . 17.4 m -120.68 150.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -99.24 101.19 12.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.013 -1.054 . . . . 0.0 109.625 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 10.8 p-10 -120.34 91.55 3.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.72 ' O ' HG12 ' A' ' 176' ' ' VAL . 5.0 m-70 -120.98 -38.03 2.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 175' ' ' HIS . 2.0 p 106.19 144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.494 0.664 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.26 131.16 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 109.823 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.3 58.2 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.5 OUTLIER -69.33 90.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.867 -1.372 . . . . 0.0 109.826 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.7 OUTLIER 64.59 -56.09 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 109.611 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 m -174.17 71.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.4 t80 -121.52 80.25 38.54 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.443 -0.785 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -83.14 -51.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.036 2.49 . . . . 0.0 112.15 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.29 65.73 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.8 36.88 28.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.424 -1.045 . . . . 0.0 109.212 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -147.66 80.4 9.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.295 . . . . 0.0 112.283 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' OE1' ' O ' ' A' ' 178' ' ' GLY . 94.7 mt-10 -104.54 155.47 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.563 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.699 ' NH1' HD13 ' A' ' 14' ' ' ILE . 95.6 mtt180 -119.92 155.65 32.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.71 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.05 158.69 22.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.89 -21.66 38.25 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -51.93 -36.21 48.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.246 . . . . 0.0 110.232 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 4' ' ' CYS . 29.4 m -63.12 139.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.041 -1.037 . . . . 0.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 8' ' ' SER . 8.7 t -125.81 47.86 2.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.647 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 57.52 45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.17 95.93 42.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 0.0 109.199 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.55 -38.9 28.95 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.08 1.853 . . . . 0.0 112.248 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.77 -42.86 90.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.017 -1.052 . . . . 0.0 108.557 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -69.8 -46.79 64.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.342 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' NH1' ' A' ' 3' ' ' ARG . 81.6 mt -61.46 -39.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.42 99.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.787 -1.195 . . . . 0.0 107.853 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -65.91 -36.88 84.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.543 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.4 t-80 -57.31 -51.09 70.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.765 . . . . 0.0 109.892 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 89.5 m-20 -67.16 -41.21 86.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.675 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 60.6 t30 -57.35 -47.37 81.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.097 -1.002 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.1 mt-10 -157.79 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.956 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.61 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 25.5 t90 55.39 95.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 110.072 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.47 0.67 40.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 169' ' ' CYS . 54.3 t -81.79 121.92 79.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.58 127.88 14.51 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.969 1.78 . . . . 0.0 112.832 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -114.97 132.9 56.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.8 p -118.42 4.52 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -0.772 . . . . 0.0 109.889 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -85.14 114.03 21.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.008 -1.057 . . . . 0.0 109.628 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 m -58.23 -39.88 80.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 109.992 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -60.49 -41.7 94.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.066 -1.021 . . . . 0.0 109.13 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -69.52 -45.91 67.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 113' ' ' ALA . 87.3 mt -58.98 -48.17 82.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 0.0 109.795 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 76.1 t80 -63.07 -46.12 88.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.86 -32.65 74.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.51 -51.33 69.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 110.169 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.038 -1.038 . . . . 0.0 110.671 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.22 97.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.01 -36.43 83.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.813 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.1 -29.37 67.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 110.02 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.53 24.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -62.75 -36.39 82.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -1.229 . . . . 0.0 109.568 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.2 tt0 -52.56 -36.06 55.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.711 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.35 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.72 64.94 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mt -116.27 -148.17 0.42 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -1.116 . . . . 0.0 109.826 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 p -140.32 159.11 42.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.497 -0.752 . . . . 0.0 109.801 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HE1' HD21 ' A' ' 50' ' ' LEU . 5.4 t-105 -51.09 -43.56 61.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.415 -0.803 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 48' ' ' THR . 3.2 tp -60.89 -36.33 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.868 -1.145 . . . . 0.0 110.553 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 47' ' ' ILE . 86.5 m -65.56 -38.79 90.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.921 -1.112 . . . . 0.0 109.759 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' GLN . 58.0 t -66.33 -39.17 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 0.0 111.086 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.586 HD21 ' HE1' ' A' ' 46' ' ' TRP . 82.5 mt -53.95 -54.72 34.94 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.781 -1.2 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -57.48 -45.44 84.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.024 . . . . 0.0 108.772 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -27.09 66.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.408 -0.808 . . . . 0.0 109.607 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' VAL . 43.0 ttp180 -54.31 -44.8 72.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.0 -40.85 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.845 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 55' ' ' ASN . 2.5 m120 -65.26 -35.75 82.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.551 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' OH ' ' CE1' ' A' ' 63' ' ' PHE . 87.6 t80 -59.49 -48.59 81.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.0 ptm180 -69.93 -22.85 63.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.12 . . . . 0.0 109.286 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.04 95.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 108.417 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -38.22 11.72 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.011 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 96.5 m-85 -99.91 28.59 4.69 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' N ' ' O ' ' A' ' 57' ' ' ARG . 7.9 t-80 -49.37 -36.71 22.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 108.584 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 63' ' ' PHE . 56.9 mt-30 -81.61 -49.77 10.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.93 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 52.3 t80 39.32 39.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.524 -0.735 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.765 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -62.85 139.79 97.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 108.673 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.41 -52.18 1.18 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.111 1.874 . . . . 0.0 112.633 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.64 -45.59 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.25 -42.99 99.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 64' ' ' ASP . 97.5 t -65.04 -39.29 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.034 -1.041 . . . . 0.0 109.715 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.58 71.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.994 -1.066 . . . . 0.0 108.446 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.53 26.43 9.02 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.327 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.1 ttm -64.38 159.61 20.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.18 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -102.03 152.31 21.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.018 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.299 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.34 -37.31 80.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.088 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -61.6 -40.83 96.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.262 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 92' ' ' ILE . 77.1 t -57.67 -44.7 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.384 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.36 -39.74 95.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -65.39 -45.1 85.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.894 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 83.9 mt -63.2 -36.51 83.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.895 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -57.66 -37.35 58.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.835 -1.165 . . . . 0.0 108.987 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -83.82 -20.43 33.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.8 t0 -85.73 115.31 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 110.905 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 63.94 -25.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.23 -31.74 0.67 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 83' ' ' ALA . 20.4 pt 30.12 58.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 122.0 -0.706 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 85' ' ' ILE . 76.9 mt 56.8 159.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 86' ' ' ILE . 97.2 mtt180 -51.96 131.1 31.02 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.729 ' HD1' HG13 ' A' ' 92' ' ' ILE . 1.8 t-80 -148.21 9.15 0.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 109.63 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.32 -45.37 80.34 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.45 -46.49 25.6 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 28.6 mttt -62.34 -40.39 96.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.466 -1.02 . . . . 0.0 109.871 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.729 HG13 ' HD1' ' A' ' 88' ' ' HIS . 40.9 mt -54.65 -42.32 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.829 -1.17 . . . . 0.0 108.861 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -58.91 -35.81 73.68 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.14 85.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.23 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.64 -49.97 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.119 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -57.59 -48.64 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 109.024 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.0 99.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 32' ' ' PHE . 43.6 t30 -57.36 -39.79 76.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 0.0 109.557 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.53 92.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.953 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -61.46 -42.63 99.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.109 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -68.86 -39.53 79.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.188 -0.945 . . . . 0.0 108.987 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -61.95 -45.64 92.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 103' ' ' LEU . 31.6 tp -65.45 -39.57 92.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.817 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.2 -40.62 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 109.892 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 23.4 ttt -66.11 -40.18 90.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 109.762 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 109' ' ' GLY . 83.4 tt0 -65.06 -31.55 72.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -52.83 -36.33 58.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.126 -0.984 . . . . 0.0 108.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -79.55 -14.24 58.99 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 109.071 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 75.86 45.27 17.2 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -126.81 85.21 61.28 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.834 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.04 143.17 84.32 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.886 2.39 . . . . 0.0 112.481 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 116' ' ' VAL . 73.5 m-85 -61.63 -40.15 93.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -60.98 -47.5 86.18 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.61 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -65.36 -44.06 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.55 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.7 t80 -67.26 -44.46 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.68 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 112' ' ' PHE . 50.4 t -60.49 -45.35 97.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.434 -0.791 . . . . 0.0 109.898 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -58.79 -36.06 73.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.94 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 t -61.94 -38.14 87.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.55 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.6 m-85 -65.64 -32.62 74.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.236 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -97.2 22.78 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.152 -0.968 . . . . 0.0 109.484 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 122' ' ' HIS . 10.3 m120 61.52 35.93 17.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.605 -0.685 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 40.02 32.3 0.11 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.576 -0.703 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -129.1 141.86 43.22 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.119 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.56 146.31 61.04 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.129 1.886 . . . . 0.0 111.864 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.719 ' HB2' HG12 ' A' ' 172' ' ' VAL . 89.9 mm-40 -107.75 143.88 35.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.632 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 ttp -126.62 145.11 50.68 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.1 t -126.43 155.5 42.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -131.37 48.03 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.01 151.1 28.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -103.07 -29.35 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -128.02 154.75 45.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.469 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -58.98 -34.88 72.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.3 t -58.95 -39.8 82.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.105 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.76 -34.42 77.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.069 -1.02 . . . . 0.0 110.033 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.94 115.69 40.78 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.263 -0.898 . . . . 0.0 109.831 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.44 139.91 11.74 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.241 1.961 . . . . 0.0 112.419 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 t -91.16 -2.5 57.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.215 -0.928 . . . . 0.0 108.9 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.9 t -115.99 99.98 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -116.09 151.7 46.91 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -53.32 -36.24 77.78 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.082 1.855 . . . . 0.0 112.066 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.85 52.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.09 -1.006 . . . . 0.0 109.286 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.4 t -61.9 -46.71 88.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.583 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.82 -43.45 96.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.653 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.67 -38.92 80.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 149' ' ' LEU . 9.0 tt -61.59 -40.63 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -61.97 -43.85 97.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -61.93 -38.04 86.96 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.282 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.77 70.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 145' ' ' LEU . 53.6 mt -64.09 -34.51 78.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 108.515 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -58.03 -35.19 70.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.551 -0.718 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -59.86 -40.3 88.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.55 -20.6 66.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.865 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.13 32.04 7.7 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.399 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 52.9 m-85 -85.02 143.34 28.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.928 -1.337 . . . . 0.0 109.605 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.649 ' O ' HG13 ' A' ' 157' ' ' VAL . 45.0 mttp -97.9 178.24 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.406 -0.809 . . . . 0.0 109.701 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 29.9 p90 43.82 45.0 6.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.373 -0.829 . . . . 0.0 109.601 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 155' ' ' LYS . 23.0 m -112.89 24.39 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.759 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.81 153.41 0.35 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 159' ' ' THR . 0.1 OUTLIER -61.75 -22.98 65.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -1.125 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 57.8 m -66.29 -44.98 81.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.32 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' OG ' ' A' ' 164' ' ' SER . 54.1 mt -65.35 -35.57 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.4 -0.813 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 72.2 m -60.64 -43.43 97.57 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.144 -0.972 . . . . 0.0 108.909 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.7 -39.17 93.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.324 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 93.7 p -61.23 -37.58 83.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -64.91 -42.47 94.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 109.301 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.4 mtp -61.69 -35.26 77.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -60.71 -45.67 93.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.787 . . . . 0.0 110.424 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB2' ' HH2' ' A' ' 46' ' ' TRP . . . -80.72 -38.3 29.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.717 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 23' ' ' VAL . 18.9 t -61.57 -35.45 77.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 110.544 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.43 9.42 57.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 171' ' ' LEU . 1.4 tp -53.07 -34.23 55.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -1.171 . . . . 0.0 108.753 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 125' ' ' GLN . 28.2 m -120.89 147.66 24.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 127' ' ' THR . 61.6 m-20 -89.76 105.86 18.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.988 -1.07 . . . . 0.0 108.52 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.602 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 89.4 m-20 -119.55 -179.9 4.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.813 -0.554 . . . . 0.0 109.911 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 176' ' ' VAL . 14.7 m170 118.15 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 175' ' ' HIS . 8.3 m 49.08 165.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.413 -0.805 . . . . 0.0 109.866 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 177' ' ' VAL . 5.0 p -74.9 -28.38 21.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.641 -1.287 . . . . 0.0 109.932 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.481 ' O ' ' OE1' ' A' ' 2' ' ' GLU . . . -58.54 -39.37 93.09 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.92 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 180' ' ' CYS . 8.7 t -59.46 101.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.902 -1.352 . . . . 0.0 109.148 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 179' ' ' CYS . 91.4 m -43.2 -30.46 0.48 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 109.401 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 99.7 m -52.1 -31.27 29.92 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.8 t80 -119.77 80.72 24.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.1 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.698 2.265 . . . . 0.0 112.556 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.63 25.78 37.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 m120 60.34 46.58 9.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.497 -1.002 . . . . 0.0 109.709 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -123.72 80.59 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.501 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.835 2.357 . . . . 0.0 112.315 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.704 0.764 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -143.7 148.02 35.12 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.625 -0.672 . . . . 0.0 109.386 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.585 ' NH1' ' OD2' ' A' ' 18' ' ' ASP . 10.2 tpp180 -117.75 158.13 25.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 0.0 109.269 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.2 m -39.93 148.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.44 -23.72 25.79 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.174 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' HG12 ' A' ' 7' ' ' VAL . 68.1 p-90 -62.5 -31.84 72.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.576 -1.543 . . . . 0.0 109.714 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' VAL . 5.1 m -68.58 128.95 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.03 -1.043 . . . . 0.0 109.177 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -172.99 53.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.966 . . . . 0.0 109.762 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -145.52 -104.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.253 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -91.89 150.78 41.27 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.086 -1.009 . . . . 0.0 109.101 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.22 -19.52 42.5 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.411 2.074 . . . . 0.0 112.076 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.89 -34.87 78.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 108.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -57.45 -50.98 71.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 109.32 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.94 -34.3 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.07 91.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 108.917 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.13 -36.52 82.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.6 t-80 -56.55 -46.43 80.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.623 -0.673 . . . . 0.0 109.533 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 80.8 m-20 -87.2 -43.68 12.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 110.662 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' GLU . 82.8 m-20 -58.89 -52.88 63.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.139 -0.976 . . . . 0.0 110.586 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 19' ' ' ASN . 93.4 mt-10 -157.57 109.63 2.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 108.882 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.676 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 20.5 t90 -174.08 96.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.724 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.06 59.65 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 21' ' ' TRP . 2.2 t -71.65 136.46 83.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.318 -1.107 . . . . 0.0 109.021 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.3 123.18 11.41 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.677 1.585 . . . . 0.0 111.96 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 31' ' ' LEU . 95.6 mt-10 -119.63 135.16 54.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -125.23 3.23 7.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -78.05 123.46 26.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.97 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.5 m -61.04 -40.52 93.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 110.14 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -66.27 -45.78 79.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.807 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -62.63 -46.65 87.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.1 . . . . 0.0 109.972 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 25' ' ' GLU . 10.0 mp -63.42 -37.99 89.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -61.76 -48.35 81.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.677 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.44 -32.0 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.8 tpt -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.348 -0.845 . . . . 0.0 109.567 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -65.43 -44.94 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.9 m -62.48 -44.38 96.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.975 . . . . 0.0 110.571 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.75 -42.02 86.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.54 -34.52 78.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.854 -1.154 . . . . 0.0 110.267 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.77 -37.77 62.59 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.78 -34.14 76.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -1.063 . . . . 0.0 109.725 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 44' ' ' LEU . 1.4 pt20 -62.4 -20.03 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.73 109.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.313 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.5 -31.59 6.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 41' ' ' GLN . 1.8 mt -108.99 148.23 31.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -1.038 . . . . 0.0 109.952 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.3 t -71.02 151.8 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -55.77 -30.64 61.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -49.04 -46.34 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.4 m -66.44 -39.84 89.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.7 -43.7 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.478 -0.764 . . . . 0.0 110.653 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.0 mt -55.46 -48.22 74.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.793 -1.192 . . . . 0.0 109.404 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.0 -44.72 91.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.5 -35.97 82.21 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.948 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -52.61 -43.29 65.28 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.068 . . . . 0.0 109.492 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.34 -43.6 66.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.055 . . . . 0.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 83.2 m-20 -67.09 -38.33 85.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.699 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 88.9 t80 -56.82 -48.95 76.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 61' ' ' HIS . 64.0 mtm180 -59.6 -33.21 71.18 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 55' ' ' ASN . . . -50.77 -48.78 59.26 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.657 -1.277 . . . . 0.0 108.284 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.536 ' SG ' ' OD1' ' A' ' 82' ' ' ASP . 78.9 m -94.38 -23.12 17.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 110.299 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 88.6 m-85 -112.14 15.8 20.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.267 -0.896 . . . . 0.0 112.116 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.317 -1.489 . . . . 0.0 109.718 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 64' ' ' ASP . 91.4 mt-30 -89.16 8.01 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 110.401 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -67.8 41.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 110.298 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' GLN . 90.3 m-20 -44.04 147.77 0.88 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.873 -1.142 . . . . 0.0 109.029 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -44.94 -53.09 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.35 2.033 . . . . 0.0 112.911 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.82 -44.68 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.065 -1.022 . . . . 0.0 109.799 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -63.39 -40.61 97.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -70.0 -40.12 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.07 -1.019 . . . . 0.0 110.354 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -67.81 -34.3 76.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.176 . . . . 0.0 107.991 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.27 -7.13 54.24 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 96' ' ' ILE . 44.7 ttm -52.8 151.06 4.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.505 -0.747 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.482 HE21 ' CB ' ' A' ' 74' ' ' GLU . 21.4 pt20 -116.69 164.38 14.72 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.83 -31.86 70.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.482 ' CB ' HE21 ' A' ' 72' ' ' GLN . 83.5 tt0 -56.33 -37.85 70.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.873 -1.142 . . . . 0.0 108.859 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.44 -38.63 87.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.153 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 80' ' ' VAL . 64.7 t -62.67 -39.63 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.23 -42.03 94.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.2 -0.938 . . . . 0.0 109.737 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.0 -42.83 80.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.78 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 59.5 mt -70.43 -25.88 63.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.89 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.5 t -50.47 -35.36 12.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.397 -1.44 . . . . 0.0 107.761 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -100.84 40.11 1.31 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 83' ' ' ALA . 52.3 t0 -52.4 171.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.743 0.782 . . . . 0.0 110.545 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -50.12 -33.96 20.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.851 -0.531 . . . . 0.0 111.017 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 164.32 -5.18 0.06 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 118.668 -1.729 . . . . 0.0 111.861 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 84' ' ' GLY . 35.5 pt -54.27 -170.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.47 -1.606 . . . . 0.0 108.674 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 65.9 mt -65.05 136.96 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.783 -1.198 . . . . 0.0 108.466 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 30.3 ptt180 -104.57 129.35 52.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.2 m-70 177.16 100.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -45.97 -34.64 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.77 -44.9 97.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' HZ1' ' C ' ' A' ' 86' ' ' ILE . 6.6 ttpm? -61.57 -46.64 89.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -1.2 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.491 ' CG2' HG22 ' A' ' 76' ' ' VAL . 81.4 mt -58.67 -42.82 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.218 -0.926 . . . . 0.0 109.311 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.04 -34.46 77.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.791 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.96 -46.57 84.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.384 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.38 -47.76 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.618 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.4 mt -58.55 -41.48 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.6 -42.71 95.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.185 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -57.71 -39.7 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.856 -1.379 . . . . 0.0 110.05 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -67.91 -41.94 81.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.56 -41.01 93.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 108.885 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.11 66.01 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.433 -0.792 . . . . 0.0 109.042 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -60.95 -43.52 98.58 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.498 -0.751 . . . . 0.0 109.743 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -42.84 90.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.46 -39.9 89.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.0 109.596 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.4 ttt -62.33 -39.13 92.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.786 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -64.64 -29.35 70.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.41 -32.09 48.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.125 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.492 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 18.6 m120 -84.79 -2.18 57.36 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.497 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 33.53 63.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.0 mp0 -110.2 102.65 51.8 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.268 -1.136 . . . . 0.0 109.299 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.89 134.23 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.946 1.764 . . . . 0.0 111.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.6 -43.51 98.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.12 -47.64 81.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 110.608 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.57 -34.51 74.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.047 . . . . 0.0 109.327 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -57.29 -48.03 79.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.515 -0.741 . . . . 0.0 109.37 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.43 -46.93 91.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.23 -0.919 . . . . 0.0 109.246 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.43 -33.95 75.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.2 p -59.35 -36.76 76.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.68 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.053 -1.03 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' H ' ' A' ' 123' ' ' GLN . 1.2 p -94.73 16.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.663 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 122' ' ' HIS . 21.5 m120 56.17 39.31 30.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.1 t60 44.5 31.52 0.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.341 -0.85 . . . . 0.0 109.445 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.536 ' H ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -119.65 98.21 49.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.16 143.66 18.35 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.088 1.858 . . . . 0.0 111.773 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -110.85 138.4 47.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 110.102 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.37 47.49 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.413 -0.805 . . . . 0.0 108.858 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 t -112.67 149.86 32.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.526 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -129.52 52.67 1.96 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.44 -175.87 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.772 . . . . 0.0 109.558 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -105.07 -24.27 12.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 109.699 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 t -135.84 164.66 27.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.4 mp -67.33 -30.56 70.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.0 109.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 -39.87 68.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.014 -1.054 . . . . 0.0 109.736 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.81 -32.37 74.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.998 -1.064 . . . . 0.0 109.601 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.4 121.11 79.33 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.22 140.01 21.81 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.044 1.83 . . . . 0.0 112.057 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 t -91.39 0.45 57.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 109.046 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -133.24 81.13 1.92 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.631 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -86.45 160.05 51.78 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.114 -0.991 . . . . 0.0 109.203 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.11 -38.45 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.993 1.795 . . . . 0.0 111.974 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.89 65.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 110.099 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.5 m -60.19 -42.56 95.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.84 -45.9 91.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 109.775 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.41 -37.74 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 110.121 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.4 -49.21 75.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.15 -0.969 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.8 p -64.61 -37.4 87.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 109.335 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -64.49 -39.64 94.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.18 -50.29 55.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 96.9 mt -64.57 -36.55 84.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.168 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.57 -38.29 77.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.175 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -60.93 -38.28 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.68 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -63.94 -20.64 66.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.16 33.87 5.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.31 134.52 33.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.263 . . . . 0.0 109.877 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -93.64 159.84 15.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.489 -0.757 . . . . 0.0 109.213 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.76 44.25 20.67 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.5 p -116.64 24.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.644 -0.66 . . . . 0.0 109.482 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.23 160.82 0.32 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 47.1 m -54.09 -33.02 56.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.382 -1.069 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.1 p -64.35 -40.77 96.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.32 -38.31 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.507 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -42.3 88.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.287 -0.883 . . . . 0.0 109.261 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 48.3 t80 -60.7 -41.87 96.05 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.243 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -38.63 80.92 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 108.994 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -61.03 -43.0 99.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.82 . . . . 0.0 109.788 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.88 -38.63 89.04 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 97.1 mt-30 -64.11 -42.5 96.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.42 -51.15 9.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.228 -0.92 . . . . 0.0 110.754 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 171' ' ' LEU . 42.0 t -53.46 -32.38 49.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.34 44.83 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.97 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 169' ' ' CYS . 11.1 mp -59.2 -35.21 73.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.626 -1.514 . . . . 0.0 108.438 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.13 128.17 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -106.08 102.81 12.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 52.8 p30 -119.51 91.49 3.56 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.69 . . . . 0.0 110.378 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.676 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 6.1 m170 -123.18 -95.9 0.47 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER 171.89 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.85 -41.33 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.548 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -70.88 9.65 3.61 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 52.7 t -98.44 102.62 14.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.789 -1.418 . . . . 0.0 108.985 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.563 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 14.0 p -60.5 100.11 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 1.2 m 157.6 -18.85 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.1 t80 -120.01 83.23 30.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.57 31.72 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.907 2.405 . . . . 0.0 112.329 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.48 26.04 48.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.0 t30 61.79 42.98 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.387 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.87 80.25 73.07 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.234 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.306 -1.66 0 C-N-CA 122.757 2.305 . . . . 0.0 112.128 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.542 0.687 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -119.95 160.6 22.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.767 -0.583 . . . . 0.0 109.766 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' CYS . 17.2 tpt180 -118.96 149.26 41.91 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.3 m -45.76 147.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.914 -1.116 . . . . 0.0 108.758 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.52 -10.2 53.86 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.464 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.586 ' CE2' HD22 ' A' ' 132' ' ' LEU . 63.1 m95 -56.11 -31.99 63.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.719 -1.459 . . . . 0.0 109.301 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 9' ' ' GLN . 4.1 m -66.54 -39.61 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.875 . . . . 0.0 110.354 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' VAL . 47.9 t 42.11 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 109.601 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 7' ' ' VAL . 72.9 mt-30 -122.38 162.48 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 0.0 109.369 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 9' ' ' GLN . 3.1 t0 82.05 87.38 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.29 -12.35 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.864 2.376 . . . . 0.0 113.151 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 47' ' ' ILE . 8.8 tt -62.55 -34.51 77.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.791 -1.193 . . . . 0.0 109.041 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 60.3 m-85 -59.79 -43.22 94.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 109.263 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.4 mt -61.91 -38.31 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.405 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.45 88.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.986 -1.071 . . . . 0.0 108.535 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -71.74 -33.43 68.68 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 109.086 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 25.5 t-80 -56.52 -41.3 76.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.493 -0.754 . . . . 0.0 110.021 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -89.9 -17.43 28.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 111.027 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.39 -75.1 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.688 -1.257 . . . . 0.0 109.851 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.66 99.87 4.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 108.691 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.705 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 23.8 t90 -173.39 103.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.61 0.53 60.76 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.9 p -102.74 109.93 62.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.346 -1.09 . . . . 0.0 109.001 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.49 127.62 16.31 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.119 1.879 . . . . 0.0 112.48 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -117.04 132.26 56.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 109.343 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.4 p -109.16 0.55 19.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.426 -0.796 . . . . 0.0 109.524 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.98 122.87 26.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -62.06 -34.9 77.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 109.737 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.42 -45.23 91.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.63 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.42 -44.55 90.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.033 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' CB ' ' A' ' 113' ' ' ALA . 50.6 mt -66.96 -38.58 86.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.09 -44.42 97.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.303 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.67 -32.19 72.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 110.277 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.8 tpp -66.8 -50.54 62.32 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.99 -34.21 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.964 -1.085 . . . . 0.0 110.815 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 m -72.1 -49.66 34.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.704 HD13 ' HG3' ' A' ' 53' ' ' ARG . 86.7 mt -69.67 -34.57 74.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.494 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 49.0 tp10 -57.32 -34.69 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.036 -1.04 . . . . 0.0 109.896 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.07 43.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' NE2' HD12 ' A' ' 86' ' ' ILE . 8.7 mm100 -57.52 -31.82 66.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 110.402 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HG2' HG21 ' A' ' 49' ' ' VAL . 25.4 mt-30 -55.96 -33.61 64.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.65 108.66 0.11 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.057 -1.027 . . . . 0.0 109.504 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.1 84.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -121.91 -171.18 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.2 t -116.37 155.25 28.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.67 . . . . 0.0 109.551 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 10.7 t-105 -54.58 -46.45 73.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 12' ' ' LEU . 4.3 tp -61.68 -43.66 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.094 . . . . 0.0 110.173 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 47' ' ' ILE . 61.3 m -61.86 -40.37 95.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 41' ' ' GLN . 72.3 t -67.31 -42.85 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.21 -40.61 86.35 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.654 -1.279 . . . . 0.0 109.584 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -64.37 -55.69 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 108.856 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -63.24 -34.04 76.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' HD13 ' A' ' 37' ' ' LEU . 40.2 ttt-85 -50.53 -43.73 56.03 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.316 -0.865 . . . . 0.0 108.819 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.26 -41.97 96.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB3' HG22 ' A' ' 85' ' ' ILE . 84.1 m-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 85' ' ' ILE . 5.7 m-85 -58.95 -43.05 91.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.096 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.638 HH21 ' CD2' ' A' ' 61' ' ' HIS . 48.8 mtp180 -60.65 -32.42 71.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.258 -0.901 . . . . 0.0 108.967 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.58 85.88 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.029 -1.044 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.17 -43.69 9.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.192 -0.942 . . . . 0.0 110.624 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.52 -43.23 40.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.118 -0.989 . . . . 0.0 111.891 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CD2' HH21 ' A' ' 57' ' ' ARG . 52.0 t-80 -54.43 -42.57 70.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.644 -1.285 . . . . 0.0 109.059 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.43 -36.17 81.55 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 64' ' ' ASP . 8.4 m-85 -94.88 67.11 3.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -36.05 160.5 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 121.291 0.567 . . . . 0.0 110.33 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 -36.26 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.119 2.546 . . . . 0.0 113.082 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 67' ' ' LYS . 5.3 p -59.97 -46.24 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' N ' HG13 ' A' ' 66' ' ' VAL . 99.3 mttt -66.9 -32.57 73.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.559 -0.713 . . . . 0.0 109.253 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.2 t -60.54 -43.27 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.8 . . . . 0.0 109.652 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.91 69.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.5 23.01 10.88 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.603 -0.686 . . . . 0.0 109.218 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -68.3 149.19 49.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.432 -0.793 . . . . 0.0 110.013 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -103.67 153.04 21.09 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 97.0 mt-10 -56.67 -31.81 64.78 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 108.746 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.01 -37.72 69.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.333 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.12 -38.21 85.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.523 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.38 -45.65 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.476 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 33.3 mp0 -65.69 -37.71 87.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.786 -1.196 . . . . 0.0 110.343 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -65.45 -44.94 85.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 110.092 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 82' ' ' ASP . 80.4 mt -69.59 -33.56 72.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.096 -1.002 . . . . 0.0 109.608 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 76' ' ' VAL . 57.7 t -58.23 -38.26 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 108.554 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -88.12 -53.68 4.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 89.5 m-20 -80.17 155.63 27.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.812 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 84.33 85.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.755 0.788 . . . . 0.0 109.186 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -60.3 6.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' ALA . 35.1 pt -53.3 -167.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.189 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 HD12 ' NE2' ' A' ' 40' ' ' GLN . 81.6 mt -58.31 144.56 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.915 -1.115 . . . . 0.0 108.93 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -101.0 123.53 45.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.56 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.81 86.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -52.23 -34.45 45.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.136 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.32 -43.61 98.4 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -63.61 -42.77 98.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.896 -1.355 . . . . 0.0 110.282 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.77 -46.91 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 108.976 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -59.24 -35.94 74.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.7 97.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -59.48 -40.15 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 71' ' ' MET . 85.1 mt -59.0 -46.43 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.188 -0.945 . . . . 0.0 110.157 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.3 97.41 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.77 -36.7 77.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -1.228 . . . . 0.0 110.159 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.99 -43.67 98.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -60.6 -43.47 97.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.74 -43.08 73.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.312 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.77 -45.03 95.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.492 -0.755 . . . . 0.0 110.028 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.97 -37.44 82.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.326 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.39 -40.01 81.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.501 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 3.7 tpp -62.2 -40.4 95.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.31 -28.8 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -53.53 -32.76 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.604 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 52.0 p30 -85.92 1.82 48.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.856 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.96 24.35 77.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.604 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 31.3 tt0 -108.65 106.39 58.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.383 -1.069 . . . . 0.0 109.156 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -51.17 134.37 43.61 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.89 1.726 . . . . 0.0 112.066 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -59.29 -41.65 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 109.413 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 31' ' ' LEU . . . -60.86 -35.72 77.32 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.469 -0.77 . . . . 0.0 109.707 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.57 -39.16 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 109.276 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -42.86 97.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.677 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.5 -47.56 90.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.284 -0.885 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -65.15 -33.22 75.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.88 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -59.09 -38.25 79.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.364 -0.835 . . . . 0.0 110.968 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.98 -30.63 71.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 110.459 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.45 ' HB ' HE22 ' A' ' 125' ' ' GLN . 35.3 m -101.76 17.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 108.984 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 122' ' ' HIS . 20.3 m120 57.09 41.55 27.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.586 -0.696 . . . . 0.0 109.808 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 53.6 t-80 43.34 29.59 0.25 Allowed 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.247 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.603 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 1.9 mt-30 -119.64 94.53 48.55 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.34 146.87 12.93 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.32 2.013 . . . . 0.0 112.215 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 24.2 mp0 -103.23 147.41 27.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.591 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.88 152.14 42.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.9 t -132.6 155.65 48.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -124.96 51.12 1.68 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -76.62 133.75 39.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.0 110.232 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 m -86.38 -31.4 21.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.071 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -122.01 156.89 32.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.235 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.586 HD22 ' CE2' ' A' ' 6' ' ' TRP . 50.8 mt -55.08 -38.81 68.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.999 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -63.32 -32.09 73.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.138 -0.976 . . . . 0.0 110.2 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.721 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 75.0 mm-40 -61.13 -28.04 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.478 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 1.1 mp -68.0 116.74 41.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.905 -1.122 . . . . 0.0 109.432 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.86 139.71 40.09 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.01 1.807 . . . . 0.0 112.232 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -105.86 2.73 27.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.14 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -153.24 80.88 1.19 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 109.855 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.5 p -79.85 150.01 71.55 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 108.961 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.37 -33.83 23.63 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 1.689 . . . . 0.0 112.012 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.15 70.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.902 . . . . 0.0 109.811 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -59.08 -43.92 91.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.72 -41.28 96.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.05 -42.75 75.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.934 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -62.48 -42.93 99.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 109.855 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.5 m -59.45 -42.12 91.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.137 -0.977 . . . . 0.0 109.337 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -61.59 -38.91 89.3 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.731 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.42 79.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HB2' HG21 ' A' ' 157' ' ' VAL . 40.0 mt -63.82 -38.65 91.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -58.3 -40.86 83.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -62.06 -36.86 82.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 108.874 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' A' ' 105' ' ' MET . 17.3 mmm180 -63.91 -20.41 65.83 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.594 -0.692 . . . . 0.0 109.766 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.4 17.12 29.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.44 141.08 41.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -1.138 . . . . 0.0 110.089 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 26.6 mtmt -106.3 177.0 4.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.371 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 42.4 p90 43.14 42.28 3.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 109.113 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -107.98 24.98 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -40.96 156.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.0 t -62.16 -22.23 65.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.339 -1.095 . . . . 0.0 109.605 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.6 m -67.76 -44.5 77.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 0.0 109.194 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 81.4 mt -67.53 -33.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.83 -42.38 98.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.144 -0.972 . . . . 0.0 108.584 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 50.2 t80 -67.56 -43.16 81.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.9 m -58.03 -36.43 72.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 15.4 t80 -60.03 -44.28 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.58 -0.7 . . . . 0.0 109.254 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 29.6 mtt -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 110.238 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.09 -47.2 85.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.039 -1.038 . . . . 0.0 109.92 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.87 51.62 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.644 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.673 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 65.2 m -66.13 -37.94 86.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.92 32.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.38 -36.12 66.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.304 . . . . 0.0 109.067 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' A' ' 125' ' ' GLN . 29.2 m -117.94 154.22 19.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 127' ' ' THR . 11.0 t-20 -92.67 101.29 13.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.891 -1.131 . . . . 0.0 109.051 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.634 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 77.4 m-20 -120.99 175.16 6.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.705 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 7.9 m170 135.4 3.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 69.03 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.76 -33.44 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.955 -1.09 . . . . 0.0 109.921 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -51.46 -35.08 35.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 182' ' ' TYR . 47.8 t -60.0 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.292 . . . . 0.0 108.518 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.492 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -35.84 -35.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.819 -0.55 . . . . 0.0 110.097 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 73.3 m -56.76 -34.85 67.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.149 -0.97 . . . . 0.0 109.229 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 42.7 t80 -72.21 123.33 89.34 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.606 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 73.4 Cg_endo -78.28 -172.7 1.57 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.377 2.051 . . . . 0.0 112.902 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.08 -3.53 60.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' OD1' ' A' ' 185' ' ' ASN . 24.7 p30 -94.2 13.01 24.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -1.058 . . . . 0.0 109.43 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -109.24 151.62 42.14 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.312 -1.344 0 C-N-CA 122.43 2.087 . . . . 0.0 112.161 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.641 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.6 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 177' ' ' VAL . 81.1 mt-10 -91.82 147.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.02 . . . . 0.0 109.719 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -134.93 151.56 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 109.005 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.836 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -54.67 139.14 39.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.842 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.22 -30.39 75.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.672 ' CZ2' HD22 ' A' ' 132' ' ' LEU . 55.0 m95 -52.51 -34.0 47.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.02 -1.282 . . . . 0.0 109.863 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 4' ' ' CYS . 12.3 m -59.56 134.8 24.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 109.753 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER 164.64 0.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.637 -179.689 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -109.75 -175.49 2.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.62 -0.675 . . . . 0.0 109.332 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' GLN . 11.1 m-20 -42.11 153.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.11 -16.97 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.749 2.299 . . . . 0.0 112.459 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' ILE . 27.6 tp -62.98 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.994 . . . . 0.0 109.459 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.504 ' HB2' HD13 ' A' ' 47' ' ' ILE . 60.7 t80 -64.58 -50.93 65.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.157 -0.964 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp -61.1 -39.46 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.859 -1.15 . . . . 0.0 109.915 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.08 75.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.64 -34.4 69.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.2 t-80 -54.9 -42.19 71.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 109.887 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.97 -28.28 20.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.54 -46.82 80.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.059 -1.026 . . . . 0.0 110.662 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 177.67 68.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.28 -0.887 . . . . 0.0 108.684 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.476 ' CZ3' ' CD2' ' A' ' 175' ' ' HIS . 63.8 t90 -123.09 122.62 38.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.572 -0.705 . . . . 0.0 109.801 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.55 6.08 66.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 23' ' ' VAL . 10.2 p -96.34 118.96 65.06 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.031 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.2 131.94 18.28 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.843 1.695 . . . . 0.0 111.827 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 36.1 tp10 -113.61 136.64 52.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -115.47 6.12 14.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 85.4 m-20 -86.38 117.93 25.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.8 p -67.37 -31.06 71.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.517 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.83 -45.32 92.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -67.06 -43.43 82.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.994 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.773 HD21 ' SG ' ' A' ' 169' ' ' CYS . 38.8 mt -66.11 -40.84 91.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.23 -52.61 64.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.98 -34.27 77.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.253 -0.905 . . . . 0.0 108.855 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.76 -43.26 99.27 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 109.806 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.711 HD13 ' CE2' ' A' ' 165' ' ' PHE . 3.4 mm -59.83 -48.6 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -73.79 -41.71 62.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.77 -46.94 73.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 111.841 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -69.95 -22.16 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.729 -1.232 . . . . 0.0 110.424 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 38' ' ' GLU . . . -44.55 -40.1 6.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.589 ' OE1' ' NZ ' ' A' ' 52' ' ' LYS . 15.3 mp0 -65.95 -31.1 71.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.109 . . . . 0.0 110.183 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 -30.26 2.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.912 -178.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.2 109.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.04 -36.13 3.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.558 HD13 HD13 ' A' ' 86' ' ' ILE . 10.9 mt -94.45 168.41 10.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.514 -0.992 . . . . 0.0 109.328 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.1 m -99.68 161.29 13.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 76.9 t-105 -53.85 -35.86 61.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.568 -0.707 . . . . 0.0 110.667 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 12' ' ' LEU . 10.3 tp -57.12 -39.88 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.877 -1.139 . . . . 0.0 109.872 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.49 ' N ' HG23 ' A' ' 47' ' ' ILE . 77.4 m -65.8 -37.54 86.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.323 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.8 t -65.06 -42.42 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.536 -0.727 . . . . 0.0 111.103 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 46' ' ' TRP . 90.7 mt -57.64 -50.08 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.797 -1.189 . . . . 0.0 110.56 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.4 -43.5 83.78 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.715 ' HZ1' ' NH1' ' A' ' 87' ' ' ARG . 19.6 tttt -64.03 -31.68 72.95 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.5 ttt180 -51.81 -44.0 63.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.303 -0.873 . . . . 0.0 108.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -68.42 -44.02 75.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.247 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -65.36 -36.88 85.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 109.78 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 52.5 t80 -57.47 -45.43 84.82 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.261 -0.9 . . . . 0.0 109.717 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.483 HH21 ' CD2' ' A' ' 61' ' ' HIS . 52.3 mtp180 -64.08 -28.01 69.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.44 -43.33 99.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.532 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 50.8 m -93.08 -38.58 11.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.425 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 95.8 m-85 -92.09 -52.17 4.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.275 . . . . 0.0 113.333 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CD2' HH21 ' A' ' 57' ' ' ARG . 75.3 t60 -54.28 -34.2 60.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.614 -1.304 . . . . 0.0 110.452 -178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.79 -36.87 67.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.2 m-85 -100.01 2.91 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.98 -1.075 . . . . 0.0 110.793 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.58 162.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.512 -1.368 . . . . 0.0 109.069 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.54 -35.39 8.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.005 2.47 . . . . 0.0 114.064 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.92 -47.72 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.661 -1.274 . . . . 0.0 110.048 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -64.36 -33.26 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 64' ' ' ASP . 71.5 t -56.58 -42.26 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -27.43 64.86 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.05 -1.031 . . . . 0.0 108.41 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.1 -0.33 51.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.513 -0.742 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 mtm -83.28 166.68 18.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.873 -1.142 . . . . 0.0 110.44 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -124.09 174.15 7.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.479 0.657 . . . . 0.0 110.102 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.04 -26.94 63.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.429 -0.794 . . . . 0.0 110.445 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -71.77 -29.75 64.83 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.167 -1.583 . . . . 0.0 108.897 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -66.7 -45.92 77.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 110.865 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 77' ' ' GLU . 3.9 m -65.4 -45.13 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.836 -1.165 . . . . 0.0 109.252 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 76' ' ' VAL . 83.6 tt0 -62.9 -35.29 79.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.189 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -67.81 -45.39 74.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.741 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -79.81 -20.43 46.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.396 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER -51.49 -40.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.869 -1.144 . . . . 0.0 109.355 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 31.3 tt0 -59.83 -45.19 93.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 108.992 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.6 m-20 -100.18 117.41 34.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.67 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -176.6 -67.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.806 -1.184 . . . . 0.0 110.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.38 59.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.67 HG12 ' HB1' ' A' ' 83' ' ' ALA . 18.4 pt -121.21 162.3 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.997 . . . . 0.0 109.993 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 44' ' ' LEU . 73.6 mt -63.46 -13.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 111.418 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.869 ' HE ' HD11 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -61.41 145.02 53.04 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.326 -0.859 . . . . 0.0 110.572 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -116.6 167.18 11.3 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -51.71 -39.12 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.803 -1.185 . . . . 0.0 109.757 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.48 -47.49 42.19 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 53.5 mttm -61.07 -43.01 99.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 0.0 110.471 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 94.5 mt -55.8 -40.9 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.901 -1.124 . . . . 0.0 108.976 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -58.78 -34.67 71.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.168 -0.957 . . . . 0.0 108.561 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.91 88.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.31 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.869 HD11 ' HE ' ' A' ' 87' ' ' ARG . 1.4 mp -61.58 -40.98 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 109.437 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.2 mm -56.59 -47.64 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.66 -38.6 96.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 18.4 m120 -59.12 -38.15 78.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.39 -1.065 . . . . 0.0 109.567 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.09 84.46 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.44 -42.03 99.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.19 78.71 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.26 -0.9 . . . . 0.0 109.201 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -60.45 -45.96 91.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.537 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.13 -37.46 85.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.76 -40.17 94.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.761 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.674 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 40.5 mmm -60.22 -38.13 82.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.83 -33.12 74.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.687 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.85 -36.38 62.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.77 -0.31 55.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.397 -0.815 . . . . 0.0 109.317 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.56 35.13 88.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.421 ' O ' ' CE ' ' A' ' 105' ' ' MET . 13.4 mt-10 -122.9 85.03 50.25 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.463 -1.022 . . . . 0.0 109.721 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.61 149.91 73.07 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.793 2.329 . . . . 0.0 112.288 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 70.1 m-85 -56.12 -39.41 72.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.283 -0.886 . . . . 0.0 108.963 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -57.74 -41.82 82.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.909 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -68.8 -37.6 79.38 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.007 -1.058 . . . . 0.0 109.47 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -67.85 -49.42 62.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.776 . . . . 0.0 111.235 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 117' ' ' TRP . 29.0 m -59.06 -41.81 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.869 -1.145 . . . . 0.0 110.105 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.465 ' N ' HG23 ' A' ' 116' ' ' VAL . 19.3 m95 -58.26 -39.26 78.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.907 -1.121 . . . . 0.0 109.416 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 m -60.69 -37.65 82.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.26 -31.1 70.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.048 -1.032 . . . . 0.0 110.227 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.95 19.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' HIS . 24.9 t-20 62.63 34.13 15.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.476 -0.765 . . . . 0.0 110.203 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 44.4 t-80 42.38 41.2 2.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.289 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.52 99.19 17.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.846 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.25 146.33 13.52 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.092 1.862 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG12 ' A' ' 172' ' ' VAL . 87.4 mt-30 -114.1 150.09 34.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.453 -0.779 . . . . 0.0 110.366 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.7 mtt -126.79 156.42 41.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -126.75 154.05 44.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 110.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.411 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 37.2 mm-40 -127.0 37.11 4.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -75.12 138.42 42.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.817 -0.552 . . . . 0.0 109.723 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.6 m -75.59 -34.97 60.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 108.512 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -133.42 171.13 14.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.757 0.789 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.672 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 72.1 mt -64.81 -30.81 71.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.815 -0.553 . . . . 0.0 110.658 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -58.72 -38.0 77.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.928 -1.107 . . . . 0.0 110.524 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.619 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.8 mt-10 -67.37 -28.83 68.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.888 -1.132 . . . . 0.0 110.055 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 mt -68.41 132.41 91.39 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.629 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.28 138.3 30.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.098 1.865 . . . . 0.0 111.838 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.1 t -101.36 2.44 39.58 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.253 -0.905 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.16 78.81 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.895 . . . . 0.0 109.928 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -78.56 153.67 78.7 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.138 -0.976 . . . . 0.0 108.628 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.71 -31.07 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.293 1.995 . . . . 0.0 111.785 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.86 64.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 m -61.27 -41.5 97.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.357 -0.84 . . . . 0.0 110.093 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -61.12 -44.35 97.47 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.08 -1.013 . . . . 0.0 109.165 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.79 73.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.184 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -59.47 -47.56 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.155 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -61.44 -37.37 83.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.963 -1.085 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -65.59 -41.13 93.17 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.15 90.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.23 -38.6 87.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.223 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -61.79 -35.78 79.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -59.95 -40.61 89.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.674 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 8.7 mmt180 -67.84 -20.48 65.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 109.733 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.9 25.36 9.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 5.0 m-85 -91.66 131.6 36.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.807 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -96.19 168.61 10.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 62.8 45.3 5.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.529 -0.732 . . . . 0.0 109.195 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' GLY . 19.9 m -119.05 24.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.87 159.4 0.15 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 t -54.32 -32.99 57.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.343 -1.092 . . . . 0.0 109.304 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.6 m -62.77 -41.07 99.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.89 . . . . 0.0 108.975 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 1.5 mp -62.38 -46.9 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.528 -0.733 . . . . 0.0 109.841 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -40.92 83.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -61.05 -34.44 74.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 161' ' ' ILE . 70.3 p -60.83 -43.22 98.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.206 -0.934 . . . . 0.0 109.81 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 35' ' ' ILE . 10.5 m-85 -61.02 -45.26 95.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.068 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 24.4 mtt -58.64 -40.88 84.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.45 HE22 ' HB2' ' A' ' 174' ' ' ASP . 56.3 tp60 -68.41 -45.16 73.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.84 3.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.531 -0.73 . . . . 0.0 110.324 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.773 ' SG ' HD21 ' A' ' 31' ' ' LEU . 40.1 t -48.06 -40.29 22.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.697 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.56 11.05 54.86 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.702 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD23 ' CZ2' ' A' ' 117' ' ' TRP . 87.2 mt -52.9 -37.13 60.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.735 -1.45 . . . . 0.0 107.975 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.7 m -121.94 149.31 25.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -95.06 102.23 14.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.894 -1.129 . . . . 0.0 108.988 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.45 ' HB2' HE22 ' A' ' 167' ' ' GLN . 87.8 m-20 -119.8 91.8 3.63 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.182 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.476 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 7.5 m170 -124.62 -93.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 173.48 132.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.423 ' O ' ' OE1' ' A' ' 2' ' ' GLU . 3.3 p -51.31 123.84 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 96.82 8.13 57.23 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 120.173 -1.013 . . . . 0.0 110.685 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.63 ' O ' ' N ' ' A' ' 181' ' ' CYS . 14.9 t -66.57 55.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.842 -1.387 . . . . 0.0 109.122 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.641 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 41.84 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.566 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.5 t -51.78 -33.68 36.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.411 ' OH ' ' NE2' ' A' ' 128' ' ' GLN . 10.8 t80 -119.71 90.61 43.62 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.29 -64.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.268 1.979 . . . . 0.0 111.52 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.15 -13.38 15.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -118.45 10.91 12.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -1.017 . . . . 0.0 109.606 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -148.38 155.95 42.58 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.479 -0.763 . . . . 0.0 109.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.609 2.206 . . . . 0.0 112.176 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 tpp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.57 153.8 22.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HG2' HH11 ' A' ' 3' ' ' ARG . 5.6 mtt-85 -118.04 164.86 14.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.487 -0.758 . . . . 0.0 109.468 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -62.24 149.38 42.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.917 . . . . 0.0 109.7 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.24 -20.01 57.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CE2' HD22 ' A' ' 132' ' ' LEU . 62.6 m95 -52.86 -41.43 64.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.26 . . . . 0.0 110.07 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 4' ' ' CYS . 22.3 m -71.16 137.48 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.959 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.1 OUTLIER 166.18 12.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.388 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 8' ' ' SER . 92.1 mt-30 -119.37 -134.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.46 157.29 83.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.568 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.95 -18.65 62.46 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.8 2.333 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 12' ' ' LEU . 44.4 tp -62.9 -36.87 84.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 108.996 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.73 ' CZ ' ' NE1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.19 -54.55 41.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 108.796 179.126 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.66 -43.63 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.64 92.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.67 -1.269 . . . . 0.0 108.055 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CG ' HD13 ' A' ' 50' ' ' LEU . 92.2 t80 -67.14 -32.91 74.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -55.91 -54.66 41.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 110.065 -179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.76 -39.95 84.11 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.927 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -59.94 -45.68 91.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 12.7 pt-20 175.1 122.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 0.0 109.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -171.22 92.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 109.406 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.75 -8.57 46.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 23' ' ' VAL . 1.8 m -78.38 150.04 76.32 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.15 -1.206 . . . . 0.0 108.91 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.39 123.85 12.43 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.223 1.949 . . . . 0.0 111.944 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -123.16 138.05 54.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 109.52 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.9 p -122.81 9.55 9.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.77 115.97 11.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.86 -40.42 76.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 110.639 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -63.78 -46.96 82.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.013 -1.055 . . . . 0.0 111.381 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.28 -41.58 89.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.842 -1.161 . . . . 0.0 111.921 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 113' ' ' ALA . 97.0 mt -61.74 -48.56 80.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.056 -1.028 . . . . 0.0 112.777 -177.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -77.67 -40.09 42.76 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.813 -1.179 . . . . 0.0 110.709 -177.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -31.3 71.84 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.083 -1.01 . . . . 0.0 109.381 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.638 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 3.3 ttm -74.02 -54.05 8.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 111.419 -179.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -60.4 -33.71 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.687 -1.258 . . . . 0.0 110.472 -178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -44.77 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.999 -1.063 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 56' ' ' TYR . 40.3 mt -72.2 -32.04 66.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.552 -0.717 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -54.27 -29.73 48.09 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.058 -1.026 . . . . 0.0 109.635 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.05 -42.8 23.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 98.6 mt-30 -64.31 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.12 -26.03 59.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.99 -179.34 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.05 109.6 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 108.944 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.02 -33.51 5.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 41' ' ' GLN . 4.4 mt -105.01 149.62 25.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -1.021 . . . . 0.0 109.677 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.8 m -78.71 165.01 24.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.153 -0.967 . . . . 0.0 109.741 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' NE1' ' CZ ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -61.12 -22.52 64.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.981 -1.074 . . . . 0.0 109.803 -179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -49.97 -38.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.571 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 86.7 m -74.17 -39.48 63.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 110.296 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 41' ' ' GLN . 92.7 t -71.49 -42.92 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 111.931 -178.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 16' ' ' TYR . 80.3 mt -56.47 -53.92 51.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.657 -1.277 . . . . 0.0 110.705 -178.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 4.9 ptmm? -61.19 -43.77 98.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.624 -1.298 . . . . 0.0 108.648 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 51' ' ' LYS . 1.9 mptm? -64.14 -27.92 69.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.135 -0.978 . . . . 0.0 108.621 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 53' ' ' ARG . 2.0 ttt-85 -55.37 -43.31 75.0 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.164 -0.96 . . . . 0.0 108.543 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.38 -44.08 84.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.09 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.421 HD21 ' HA3' ' A' ' 84' ' ' GLY . 51.5 t-20 -65.32 -41.68 93.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 10.0 t80 -60.99 -41.0 95.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.421 -0.799 . . . . 0.0 109.866 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 6.0 mtm180 -58.06 -38.0 75.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.182 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.34 96.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 110.852 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -73.27 -27.37 61.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.901 -1.124 . . . . 0.0 111.593 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 89.5 m-85 -122.49 -41.81 2.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.949 -1.094 . . . . 0.0 112.15 -177.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.682 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 46.8 t-80 -54.84 -39.33 68.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.63 -1.294 . . . . 0.0 109.909 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.24 -32.98 67.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.957 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' ASP . 98.4 m-85 -93.46 -2.9 53.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 59.36 150.01 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.03 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.64 -26.69 83.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.512 2.142 . . . . 0.0 113.097 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.76 -48.27 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.921 -1.112 . . . . 0.0 109.839 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -65.41 -34.67 78.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.18 -39.86 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.765 . . . . 0.0 109.165 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.58 -27.57 66.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.32 15.35 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 mtp -85.22 142.69 29.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -0.961 . . . . 0.0 109.378 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.5 167.02 10.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.731 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.6 -31.72 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 109.943 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.9 pt-20 -64.16 -38.93 92.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.065 . . . . 0.0 109.704 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 78' ' ' ARG . 31.9 t0 -61.4 -38.78 88.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 108.824 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.683 HG13 HG21 ' A' ' 92' ' ' ILE . 53.1 t -60.14 -41.61 87.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.477 -0.764 . . . . 0.0 109.004 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 80' ' ' VAL . 96.4 mt-10 -62.69 -33.37 74.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 110.266 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.594 HH21 ' CG ' ' A' ' 75' ' ' ASP . 67.6 mtm180 -66.22 -48.79 69.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.823 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.698 ' CD1' HH11 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -81.18 -19.48 43.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.993 . . . . 0.0 110.808 -178.818 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -51.26 -34.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.021 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 94.3 mt-30 -56.75 -36.15 69.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.379 -0.826 . . . . 0.0 109.155 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' O ' ' CZ ' ' A' ' 87' ' ' ARG . 24.6 t70 -89.96 115.06 26.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.088 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.37 35.81 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.814 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.754 ' N ' HH21 ' A' ' 87' ' ' ARG . . . -45.54 -29.47 2.79 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 2.6 pt -119.86 162.56 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -1.079 . . . . 0.0 108.458 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.562 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 2.6 mp -65.23 66.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.005 -1.06 . . . . 0.0 108.832 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.754 HH21 ' N ' ' A' ' 84' ' ' GLY . 1.6 ptp180 -104.12 142.74 33.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.525 -0.734 . . . . 0.0 109.686 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB3' ' A' ' 91' ' ' LYS . 82.5 t60 -127.87 156.05 43.18 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 89' ' ' ARG . 27.2 ttt-85 -48.97 -41.51 34.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.998 -1.064 . . . . 0.0 109.122 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.81 -47.44 20.07 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.684 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 11.1 tptt -60.46 -42.16 95.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.249 . . . . 0.0 110.375 -178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.683 HG21 HG13 ' A' ' 76' ' ' VAL . 72.6 mt -56.87 -39.67 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.326 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.26 -36.84 78.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 0.0 108.607 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 85.3 mt -59.19 -40.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.9 mm -55.14 -43.11 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.079 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -41.09 98.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 98' ' ' ASN . 41.8 t-20 -57.07 -44.0 82.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -1.191 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.6 82.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.549 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.39 -41.63 98.77 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.92 71.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -60.45 -52.99 62.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.0 mm? -64.36 -39.45 93.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 110.777 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.68 -42.43 92.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.848 -1.158 . . . . 0.0 110.188 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.666 ' SD ' ' CE2' ' A' ' 112' ' ' PHE . 3.9 ttt -67.94 -37.27 81.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.933 -1.105 . . . . 0.0 109.302 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLY . 85.9 tt0 -62.6 -30.49 71.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -52.89 -35.46 57.94 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.002 -1.061 . . . . 0.0 108.264 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -86.32 -10.65 54.04 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 70.17 36.02 71.13 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -129.16 87.69 53.35 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.268 -1.137 . . . . 0.0 110.11 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -57.25 146.73 80.61 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.397 2.065 . . . . 0.0 111.434 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.666 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 1.7 m-85 -61.71 -31.07 71.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.941 -1.099 . . . . 0.0 108.874 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 31' ' ' LEU . . . -55.45 -45.15 76.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.92 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -67.97 -35.24 78.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 108.936 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 119' ' ' PHE . 60.9 t80 -69.43 -50.54 44.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 117' ' ' TRP . 33.0 m -61.04 -44.72 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 0.0 110.461 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' VAL . 34.8 m95 -58.62 -36.36 73.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.841 -1.162 . . . . 0.0 108.933 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 m -60.87 -35.43 76.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 110.242 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 2.5 m-85 -60.3 -30.57 69.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 109.953 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.58 20.6 2.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.897 . . . . 0.0 109.047 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER 61.47 37.27 16.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.802 . . . . 0.0 109.888 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 122' ' ' HIS . 58.3 t-80 43.3 18.28 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.0 mt-30 -114.71 104.58 54.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.289 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.26 147.41 11.77 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.12 1.88 . . . . 0.0 112.148 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.599 ' HB2' HG12 ' A' ' 172' ' ' VAL . 94.0 mt-30 -108.85 157.76 18.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.951 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.5 mtt -126.51 150.71 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -118.97 147.4 44.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.95 118.2 21.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.41 -0.806 . . . . 0.0 109.651 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.1 m -72.5 -35.01 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 m -120.21 157.68 28.58 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 6' ' ' TRP . 49.5 mt -54.61 -38.64 67.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.385 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.7 m -62.25 -32.77 73.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.033 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.5 mm-40 -61.55 -24.5 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.997 -1.064 . . . . 0.0 110.408 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.25 127.38 93.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.875 -1.14 . . . . 0.0 109.285 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.04 140.52 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.352 2.035 . . . . 0.0 112.292 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -107.13 6.5 28.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.76 . . . . 0.0 108.997 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.3 m -134.22 94.35 3.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.775 . . . . 0.0 109.745 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 151.88 43.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.817 . . . . 0.0 108.85 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.12 -30.7 82.73 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.44 2.093 . . . . 0.0 112.323 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.17 -42.11 66.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.98 97.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.39 -43.68 93.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.235 -0.916 . . . . 0.0 109.805 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.65 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.787 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 145' ' ' LEU . 10.5 tt -60.77 -41.64 95.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.379 -0.825 . . . . 0.0 109.913 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.8 t -60.58 -49.4 77.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.939 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -61.51 -35.41 77.64 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.764 ' HB1' HH12 ' A' ' 152' ' ' ARG . . . -65.59 -45.63 82.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.99 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.0 mt -63.36 -37.57 87.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 109.829 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -58.15 -35.31 71.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.731 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -60.77 -39.14 87.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.064 . . . . 0.0 109.81 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.764 HH12 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -67.81 -20.75 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 104.72 27.89 5.86 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -96.91 130.74 44.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.304 . . . . 0.0 110.075 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -98.52 176.22 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 58.64 51.41 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.644 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.35 24.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.88 160.96 0.18 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 48.0 m -54.6 -33.11 59.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.1 m -63.91 -47.81 79.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 109.846 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.0 mt -67.16 -37.36 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.49 -42.18 92.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.289 -0.882 . . . . 0.0 108.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -66.64 -43.8 83.66 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.27 -0.894 . . . . 0.0 109.133 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.6 t -58.41 -38.17 76.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.183 -0.948 . . . . 0.0 108.747 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.68 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 75.6 t80 -60.06 -46.88 88.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.694 . . . . 0.0 109.585 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 72.9 mtp -62.67 -36.2 82.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.98 -45.52 94.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.638 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -76.83 -41.94 42.2 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.68 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 60.1 m -59.42 -37.71 78.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.52 8.74 58.28 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.04 -35.02 61.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.252 . . . . 0.0 108.414 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 125' ' ' GLN . 27.4 m -123.4 148.66 27.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.432 ' O ' HG22 ' A' ' 127' ' ' THR . 84.5 m-20 -99.43 102.42 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 109.154 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.508 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 91.5 m-20 -120.58 92.29 3.73 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 10.4 m-70 -146.65 23.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.355 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 56.72 165.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.507 -0.746 . . . . 0.0 110.34 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 176' ' ' VAL . 24.1 t -81.72 133.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 111.53 -9.66 28.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 38.4 t -71.23 24.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.87 -1.371 . . . . 0.0 108.43 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.625 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.9 m 72.58 -64.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.179 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -23.24 57.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -122.2 83.96 45.86 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CG1' ' A' ' 177' ' ' VAL . 3.0 Cg_exo -72.36 -74.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.762 2.308 . . . . 0.0 111.672 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.492 ' O ' ' OD1' ' A' ' 185' ' ' ASN . . . 89.67 -13.93 62.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 184' ' ' GLY . 83.4 m-20 -149.33 30.25 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -1.224 . . . . 0.0 109.85 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -123.66 80.82 55.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 C-N-CA 122.878 2.385 . . . . 0.0 112.277 -179.779 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -109.14 161.59 15.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 108.951 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -122.69 153.83 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 109.618 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -40.94 133.74 2.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.699 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.19 -37.82 92.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.9 m95 -57.39 -31.99 66.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.054 -1.262 . . . . 0.0 108.96 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.1 134.05 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -171.72 115.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.3 tt0 44.96 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 108.862 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 54.12 73.23 0.94 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.962 -1.086 . . . . 0.0 109.546 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -52.99 -23.57 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.6 tp -63.0 -36.93 85.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' HD13 ' A' ' 47' ' ' ILE . 76.7 t80 -61.52 -43.25 99.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.52 -39.56 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.485 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.35 -44.75 92.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.739 -1.226 . . . . 0.0 108.216 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -66.46 -35.83 81.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.616 -0.678 . . . . 0.0 109.267 178.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 5.9 t-80 -58.1 -53.54 57.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.649 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 86.1 m-20 -73.69 -45.71 50.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.0 111.484 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 89.2 m-20 -58.57 -41.97 86.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 110.578 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' CD ' ' O ' ' A' ' 19' ' ' ASN . 61.2 mm-40 -146.47 -136.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 108.543 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 16.0 t90 57.09 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.802 178.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.05 0.79 56.04 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.2 p -105.76 119.19 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.3 -1.118 . . . . 0.0 109.062 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -47.29 133.6 19.67 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.815 1.677 . . . . 0.0 112.285 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.21 139.17 49.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.459 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -124.33 1.48 8.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -81.68 112.17 18.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -60.45 -38.79 85.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -48.93 79.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -72.67 -41.24 65.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 169' ' ' CYS . 9.8 tp -61.37 -47.7 84.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 110.068 -179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.09 -43.67 94.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.825 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.54 -33.44 73.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.551 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 61.0 tpp -61.17 -44.69 96.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -35.65 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.756 -1.215 . . . . 0.0 110.412 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.91 -49.1 55.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.798 -178.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 36' ' ' CYS . 10.9 mp -69.46 -38.03 77.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.007 -1.058 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 1.2 mp0 -60.29 -29.05 68.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.889 -1.132 . . . . 0.0 109.88 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.66 -37.95 57.83 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 26.7 mt-30 -61.48 -33.68 74.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -1.183 . . . . 0.0 109.553 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -54.84 -20.22 8.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -41.8 109.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.418 -0.801 . . . . 0.0 109.038 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.52 -34.51 4.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' GLN . 10.0 mt -101.5 147.61 26.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.399 -1.059 . . . . 0.0 109.89 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.9 m -69.36 160.79 30.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.815 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 18.9 p90 -61.16 -30.98 70.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 110.3 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 11.1 tp -58.11 -37.24 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.937 -1.102 . . . . 0.0 109.948 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 ' N ' HG23 ' A' ' 47' ' ' ILE . 87.8 m -65.68 -38.28 88.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.458 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 41' ' ' GLN . 88.2 t -64.4 -39.65 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.509 -0.745 . . . . 0.0 110.874 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' LEU . 97.3 mt -55.62 -49.16 73.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.966 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 1.4 ptpm? -65.73 -49.4 68.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.814 -1.179 . . . . 0.0 110.049 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' NZ ' ' NE2' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -67.48 -26.75 66.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.922 -1.111 . . . . 0.0 109.244 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 53' ' ' ARG . 30.0 ttt-85 -58.59 -43.57 89.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 108.975 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.56 -44.22 87.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.945 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 43.5 t30 -65.7 -40.12 91.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.018 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 75.8 t80 -59.06 -43.15 91.7 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.467 -0.771 . . . . 0.0 109.46 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -57.92 -35.71 71.45 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.28 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.21 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.118 -0.989 . . . . 0.0 109.85 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.4 m -92.71 -13.79 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 111.413 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 64.6 m-85 -124.97 -46.96 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.98 -1.075 . . . . 0.0 111.712 -178.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -55.84 -41.1 73.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.855 -1.153 . . . . 0.0 110.156 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.67 -37.27 73.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.627 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.2 m-85 -83.43 -3.64 57.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 59.45 150.14 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.967 -1.083 . . . . 0.0 108.97 -179.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.68 -26.28 75.38 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.526 2.151 . . . . 0.0 112.925 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.74 -48.04 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.948 -1.095 . . . . 0.0 109.908 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 71' ' ' MET . 26.1 mttt -64.63 -35.27 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.097 -1.002 . . . . 0.0 109.194 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.74 -42.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.523 -0.736 . . . . 0.0 109.165 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.33 -16.78 59.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.44 16.72 19.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 110.888 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.564 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 mtm -80.88 160.36 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.622 -1.298 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.68 163.01 12.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.502 -0.749 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.74 -33.4 64.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.637 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 58.0 mp0 -62.96 -37.07 85.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 12.5 t0 -61.56 -39.69 92.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.38 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 92' ' ' ILE . 73.7 t -62.1 -41.49 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.89 -35.93 81.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -59.0 -43.92 91.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.8 -33.56 74.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.902 . . . . 0.0 109.636 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 74.8 t -57.11 -36.76 52.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.242 -0.911 . . . . 0.0 108.66 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -61.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -99.47 118.65 36.53 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.5 -68.61 0.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 81.42 3.39 90.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' ILE . 38.2 pt -126.32 174.39 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' O ' ' CE1' ' A' ' 88' ' ' HIS . 76.9 mt -43.54 138.98 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.985 -1.072 . . . . 0.0 108.942 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -93.38 136.94 33.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.243 -178.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.675 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER 171.15 82.77 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HA ' HD12 ' A' ' 92' ' ' ILE . 68.1 ttt180 -50.96 -37.06 42.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.028 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.56 98.71 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -64.54 -40.41 95.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.179 -1.189 . . . . 0.0 109.005 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 76' ' ' VAL . 82.1 mt -57.33 -40.96 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 108.72 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -57.12 -39.24 74.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 108.778 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB1' ' HE1' ' A' ' 156' ' ' PHE . . . -63.78 -37.13 86.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.748 . . . . 0.0 109.461 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.7 mm -57.96 -46.71 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.34 -46.92 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 109.311 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -64.11 -40.4 98.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -61.56 -37.45 83.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.228 -1.16 . . . . 0.0 109.961 -179.513 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.37 -44.33 87.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.065 -1.022 . . . . 0.0 109.732 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HE ' ' HA2' ' A' ' 97' ' ' GLY . 86.2 mtm180 -62.86 -41.88 99.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.703 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.13 91.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -61.91 -47.29 85.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.92 -37.16 85.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -56.03 -42.6 76.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 23.9 ttt -64.69 -38.79 92.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 109.611 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.68 -33.86 75.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -53.52 -30.72 42.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 108.419 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.46 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 35.2 t-20 -77.28 -10.89 59.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.23 24.1 61.97 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 1.6 mp0 -113.03 102.71 55.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -50.6 134.7 40.44 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.917 1.745 . . . . 0.0 111.96 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.1 -43.19 99.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.546 -0.721 . . . . 0.0 110.107 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.53 92.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.583 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.09 -38.32 79.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.96 -1.088 . . . . 0.0 109.604 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.34 89.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.28 -44.82 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.198 -0.939 . . . . 0.0 109.68 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -62.17 -35.86 80.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.212 -0.93 . . . . 0.0 109.754 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.2 t -60.0 -38.01 81.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.432 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.79 -31.16 71.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.987 -1.071 . . . . 0.0 110.289 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.5 16.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 108.923 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 122' ' ' HIS . 26.5 t30 60.57 38.06 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.55 -0.719 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 15.9 t-80 44.3 28.68 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.434 -0.791 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.5 tp60 -117.66 98.53 51.79 Favored Pre-proline 0 C--N 1.306 -1.315 0 O-C-N 121.505 -0.747 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.38 145.07 12.28 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.116 1.878 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 94.8 mm-40 -114.33 153.33 29.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 110.291 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 5.9 ptp -133.73 156.13 48.51 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.2 t -125.21 156.1 39.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 110.056 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -128.09 49.26 2.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -81.58 127.79 33.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.6 m -70.77 -39.84 73.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.072 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 132' ' ' LEU . 22.2 m -126.85 158.93 35.38 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 6' ' ' TRP . 68.5 mt -56.24 -33.19 65.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.3 m -58.1 -36.36 72.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.392 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 76.8 mm-40 -62.48 -32.4 73.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.899 -1.126 . . . . 0.0 110.033 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 137' ' ' THR . 31.8 mt -68.2 120.64 76.01 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.109 -0.994 . . . . 0.0 109.645 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.644 ' C ' ' H ' ' A' ' 138' ' ' SER . 55.8 Cg_endo -75.87 -9.0 19.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.084 1.856 . . . . 0.0 111.955 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.576 HG23 ' C ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER 50.65 -0.24 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.822 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 136' ' ' PRO . 3.1 m -128.41 96.27 4.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.915 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 157.15 36.37 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.458 -0.776 . . . . 0.0 108.909 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -52.9 -38.31 78.78 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.898 1.732 . . . . 0.0 112.283 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.77 72.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 110.243 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -63.51 -40.99 98.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.966 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.72 -44.53 85.76 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.219 -0.925 . . . . 0.0 109.861 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.69 62.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 110.171 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -56.14 -47.48 78.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.167 -0.958 . . . . 0.0 109.638 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.5 p -67.6 -35.88 79.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.068 -1.02 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -64.65 -38.86 92.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.729 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.69 93.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.4 -36.29 81.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -60.44 -43.81 96.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.994 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -61.47 -38.06 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.667 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -64.53 -20.36 66.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 14.15 10.54 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.081 -1.056 . . . . 0.0 110.563 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.6 134.59 33.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.817 -1.402 . . . . 0.0 109.92 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.614 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 30.2 mmtm -103.38 -173.23 2.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 7.8 p90 44.23 54.74 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 108.86 -179.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 155' ' ' LYS . 31.2 m -118.29 25.49 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.633 -0.667 . . . . 0.0 109.947 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -38.55 149.06 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -24.52 58.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -1.09 . . . . 0.0 109.467 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.4 p -71.61 -41.44 68.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.0 -36.37 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -46.27 86.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.355 -0.84 . . . . 0.0 109.495 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.47 -45.31 94.21 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.4 m -60.72 -39.62 89.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.032 -1.043 . . . . 0.0 108.512 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.2 -42.68 99.01 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 0.0 109.386 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -62.36 -37.73 86.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -59.4 -42.63 92.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.14 -0.975 . . . . 0.0 109.649 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.52 -38.75 67.97 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.359 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 31' ' ' LEU . 44.4 t -63.72 -41.9 98.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.785 . . . . 0.0 109.709 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.11 54.93 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.79 -37.96 71.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.044 -1.268 . . . . 0.0 108.755 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 125' ' ' GLN . 3.3 m -119.19 137.45 53.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 127' ' ' THR . 46.3 t-20 -95.34 101.5 13.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.704 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 51.4 p-10 -121.1 91.77 3.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.721 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.438 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 5.1 m-70 -125.15 4.01 7.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 109.162 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 177' ' ' VAL . 0.5 OUTLIER 67.18 164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.387 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 176' ' ' VAL . 58.7 t -87.72 137.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.353 -0.842 . . . . 0.0 109.12 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 104.32 -10.21 50.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 1.5 t -62.55 3.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -1.218 . . . . 0.0 108.611 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.589 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.4 t 70.96 -52.0 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 109.034 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.5 m -62.01 -34.76 76.79 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.44 -0.788 . . . . 0.0 109.765 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 14.7 t80 -122.81 82.75 49.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.51 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 185' ' ' ASN . 57.5 Cg_endo -80.81 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.634 2.223 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.57 -14.72 1.8 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 183' ' ' PRO . 37.6 t-20 -90.22 1.95 55.91 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.376 -1.073 . . . . 0.0 108.759 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -108.82 156.87 38.2 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 122.813 2.342 . . . . 0.0 112.315 179.875 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 178' ' ' GLY . 20.5 pt-20 -117.42 148.45 41.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.78 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 40.8 mtm-85 -125.64 159.89 31.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.13 151.79 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.46 -20.2 36.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.694 ' CE2' HD22 ' A' ' 132' ' ' LEU . 59.7 m95 -48.5 -31.36 6.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 110.014 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 24.1 t -100.21 135.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 10.0 p -156.74 111.68 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.479 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.948 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 8' ' ' SER . 16.9 m-20 -141.24 78.75 18.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.67 -38.9 94.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.632 2.222 . . . . 0.0 112.482 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.99 -39.22 93.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 108.946 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.548 ' CD1' HG22 ' A' ' 7' ' ' VAL . 38.1 t80 -61.92 -42.9 99.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 109.303 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.579 ' CG1' HG11 ' A' ' 7' ' ' VAL . 92.3 mt -56.71 -39.94 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.66 90.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.116 . . . . 0.0 108.318 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -65.81 -35.99 82.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.036 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 14.3 t-80 -59.53 -49.25 78.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.073 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -72.82 -34.4 66.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.408 -0.807 . . . . 0.0 111.284 -178.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -67.63 -70.65 0.24 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.893 -1.129 . . . . 0.0 109.939 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -147.17 114.65 6.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 108.873 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.809 ' HE1' HE21 ' A' ' 167' ' ' GLN . 21.6 t90 -172.67 104.73 0.15 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.28 -17.13 48.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -82.24 139.8 45.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 108.47 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.78 132.92 45.02 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.037 1.825 . . . . 0.0 113.066 -178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.57 127.75 54.78 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.5 p -112.59 10.65 19.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.79 . . . . 0.0 109.34 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD2' ' NZ ' ' A' ' 30' ' ' LYS . 58.8 t0 -79.91 118.01 21.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.534 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 5.1 p -63.79 -33.88 76.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.594 -0.692 . . . . 0.0 110.329 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 10.1 mttp -63.19 -44.16 96.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.963 -1.086 . . . . 0.0 109.975 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' NZ ' ' OD2' ' A' ' 27' ' ' ASP . 49.7 mttp -60.12 -39.17 85.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 165' ' ' PHE . 3.9 mm? -58.57 -40.41 83.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.971 -1.08 . . . . 0.0 110.263 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.2 m-30 -65.55 -57.12 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.118 -0.989 . . . . 0.0 111.296 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' C ' HH12 ' A' ' 53' ' ' ARG . 32.8 mp0 -71.98 -32.03 66.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.947 -1.096 . . . . 0.0 111.648 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.9 tpt -61.16 -52.83 63.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.933 -1.104 . . . . 0.0 110.405 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -67.65 -32.7 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.06 -1.025 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.63 -47.87 83.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.946 -1.096 . . . . 0.0 110.387 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 37' ' ' LEU . 4.0 mm? -67.51 -35.72 79.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 110.705 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' NE2' ' A' ' 41' ' ' GLN . 76.0 mm-40 -58.54 -33.91 70.42 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.863 -1.148 . . . . 0.0 109.83 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.39 94.53 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 95' ' ' ILE . 98.4 mt-30 -63.68 -32.02 73.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.14 . . . . 0.0 110.264 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -43.61 -37.07 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.0 109.959 -178.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.04 117.2 1.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.017 -1.052 . . . . 0.0 109.362 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.13 -7.78 72.76 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 HG21 ' A' ' 48' ' ' THR . 3.9 mp -121.52 -165.72 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -1.033 . . . . 0.0 109.91 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -114.99 151.07 34.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.551 -0.718 . . . . 0.0 109.499 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' CZ2' ' NE2' ' A' ' 167' ' ' GLN . 3.7 t-105 -52.25 -43.66 64.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.925 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.6 -31.91 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.0 110.374 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.621 HG21 HD23 ' A' ' 44' ' ' LEU . 78.8 m -62.44 -37.51 86.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.052 -1.03 . . . . 0.0 110.3 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 66.5 t -59.45 -40.33 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.14 -47.85 84.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 110.181 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -59.36 -48.59 81.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.839 -1.163 . . . . 0.0 108.669 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -68.96 -28.97 67.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.524 -0.735 . . . . 0.0 109.487 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.551 HH12 ' C ' ' A' ' 33' ' ' GLU . 19.6 tpt180 -50.39 -45.68 55.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.896 -1.127 . . . . 0.0 108.442 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.36 -43.92 63.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.033 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 85' ' ' ILE . 42.3 t-20 -63.36 -41.42 98.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.057 -1.027 . . . . 0.0 109.84 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 41.3 t80 -57.45 -42.89 83.4 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.59 HH11 ' CD2' ' A' ' 61' ' ' HIS . 40.3 ttm-85 -58.61 -36.6 74.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.777 . . . . 0.0 110.06 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 62' ' ' GLN . . . -67.02 -33.22 75.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 111.965 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 m -92.18 -45.66 8.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.583 -1.323 . . . . 0.0 112.329 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -86.27 -46.43 10.34 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.932 -1.105 . . . . 0.0 112.246 -177.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CD2' HH11 ' A' ' 57' ' ' ARG . 2.1 t60 -51.63 -40.07 59.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.544 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.67 ' NE2' ' CE2' ' A' ' 63' ' ' PHE . 10.8 pt20 -58.18 -32.84 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.055 -1.028 . . . . 0.0 109.842 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 62' ' ' GLN . 70.8 m-85 -96.47 2.54 52.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.088 . . . . 0.0 110.148 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.19 161.1 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.915 -1.116 . . . . 0.0 109.442 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.05 -26.07 31.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.676 2.25 . . . . 0.0 112.996 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.04 -48.52 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.954 -1.091 . . . . 0.0 110.093 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -65.63 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.273 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.7 t -58.16 -41.42 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.43 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 -28.27 65.55 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.68 20.43 18.02 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.643 -0.661 . . . . 0.0 109.771 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mtp -83.74 151.83 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 0.0 109.054 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.47 159.13 15.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.434 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.88 -33.3 66.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.173 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.79 -35.88 77.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.08 -38.54 86.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 108.746 179.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 74.3 t -59.28 -39.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.784 . . . . 0.0 109.216 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.76 -40.97 94.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.288 -0.883 . . . . 0.0 109.352 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -67.88 -40.54 83.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 109.867 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 79' ' ' LEU . 87.0 mt -64.22 -33.3 75.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 110.499 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' VAL . 75.3 t -55.69 -35.26 38.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 109.051 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -99.94 3.66 44.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.7 t0 -83.4 119.6 24.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.98 -1.075 . . . . 0.0 110.281 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.37 -16.09 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 110.031 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.88 31.9 54.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.694 HG22 ' CG ' ' A' ' 55' ' ' ASN . 38.9 pt -59.51 -146.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.08 -1.247 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.3 mt -76.28 136.22 25.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.0 108.803 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 12.9 ptm180 -96.77 126.28 41.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 166.37 83.78 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -49.88 -34.16 19.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.0 88.35 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -70.83 -40.11 72.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.913 -1.346 . . . . 0.0 109.834 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG21 HG13 ' A' ' 76' ' ' VAL . 86.8 mt -61.38 -40.62 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.149 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.01 -36.63 77.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.209 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.9 90.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.451 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.832 HD11 ' NE2' ' A' ' 40' ' ' GLN . 93.6 mt -60.74 -41.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.392 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 76' ' ' VAL . 87.9 mt -56.91 -43.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.07 96.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 84.4 m-20 -58.23 -38.01 76.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.99 75.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 36.4 ttm-85 -60.92 -43.44 98.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.932 . . . . 0.0 109.395 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.48 75.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.22 -0.925 . . . . 0.0 108.815 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.56 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 88.2 t80 -62.86 -44.87 94.98 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.1 mt -63.54 -40.33 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.022 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.87 -39.26 84.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.081 -1.012 . . . . 0.0 109.13 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.7 tpt -63.02 -40.44 97.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.638 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.81 -35.31 80.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.914 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -53.06 -33.48 52.19 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 108.81 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.89 0.43 57.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.266 -0.896 . . . . 0.0 109.466 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 58.23 43.26 95.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -124.02 85.65 54.31 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -55.87 138.28 81.4 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.626 2.218 . . . . 0.0 112.475 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 116' ' ' VAL . 69.4 m-85 -62.31 -40.54 96.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.04 -47.05 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.753 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.83 -37.85 85.3 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.005 -1.06 . . . . 0.0 109.254 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.431 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 69.0 t80 -68.91 -51.13 43.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' PHE . 8.7 m -63.85 -41.69 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.0 109.94 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' N ' HG23 ' A' ' 116' ' ' VAL . 13.5 m95 -57.7 -38.95 76.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.008 -1.057 . . . . 0.0 109.432 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.0 p -65.59 -30.09 70.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.035 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.9 m-85 -63.15 -37.62 87.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.05 -1.031 . . . . 0.0 110.455 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.1 p -93.84 23.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.984 -1.073 . . . . 0.0 109.667 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.5 m-80 75.27 21.23 1.9 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.182 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 59.16 27.8 16.91 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 124' ' ' PRO . 1.3 pp0? -136.93 152.35 73.9 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.582 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 60.5 Cg_endo -74.91 148.2 35.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.998 2.466 . . . . 0.0 112.793 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.684 ' HB2' HG12 ' A' ' 172' ' ' VAL . 69.1 mt-30 -104.73 150.85 24.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.944 . . . . 0.0 109.143 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 41.7 ttp -126.68 143.75 51.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 108.948 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.443 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -111.64 160.63 17.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -138.51 57.4 1.69 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -112.05 157.28 20.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.589 -0.694 . . . . 0.0 109.684 -179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -40.15 8.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -110.4 152.51 26.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.474 -0.766 . . . . 0.0 109.19 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 6' ' ' TRP . 54.1 mt -59.98 -32.4 70.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.413 -0.804 . . . . 0.0 109.265 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -57.59 -38.68 75.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 0.0 109.601 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.605 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 97.7 mt-10 -66.21 -30.41 70.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.079 -1.013 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mt -70.0 124.99 91.77 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.54 134.54 17.05 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.769 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.66 -6.41 57.5 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.128 -0.983 . . . . 0.0 109.101 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -137.68 87.36 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.353 -0.842 . . . . 0.0 109.513 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.03 165.42 37.02 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 108.816 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.94 -39.06 59.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.022 1.815 . . . . 0.0 112.314 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.74 -43.17 80.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 109.839 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.432 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 20.8 t -61.55 -42.08 98.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.46 -47.45 83.95 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.288 -0.882 . . . . 0.0 109.812 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.77 -39.92 63.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.61 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.0 tt -64.95 -42.78 94.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -62.15 -39.0 91.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.039 -1.038 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.83 -38.85 92.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.635 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.27 80.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.173 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' A' ' 157' ' ' VAL . 83.7 mt -65.17 -38.97 92.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.318 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.1 -36.88 78.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.417 -0.802 . . . . 0.0 109.234 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.11 -37.56 80.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -64.18 -20.87 66.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.082 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.33 18.71 13.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -73.68 137.02 43.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.302 . . . . 0.0 109.709 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -96.97 157.14 16.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 57.15 48.75 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 109.271 -179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 157' ' ' VAL . 12.3 p -117.64 24.63 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.78 168.09 0.66 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -55.3 -35.3 64.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -1.114 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.5 m -60.86 -44.53 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.806 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.82 -42.6 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.037 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.432 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.62 -42.8 95.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 109.199 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.84 -37.27 81.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.275 -0.89 . . . . 0.0 108.926 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.48 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 13.6 t -59.59 -47.43 85.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.35 -0.844 . . . . 0.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.67 -39.59 91.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 108.942 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.516 ' SD ' HD22 ' A' ' 171' ' ' LEU . 75.1 mmm -59.14 -38.48 79.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 108.872 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.809 HE21 ' HE1' ' A' ' 21' ' ' TRP . 40.9 tt0 -65.11 -44.29 89.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.48 -0.763 . . . . 0.0 110.171 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.9 -46.17 63.03 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.0 110.227 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.514 ' O ' ' O ' ' A' ' 23' ' ' VAL . 7.6 m -64.15 -31.85 73.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 109.577 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.98 12.29 62.23 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.626 179.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.516 HD22 ' SD ' ' A' ' 166' ' ' MET . 6.6 mp -52.26 -30.3 27.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.747 -1.443 . . . . 0.0 107.965 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 125' ' ' GLN . 34.2 m -123.14 149.16 26.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -98.71 104.58 16.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.192 -0.942 . . . . 0.0 108.541 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 49.7 p30 -119.12 92.45 3.8 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.234 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.943 ' O ' HG13 ' A' ' 176' ' ' VAL . 18.1 m-70 -134.65 -62.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.07 -98.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.654 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.477 ' H ' HG23 ' A' ' 176' ' ' VAL . 40.5 t -152.86 -14.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' O ' ' OE2' ' A' ' 2' ' ' GLU . . . -156.9 59.2 0.36 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 181' ' ' CYS . 51.2 t -98.2 125.9 43.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 -64.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 28.0 p -173.03 55.21 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 2.4 t80 -123.88 86.65 53.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.716 . . . . 0.0 109.344 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.17 -82.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.266 1.977 . . . . 0.0 111.976 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 83.61 3.24 89.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.01 24.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -1.207 . . . . 0.0 109.783 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -133.63 80.29 56.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.802 . . . . 0.0 109.428 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.306 -1.663 0 C-N-CA 122.876 2.384 . . . . 0.0 112.362 -179.994 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 177' ' ' VAL . 19.8 pt-20 -76.29 150.83 36.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 3' ' ' ARG . 15.0 ptt-85 -148.11 173.13 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.562 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 56.5 m -47.09 151.03 0.71 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.279 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.52 -22.38 7.79 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.349 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CE3' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -76.08 -4.18 40.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.564 -1.551 . . . . 0.0 110.371 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.13 130.63 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.987 -1.07 . . . . 0.0 109.211 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 p -79.25 158.16 27.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.56 -34.12 75.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 109.311 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 5.9 m-20 -52.21 114.04 5.0 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.9 -24.52 13.88 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.898 1.732 . . . . 0.0 112.384 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.89 -40.34 97.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.347 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -67.15 -49.22 65.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 109.068 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.99 -36.25 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.375 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.02 99.77 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' NH2' ' A' ' 53' ' ' ARG . 67.9 t80 -66.62 -37.06 84.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 3.8 t-80 -56.61 -47.54 79.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.785 . . . . 0.0 109.521 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.95 -46.34 16.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.873 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -58.42 -40.33 82.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.721 -178.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 21' ' ' TRP . 94.2 mt-10 -149.92 -132.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' CE3' ' NE2' ' A' ' 175' ' ' HIS . 22.2 t90 54.17 105.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.831 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 -23.05 36.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.05 136.63 72.9 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.227 -1.161 . . . . 0.0 108.389 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.78 126.73 16.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.911 1.741 . . . . 0.0 112.68 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -115.38 123.54 48.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.7 p -109.13 1.02 20.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -78.28 119.39 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.01 -1.056 . . . . 0.0 109.126 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.6 p -63.02 -34.3 77.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.78 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 42.8 mttt -62.97 -51.17 67.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.09 -1.006 . . . . 0.0 109.292 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -66.9 -40.32 87.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.103 -0.998 . . . . 0.0 109.207 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -47.1 85.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.304 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -61.66 -41.9 98.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.725 . . . . 0.0 109.421 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 2.2 mp0 -70.56 -31.52 68.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 109.871 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.535 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -56.69 -51.03 70.36 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 110.128 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -71.72 -33.22 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.042 -1.036 . . . . 0.0 110.09 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -49.53 67.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.039 . . . . 0.0 109.945 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.8 mm? -67.88 -36.32 80.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.51 -33.89 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.356 -0.84 . . . . 0.0 109.723 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.49 -34.22 59.71 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HB3' HG22 ' A' ' 49' ' ' VAL . 9.0 tp-100 -57.85 -35.28 70.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -1.182 . . . . 0.0 109.839 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB2' HG21 ' A' ' 49' ' ' VAL . 32.3 tt0 -54.72 -38.28 66.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.84 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.37 110.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.53 -15.86 61.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 48' ' ' THR . 1.3 mt -121.67 -143.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -1.07 . . . . 0.0 109.967 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.5 m -127.59 154.39 45.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.743 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CE3' ' OE1' ' A' ' 41' ' ' GLN . 4.6 t-105 -54.33 -40.77 68.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.375 -0.828 . . . . 0.0 109.836 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 48' ' ' THR . 3.1 tp -62.5 -35.13 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.272 -0.892 . . . . 0.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 60.7 m -61.44 -40.56 94.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.006 -1.059 . . . . 0.0 110.337 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 41' ' ' GLN . 73.9 t -66.68 -39.67 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 111.03 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 HH21 ' A' ' 53' ' ' ARG . 43.1 mt -53.98 -52.42 60.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.879 -1.138 . . . . 0.0 109.801 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -57.9 -39.99 79.25 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -68.05 -31.44 71.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.314 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.588 ' NH2' ' CE1' ' A' ' 16' ' ' TYR . 11.6 ttm180 -54.07 -48.26 70.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.971 -1.081 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.5 pt-20 -72.31 -44.02 63.32 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.931 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.783 ' CG ' HG22 ' A' ' 85' ' ' ILE . 47.6 t-20 -62.41 -37.27 85.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.122 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 74.8 t80 -57.88 -45.06 86.93 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.45 -0.781 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.586 HH11 ' CE1' ' A' ' 61' ' ' HIS . 46.4 mtt-85 -58.55 -37.66 76.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.989 -1.07 . . . . 0.0 109.297 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.01 87.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.62 -1.3 . . . . 0.0 110.271 -179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -94.27 -16.24 23.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 112.074 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 67.9 m-85 -113.93 -47.8 2.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.815 -1.178 . . . . 0.0 113.078 -177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.586 ' CE1' HH11 ' A' ' 57' ' ' ARG . 0.1 OUTLIER -50.3 -38.52 41.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.287 -1.508 . . . . 0.0 109.721 -178.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.47 -37.24 77.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.063 -1.023 . . . . 0.0 108.335 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.675 ' O ' HG23 ' A' ' 68' ' ' VAL . 98.7 m-85 -101.41 67.44 1.15 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -35.55 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 121.286 0.565 . . . . 0.0 110.574 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -43.47 -43.02 10.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.055 2.503 . . . . 0.0 113.279 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.961 -1.087 . . . . 0.0 109.355 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -67.21 -34.04 76.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.395 -0.816 . . . . 0.0 109.584 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' PHE . 95.8 t -61.38 -41.04 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.0 109.352 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.17 73.58 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.13 12.34 11.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.4 ttm -69.42 138.44 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.472 -0.767 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 32.4 tp60 -106.54 167.49 9.81 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 77.0 mm-40 -61.01 -33.6 73.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.896 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.96 -36.16 76.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 108.998 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -60.68 -38.71 85.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.29 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 ' NE2' ' A' ' 93' ' ' GLN . 86.2 t -59.83 -44.0 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -38.21 90.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -65.11 -45.57 84.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.94 -40.67 75.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.5 t -59.21 -36.51 63.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.156 -0.965 . . . . 0.0 108.493 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.82 -56.32 3.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.477 -0.765 . . . . 0.0 109.3 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.18 107.11 19.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.256 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.66 -57.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 109.662 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . 74.92 43.51 27.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.783 HG22 ' CG ' ' A' ' 55' ' ' ASN . 48.0 pt -122.28 165.44 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -1.015 . . . . 0.0 110.213 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 87' ' ' ARG . 13.3 tt -45.24 174.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.55 -0.718 . . . . 0.0 109.114 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 86' ' ' ILE . 61.9 mtp180 -51.21 146.67 6.37 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.412 ' CD2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -161.59 13.59 0.09 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.669 -1.27 . . . . 0.0 110.795 -178.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.671 ' CG ' HH11 ' A' ' 89' ' ' ARG . 2.3 mtt-85 -60.45 -64.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.649 -1.282 . . . . 0.0 108.96 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.86 51.13 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -61.05 -43.75 98.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.235 . . . . 0.0 109.734 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 76' ' ' VAL . 53.0 mt -54.66 -39.04 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.754 -1.217 . . . . 0.0 108.766 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.629 ' NE2' HG21 ' A' ' 76' ' ' VAL . 95.9 mm-40 -59.05 -35.99 74.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 108.711 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.11 80.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.37 -43.33 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.67 -44.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.063 -1.023 . . . . 0.0 109.246 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.94 96.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.3 -36.22 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -1.132 . . . . 0.0 109.716 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.82 98.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 109.822 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.27 -43.8 98.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.58 70.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.339 -0.851 . . . . 0.0 109.139 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 32' ' ' PHE . 68.9 t80 -59.8 -46.14 90.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 110.152 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.54 -43.58 84.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.221 -0.924 . . . . 0.0 109.921 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -64.37 -38.94 92.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -61.43 -38.33 86.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -0.96 . . . . 0.0 109.486 -179.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.85 -31.07 71.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.826 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.35 -32.43 49.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.206 -0.934 . . . . 0.0 108.834 -179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -76.33 -18.24 59.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.76 53.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -121.04 85.43 40.87 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.512 -0.993 . . . . 0.0 109.253 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.01 144.01 29.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.563 2.175 . . . . 0.0 112.45 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 71.8 m-85 -58.25 -41.8 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.12 -47.83 82.85 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.541 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.23 -41.83 98.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.616 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 78.8 t80 -63.83 -46.72 83.78 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.5 -44.17 95.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -56.96 -34.56 68.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.099 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -62.05 -38.92 90.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.66 -29.92 70.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 0.0 110.837 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 33.2 m -105.95 21.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 108.787 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.587 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 13.6 t-20 81.09 -52.24 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 1.7 t60 149.99 -18.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.35 147.61 38.61 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.631 -178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.32 154.99 36.78 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.737 2.292 . . . . 0.0 112.101 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -102.79 144.58 30.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.331 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.5 mtt -114.66 150.42 35.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -94.12 159.6 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.09 -1.007 . . . . 0.0 110.248 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -147.5 61.55 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -136.79 166.27 23.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.0 m -109.32 -23.95 11.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.034 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -124.4 153.03 42.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.769 . . . . 0.0 109.715 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.635 HD13 ' CE3' ' A' ' 6' ' ' TRP . 61.7 mt -61.15 -32.22 71.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.424 -0.797 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.8 m -60.32 -37.08 79.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.014 . . . . 0.0 109.987 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.617 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.0 mt-10 -65.77 -26.14 67.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 110.21 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 1.6 mp -67.56 129.61 93.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.035 -1.041 . . . . 0.0 109.521 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.84 135.98 20.14 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.135 1.89 . . . . 0.0 111.94 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -0.11 28.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -126.98 96.22 4.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 151.85 44.61 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.28 -31.16 92.55 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.224 1.949 . . . . 0.0 112.305 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.91 69.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.96 . . . . 0.0 110.008 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.7 p -64.42 -40.69 96.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.6 -46.47 75.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.66 -38.02 73.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.885 . . . . 0.0 109.863 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.9 tt -63.07 -47.8 81.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.193 -0.942 . . . . 0.0 109.739 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -55.99 -40.58 73.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.617 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -61.95 -36.45 81.46 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -52.11 46.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.9 mp -62.91 -34.44 77.43 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.996 -1.065 . . . . 0.0 109.489 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -58.61 -43.38 89.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.371 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -62.71 -35.41 79.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.079 -1.013 . . . . 0.0 109.252 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.616 ' NH2' ' CD2' ' A' ' 115' ' ' PHE . 98.0 mtt180 -63.85 -19.8 65.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 109.819 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.67 16.24 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.094 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -88.26 133.09 34.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.238 . . . . 0.0 109.367 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' HG13 ' A' ' 157' ' ' VAL . 11.9 mtpt -100.82 -172.42 2.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.532 -0.73 . . . . 0.0 109.982 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 18.3 p90 42.81 44.13 3.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.419 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 155' ' ' LYS . 19.4 m -112.03 24.3 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 109.487 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.56 159.55 0.04 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 41.4 m -54.76 -30.83 57.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.444 -1.033 . . . . 0.0 109.35 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.4 p -70.12 -39.92 75.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 109.849 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.27 -42.03 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 19.3 p -67.06 -48.41 68.38 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.143 -0.973 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 64.5 t80 -61.6 -42.3 98.67 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.093 -1.004 . . . . 0.0 109.318 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.5 m -60.57 -40.89 93.33 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.38 -40.78 95.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.937 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.12 -38.93 80.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.083 -1.01 . . . . 0.0 109.324 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.51 -42.27 78.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.535 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -71.69 -44.7 63.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.828 . . . . 0.0 110.798 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -28.82 69.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.36 59.45 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.86 -36.9 28.73 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.92 138.34 53.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -85.85 101.7 13.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.965 -1.084 . . . . 0.0 108.575 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -120.56 91.48 3.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.711 -0.618 . . . . 0.0 110.356 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.637 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 5.6 m170 -125.97 -93.33 0.49 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -175.21 140.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.49 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 29.1 m -53.04 128.47 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 109.116 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.7 32.76 36.16 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 181' ' ' CYS . 23.4 t -95.99 124.25 39.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.833 -1.392 . . . . 0.0 109.231 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 59.7 m 55.49 -77.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.699 -0.626 . . . . 0.0 109.805 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' CYS . 48.6 m -156.04 50.2 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.202 -0.936 . . . . 0.0 109.708 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 t80 -123.72 79.46 56.09 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.2 -8.17 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.884 2.389 . . . . 0.0 112.174 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.496 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 82.09 24.77 54.15 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.5 OUTLIER 44.2 40.85 3.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.62 -0.929 . . . . 0.0 109.516 -179.707 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -125.99 80.44 67.68 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--N 1.306 -1.708 0 C-N-CA 122.937 2.425 . . . . 0.0 112.319 -179.975 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -76.43 143.69 40.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.721 ' NH1' HD13 ' A' ' 14' ' ' ILE . 43.3 ttm180 -132.88 157.0 46.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.421 -0.8 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -35.29 126.82 0.59 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.488 0.661 . . . . 0.0 110.492 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.49 -30.55 77.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CZ2' ' OD2' ' A' ' 174' ' ' ASP . 16.3 m95 -47.83 -30.39 4.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.262 . . . . 0.0 109.118 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.8 t -56.33 138.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 10' ' ' ASP . 8.7 t -134.67 -172.55 3.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 tt0 -63.33 65.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.139 -0.975 . . . . 0.0 109.431 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 8' ' ' SER . 14.4 m-20 -159.42 88.61 2.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -52.46 -26.95 30.04 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.333 2.022 . . . . 0.0 112.154 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.4 tp -63.02 -37.08 85.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.052 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.93 -44.92 95.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD13 ' NH1' ' A' ' 3' ' ' ARG . 87.3 mt -57.96 -39.1 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.089 -1.007 . . . . 0.0 109.906 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.25 98.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.973 -1.079 . . . . 0.0 108.178 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.36 -38.38 84.68 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.541 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 2.8 t-80 -57.57 -50.21 73.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 109.778 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 88.5 m-20 -73.23 -41.6 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.299 -0.876 . . . . 0.0 110.792 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.81 -44.68 86.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.033 -1.042 . . . . 0.0 110.703 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 21' ' ' TRP . 95.5 mt-10 -154.24 -120.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 108.978 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.525 ' CZ3' ' CE1' ' A' ' 175' ' ' HIS . 26.4 t90 53.67 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.915 178.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.64 -6.79 57.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.73 130.81 33.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 108.518 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.29 127.54 22.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.516 1.477 . . . . 0.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.05 132.91 56.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.472 -0.768 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 p -108.59 3.99 23.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.414 -0.804 . . . . 0.0 109.294 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -80.68 116.04 20.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.7 p -61.21 -32.21 71.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.26 -41.17 96.45 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.78 -52.14 47.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.852 HD21 ' SG ' ' A' ' 169' ' ' CYS . 8.1 mp -63.6 -39.33 94.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.049 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -63.88 -52.95 57.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.64 -33.05 74.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 110.364 -179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.78 -46.52 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.06 -1.025 . . . . 0.0 110.63 -179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -62.52 -47.44 83.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 110.434 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.09 -42.2 80.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.778 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE1' ' OE1' ' A' ' 41' ' ' GLN . 71.2 mm-40 -65.87 -29.57 70.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 111.165 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.46 30.54 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.477 -1.344 . . . . 0.0 109.768 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 87' ' ' ARG . 10.6 mm100 -66.53 -30.29 70.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.16 . . . . 0.0 110.042 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.3 pt20 -46.8 -25.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.26 124.76 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.209 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.41 3.59 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 mt -105.75 155.97 18.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.691 -0.887 . . . . 0.0 109.767 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -83.79 148.26 27.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.002 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -58.34 -25.15 61.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.65 -41.41 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.687 -179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 94.9 m -67.18 -35.46 79.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.901 -1.124 . . . . 0.0 109.578 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.96 -36.27 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 0.0 110.957 -178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.63 -50.32 65.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.778 -1.201 . . . . 0.0 109.91 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.22 -45.35 94.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.986 -1.071 . . . . 0.0 108.952 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.38 -31.37 72.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.247 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -54.81 -42.83 72.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 108.633 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.78 -43.89 95.02 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.415 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.66 -37.29 87.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.019 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 73.6 t80 -59.16 -44.2 92.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.593 HH21 ' CD2' ' A' ' 61' ' ' HIS . 55.5 mtp180 -59.95 -37.3 79.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.87 -38.26 84.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.568 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -93.22 -24.7 18.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.054 . . . . 0.0 111.781 -178.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 76.5 m-85 -108.65 -28.87 9.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.797 -1.189 . . . . 0.0 112.139 -178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' CD2' HH21 ' A' ' 57' ' ' ARG . 65.4 t-80 -57.93 -42.36 84.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.635 -1.29 . . . . 0.0 109.556 -179.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.26 -36.67 84.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.4 m-85 -99.47 65.01 1.35 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.276 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -38.78 163.98 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -42.94 -39.85 8.04 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 123.1 2.534 . . . . 0.0 113.334 -179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.89 -39.11 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.568 -1.332 . . . . 0.0 109.295 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -73.26 -38.65 65.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 111.698 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 1.3 m -66.01 -45.61 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.488 -1.382 . . . . 0.0 110.418 -178.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . . . -64.4 -32.5 74.14 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.91 23.41 5.57 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.684 ' SD ' HD11 ' A' ' 96' ' ' ILE . 48.6 ttm -75.51 150.03 38.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.652 0.739 . . . . 0.0 110.526 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.45 156.34 19.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 60.4 mp0 -58.28 -32.07 68.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 0.0 109.47 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.91 -39.54 85.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.012 . . . . 0.0 109.226 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.42 -39.5 83.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 109.693 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 80' ' ' VAL . 76.3 t -63.01 -36.9 77.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.25 -42.58 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.38 -0.825 . . . . 0.0 110.371 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 78' ' ' ARG . 49.6 mtm-85 -65.73 -42.01 91.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.106 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 82' ' ' ASP . 84.9 mt -68.01 -34.51 76.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.996 -1.065 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' VAL . 48.2 t -56.95 -37.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 108.968 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -68.28 -51.41 45.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 108.873 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' LEU . 3.3 p-10 -100.37 115.67 30.54 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.7 -84.52 0.62 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.353 -0.842 . . . . 0.0 110.366 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.25 10.71 63.04 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 86' ' ' ILE . 28.0 pt -127.99 174.46 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.837 -0.802 . . . . 0.0 109.158 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.763 HG23 ' N ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.8 -145.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 109.75 -180.0 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.763 ' N ' HG23 ' A' ' 86' ' ' ILE . 60.8 mtp180 -52.32 151.19 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 90' ' ' GLY . 5.1 p80 -132.83 -171.3 2.64 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.422 ' H ' HD12 ' A' ' 92' ' ' ILE . 45.1 ttp180 54.94 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.95 . . . . 0.0 109.576 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.81 -47.06 92.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.75 -47.87 79.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.534 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 89' ' ' ARG . 74.1 mt -56.89 -45.77 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 110.492 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -59.49 -35.21 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 109.52 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 98' ' ' ASN . . . -64.71 -37.65 88.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.578 HG21 ' CE1' ' A' ' 60' ' ' PHE . 24.0 mm -62.25 -44.94 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.483 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.684 HD11 ' SD ' ' A' ' 71' ' ' MET . 71.3 mt -57.76 -45.78 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.44 -40.21 86.85 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.924 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 83.2 m-20 -60.8 -40.44 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.94 -1.329 . . . . 0.0 110.154 -178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -66.7 -37.81 85.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.22 -43.56 87.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.376 -0.828 . . . . 0.0 109.294 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -75.3 -43.33 51.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -61.13 -46.93 88.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 110.042 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -41.09 97.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -61.25 -40.19 93.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.426 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 23.9 ttt -62.89 -43.38 98.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.237 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -67.55 -30.68 70.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.865 . . . . 0.0 109.302 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.99 -28.0 21.82 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.362 -0.836 . . . . 0.0 108.811 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' OD1' ' OE1' ' A' ' 110' ' ' GLU . 22.5 t-20 -75.65 -16.5 60.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.809 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.28 10.39 62.32 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' OE1' ' OD1' ' A' ' 108' ' ' ASN . 0.7 OUTLIER -103.62 107.22 55.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.249 -1.148 . . . . 0.0 109.06 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.44 133.61 25.72 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.969 1.779 . . . . 0.0 112.37 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 29.1 t80 -61.59 -43.91 97.98 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.538 0.685 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.46 98.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.96 -37.6 71.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.048 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.408 -0.808 . . . . 0.0 109.031 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.61 -44.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.564 ' CH2' HD23 ' A' ' 171' ' ' LEU . 92.4 m95 -63.13 -31.79 73.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.625 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.1 p -60.52 -35.09 75.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.735 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.86 -34.42 77.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.959 -1.088 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.12 15.56 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.012 -1.055 . . . . 0.0 109.225 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.45 37.61 29.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.047 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.7 m80 48.5 37.64 9.4 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.37 -0.832 . . . . 0.0 109.369 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.16 91.58 47.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 109.64 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -51.37 148.84 18.43 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.205 1.937 . . . . 0.0 111.488 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.609 ' HB2' HG12 ' A' ' 172' ' ' VAL . 91.6 mt-30 -107.73 147.58 30.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.5 mmm -128.19 144.56 51.13 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.0 t -137.07 159.23 42.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -137.12 45.01 2.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.515 -0.741 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -63.38 146.44 53.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.876 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.5 m -68.89 -40.76 79.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -138.75 172.35 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.482 -0.761 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 135' ' ' ILE . 34.8 mt -61.44 -33.45 73.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 t -57.78 -41.16 81.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.46 -179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.695 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.1 mm-40 -64.77 -30.18 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 109.725 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 132' ' ' LEU . 97.2 mt -73.35 123.04 89.07 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.72 139.28 17.69 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.116 1.877 . . . . 0.0 111.409 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -1.03 55.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.089 -1.007 . . . . 0.0 109.16 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 m -125.55 94.8 4.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -101.46 152.27 37.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.199 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -50.13 -36.97 47.31 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.01 1.807 . . . . 0.0 112.514 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.93 66.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.272 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.5 p -62.2 -41.34 98.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.018 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.49 -43.67 89.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.852 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.58 85.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.176 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 149' ' ' LEU . 6.5 tt -60.98 -46.25 91.49 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.184 -0.948 . . . . 0.0 110.132 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.4 t -58.32 -41.58 84.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.084 -1.01 . . . . 0.0 109.411 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -63.2 -36.48 83.79 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.43 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.82 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.849 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -63.52 -34.53 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.997 . . . . 0.0 109.115 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -58.31 -42.77 87.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.36 -34.3 76.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.182 -0.949 . . . . 0.0 109.319 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -63.82 -20.19 65.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.298 -0.877 . . . . 0.0 109.275 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 101.59 24.51 8.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.474 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.4 m-85 -89.65 137.19 32.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.01 162.6 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 66.51 49.38 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.277 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 158' ' ' GLY . 24.0 m -119.7 24.92 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.8 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.24 151.48 0.4 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.9 m -53.73 -31.45 48.32 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 m -66.46 -46.04 77.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 HE21 ' A' ' 41' ' ' GLN . 13.8 mt -63.74 -39.46 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.299 -0.876 . . . . 0.0 109.674 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -45.22 92.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -60.72 -46.29 90.97 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 t -61.44 -40.45 94.53 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 108.886 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -42.55 99.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.6 -0.688 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 83.9 mtp -60.85 -38.09 84.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.623 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.3 -42.44 95.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.157 -0.964 . . . . 0.0 109.703 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.3 66.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.379 -0.826 . . . . 0.0 110.023 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.852 ' SG ' HD21 ' A' ' 31' ' ' LEU . 42.4 t -60.44 -36.43 78.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.39 4.76 57.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD23 ' CH2' ' A' ' 117' ' ' TRP . 79.4 mt -55.95 -35.99 67.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.097 -1.237 . . . . 0.0 108.662 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.609 HG12 ' HB2' ' A' ' 125' ' ' GLN . 18.8 m -126.22 148.3 30.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 127' ' ' THR . 13.5 m-80 -105.07 103.1 12.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.868 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CZ2' ' A' ' 6' ' ' TRP . 7.4 p-10 -119.15 91.64 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 109.754 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.525 ' CE1' ' CZ3' ' A' ' 21' ' ' TRP . 8.7 m170 -118.31 -93.29 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.884 HG13 ' H ' ' A' ' 178' ' ' GLY . 0.4 OUTLIER -175.6 134.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.261 -0.9 . . . . 0.0 108.883 178.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.01 -11.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.884 ' H ' HG13 ' A' ' 176' ' ' VAL . . . -115.87 29.93 6.88 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.58 133.12 44.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.9 -1.353 . . . . 0.0 109.366 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 61.4 m -54.72 -38.68 67.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 0.0 109.185 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -41.08 99.09 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.203 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 83.7 t80 -124.22 81.51 57.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.383 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 185' ' ' ASN . 32.5 Cg_exo -53.78 -40.7 79.08 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.536 2.158 . . . . 0.0 112.007 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.49 -14.18 2.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 183' ' ' PRO . 11.4 p30 -159.54 21.56 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.974 -1.31 . . . . 0.0 109.893 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.09 83.82 9.96 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.567 2.178 . . . . 0.0 112.249 -179.83 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_